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Summary
1. The majority of the work in this thesis was concerned with 
investigating whether or not the enzymes of the mandelate pathway in 
Acinetobacter calcoaceticus exist as an enzyme complex. The possible 
physiological importance of metabolic compartmentation by 'soluble' enzyme 
interactions in both prokaryotes and eukaryotes is discussed and some 
examples of such interactions are illustrated in the Introduction.
2. A gentle method for disrupting A. calcoaceticus after lysozyme 
treatment was developed. The outer and inner membranes of A.calcoaceticus 
were separated by centrifugation and their purity was assessed by enzyme 
distribution studies, measurement of KDO, SDS PAGE and electron microscopy. 
The lactate and mandelate dehydrogenases were found in the inner membrane.
3. A method for the purification of L-mandelate dehydrogenase was 
developed. This involved Triton X-100 extraction from a 'wall + membrane' 
fraction, ion exchange chromatography on DEAE-Sephacel, (NH^^SO^ 
fractionation, gel filtration chromatography on Ultrogel AcA 34 followed 
by a second ion exchange on DEAE-Sephacel. L-Mandelate dehydrogenase was 
purified almost to homogeneity as determined by SDS PAGE.
4. Antibodies were raised against the denatured enzyme by cutting the 
protein-stained band.from an SDS polyacrylamide gel. Although the 
antibodies had no effect on enzyme activity, a positive band corresponding 
to L-mandelate dehydrogenase was detected on immunoblotting bacterial 
extracts containing L-mandelate dehydrogenase activity. No such band was 
observed on imnunoblotting extracts from mutants with no detectable 
L-mandelate dehydrogenase activity (C1123 and C1408).
5. Some properties of the purified L-mandelate dehydrogenase were 
determined to allow a comparison with those of the purified D-mandelate 
dehydrogenase and lactate dehydrogenases from A.calcoaceticus and the 
lactate dehydrogenases from other bacteria. L-Mandelate dehydrogenase 
was found to be a monomer with an Mr of 44,000, pH optimum of 7.5 and
K for L-mandelate of 186pM. L-Mandelate dehydrogenase was shown to be 
completely stereospecific for its substrate and neither D nor L-lactate 
acted as a substrate. L-Mandelate dehydrogenase was inhibited by 
D-mandelate but only at high concentrations (> lOmM). L-Mandelate 
dehydrogenase was unaffected by metal chelating reagents but was sensitive 
to reagents which react with sulphydryl groups such as mercuric chloride 
and £-chloromercuribenzoate. FMN was identified as the non-covalently 
bound cofactor of L-mandelate dehydrogenase on the basis of the 
fluorescence of the acid extractable material.
6. Problems were encountered with the aldehyde dehydrogenase-linked 
phenylglyoxylate decarboxylase assay when there were high amounts of 
NADH oxidase activity present in the sample and so a method was developed 
linking phenylglyoxylate decarboxylase activity to alcohol dehydrogenase 
activity. This method proved accurate and reliable and it was possible 
to correct for NADH oxidase activity in the sample by including a minus 
substrate (phenylglyoxylate) control.
7. Several methods were used to study possible enzyme interactions in 
the mandelate pathway of A.calcoaceticus.
a) Extracts prepared after disrupting bacteria by j sonication or French 
pressing or after lysozyme treatment were studied by ultracentrifugation. 
As well as the mandelate enzymes, the control enzymes, catechol-1,2- 
dioxygenase (a low M 'soluble' enzyme from a related part of metabolism), 
isocitrate dehydrogenase (a low 'soluble' enzyme from an unrelated 
part of metabolism) and glutamine synthetase (a 'soluble' enzyme from an 
unrelated part of metabolism with a high Mr = 600,000) were assayed in 
these experiments. Phenylglyoxylate decarboxylase has previously been 
believed to be a 'soluble' enzyme, however, the amount of phenylglyoxylate 
decarboxylase recovered in the high speed ' pellet! (where most of the 
L-mandelate dehydrogenase activity was located) varied (5-55%) with the
disruption method whereas more or less the same amount of glutamine 
synthetase (30-40%) sedimented irrespective of the method of disruption.
XVlll.
It was concluded that the high proportion of phenylglyoxylate 
decarboxylase recovered in the membrane fraction after bacteria had been 
disrupted by two passages through the French press was not simply a 
consequence of the Mr (230,000) of this enzyme. Homogenates prepared 
by disrupting bacteria by twD passages through the French press were 
used to further investigate the association of phenylglyoxylate 
decarboxylase with the membrane fraction.
b) The amount of phenylglyoxylate decarboxylase recovered in the pellet 
varied with the protein concentration of the homogenate. At high protein 
concentrations (60mg ml ^)} 92% phenylglyoxylate decarboxylase was recovered 
in the pellet whereas at low protein concentrations (3mg ml )^ only 22% 
phenylglyoxylate decarboxylase was recovered in this fraction. The 
amount of the control 'soluble' enzymes recovered in the pellet also 
varied with the protein concentration of the homogenate but there was 
always substantially more phenylglyoxylate decarboxylase than the other 
'soluble' enzymes in this fraction. That so much phenylglyoxylate 
decarboxylase could be recovered in the high speed pellet was taken to 
indicate the possibility of a specific association of phenylglyoxylate 
decarboxylase with the membrane.
c) Particular care was taken in the choice of disruption buffers.
However, attempts to remove the non-specifically bound control 'soluble' 
enzymes from the membrane fraction while leaving PGDC associated were 
unsuccessful.
d) Homogenates prepared by French press treatment were studied by gel 
filtration chromatography and density gradient centrifugation. However, 
no evidence for the co-purification of L-mandelate dehydrogenase and 
phenylglyoxylate decarboxylase was obtained even in the presence of high 
protein concentrations.
e) No evidence of co-immunoprecipitation of the enzymes by anti- 
D-mandelate dehydrogenase, anti-L-mandelate dehydrogenase or anti- 
phenylglyoxylate decarboxylase was obtained.
f) The in vivo crosslinking experiments with dimethylsuberimidate 
(which crosslinks lysine residues) on Pseudomonas putida reported by 
Halpin et al. (1981) were repeated and expanded. Control and cross linked 
extracts were analysed by ultracentrifugation and gel filtration 
chromatography but in contrast to the conclusions made by these authors, 
it was clear that only non-specific cross linking was occurring.
g) No specific crosslinking was observed in similar experiments on 
A.calcoaceticus even when the bacteria were suppliedwithsubstrates and 
cofactors for the mandelate enzymes.
h) It is generally thought that a high pH (>y 8.0) is required for 
dimethylimidate crosslinking activity. However, since phenylglyoxylate 
decarboxylase dissociates at pH8.0, a method for cross linking both intact 
bacteria and homogenates with these reagents at pH7.5 was developed.
i) Control and crosslinked extracts were analysed by immunoblotting 
with anti-D-mandelate dehydrogenase, anti-L-mandelate dehydrogenase and 
anti-phenylglyoxylate decarboxylase. Although there was evidence for 
the formation of high Mr species, there was no evidence for specific 
crosslinking of phenylglyoxylate decarboxylase to either of the 
mandelate dehydrogenases.
j) No specific crosslinking with phenylene dimaleimide (which crosslinks
sulphydryl groups) was obtained when either intact bacteria or homogenates 
prepared by French press treatment were treated with phenylene dimaleimide.
8. The difficulties relating to the possible lability of enzyme
interactions and the inadequacy of the techniques available for studying 
such interactions, as well as possible future experiments, are discussed in 
the final chapter of the thesis.
CHAPTER 1 INTRODUCTION
1.1 Acinetobacter calcoaceticus
Until recently the genus Acinetobacter was generally considered 
to comprise the single species calcoaceticus which was divided into 
four biotypes: anitratus, haemolyticus, alcaligenes and lwoffii
(Vivian et al., 1981). However, Bouvet SeGrimont (1986) have 
proposed that the genus Acinetobacter be divided into six species: 
calcoaceticus, lwoffii, haemolyticus, baumannii, junii and johnsonii.
All acinetobacters are aerobic, gram-negative, non-motile 
(although ’twitching' has been demonstrated in some strains), catalase- 
positive and oxidase-negative, with a G+C content of 38-47 mole % 
(Henriksen, 1976). Most strains have an optimum growth temperature 
of 34-35°C (Breuil et al., 1975).
Probably as a result of their nutritional versatility, 
acinetobacters have a wide distribution in nature and have been 
isolated from soil, water and sewage (Baumann 1968; Warskow & Juni, 1972 
. Henriksen, 1973). Acinetobacters have also been found to reside in or 
on many parts of the human body, possibly as a result of contamination 
from the surroundings or as a consequence of the fact that these 
bacteria have an optimum growth temperature around 35°C (Juni, 1972; 
Henriksen, 1973; Gaughan et al., 1979). Presumably because of their 
hydrocarbon degrading properties, acinetobacters have also been found 
associated with oil pollution in aquatic environments and industrial 
effluents (Gutnick Rosenberg, 1977; Bartha & Atlas, 1977). Indeed,
A.calcoaceticus is of industrial importance since it can produce an 
extracellular polyanionic emulsifier called 'emulsan' (Rubinovitz 
et al., 1982).
Recently, Acinetobacter has received increasing attention because 
of its apparent pathogenic properties. It has been associated with a 
variety of infections such as septicaemia and urinary tract infections 
(Glew et al., 1977; Retailliau et al., 1979; Lowes et al., 1980;
Hoffman et al., 1982), endocarditis (Henriksen, 1973; Cohen et al., 
1980; Rao et al., 1980), meningitis (Ghoneim Se Halaka, 1980; Berk 
& McCabe, 1981; Kabayashi et al., 1983), pneumonia (Glew et al.,
1977; Rudin et al., 1979; Holton Se Shorvon, 1982; Markham Se 
Te1for-Brunton, 1983), repiratory tract infections (O'Connell &
Hamilton, 1 9 8 1 ) , skin and wound infections (Glew et al., 1977) and 
peritonitis (Roxe Se Santhanam, 198 3 ; Larson, 1 9 8 4 ) . However, some 
evidence suggests that Acinetobacter is merely an opportunistic bacteria 
and its pathogenicity may be overestimated (Juni, 1 9 7 2 ; Markham Se 
Telfor-Brunton, 1 9 8 3 ).
Acinetobacters are often resistant to many antibiotics (French 
et al., 1980; Markham 8c Telfor-Brunton, 1983; Holton Sc Shorvon, 1983) 
and in some cases this has been shown to be due to transferable plasmids 
(Hinchliffe Se Vivian, 1980a; Devaud et al., 1982; Goldstein et al., 
1983). This genus is relatively resistant to ionising radiation 
(Kairiyama et al., 1979) which is sometimes used in food preservation 
and as a result, acinetobacters have been associated with food spoilage 
(Ito et al., 1976; Firstenberg-Eden et al., 1980).
The wide nutritional versatility, frequency of occurrence and 
possible clinical importance of acinetobacters has stimulated research 
in the development of systems of genetic transformation (Juni, 1978; 
Ahlquist et al., 1980), transduction (Herman Sc Juni, 1974; Juni, 1978) 
and conjugation using plasmids (Towner Sc Vivian, 1976a,b; Towner, 1978; 
Hinchliffe Se Vivian, 1980a,b,c). In addition, a circular linkage map 
has been established using plasmid RP4 mediated chromosome transfer 
(Towner Se Vivian, 1976b; Towner, 1978) and the discovery of the 
involvement of transposition in this event should prove useful in 
improving this technique (Towner, 1983).
3.
Strain NCIB 8250 has been classified as a strain of Acinetobacter 
calcoaceticus (Fewson, 1967a,b; Baumann et al., 1968). This organism, 
which grows at an optimal temperature of 30°C (Fewson, 1967b), is unable 
to metabolise carbohydrates (Cook & Fewson, 1973) but can utilise a wide 
variety of organic compounds, including many aromatics, as sole source 
of carbon and energy (Fewson, 1967b).
1.2 The mandelate pathway and its regulation in A.calcoaceticus
Mandelic acid is an aromatic acid of plant origin (Stanier, 1948) 
and both D(-) and L(+) isomers occur in nature. Mandelic acid is also 
found in the urine of industrial workers exposed to styrene (Ohtsuji Sc 
Ikeda, 1970; Elia et al., 1980). Several organisms can use mandelate 
as sole source of carbon and energy; these include bacteria of the genera 
Pseudomonas (Stainer et al., 1966) and Acinetobacter (Baumann et al., 
1968); the fungi Aspergillus niger (Jamaluddin et al., 1970) and 
Neurospora crassa (Ramakrishna Rao Sc Vaidyananathan, 1977) and the yeast 
Rhodotorula graminis (Durham, 1984).
The pathway for the catabolism of mandelate in A .calcoaceticus is 
illustrated in Figure 1. Using the technique of simultaneous adaptation 
(Stanier, 1947), Kennedy Sc Fewson (1968a) showed that in A.calcoaceticus 
wild type NCIB 8250, L-mandelate was oxidised to catechol via 
phenylglyoxylate (benzoyl-formate), benzaldehyde and benzoate. Benzyl 
alcohol was converted to catechol in a convergent pathway via 
benzaldehyde. Growth on mandelate or phenylglyoxylate resulted in the 
appearance of L(+)-mandelate dehydrogenase (LMDH), phenylglyoxylate 
decarboxylase (PGDC), benzyl alcohol dehydrogenase (BADH) and a heat- 
stable as well as a heat-labile benzaldehyde dehydrogenase (BDH I and II 
respectively) activities (Kennedy Sc Fewson, 1968b). BADH and the heat- 
labile BDH were found in extracts of bacteria grown on benzyl alcohol 
or benzaldehyde.
The mandelate pathway in A. calcoaceticus can be divided into three 
separate regulatory units (Figure 1): regulon 1 (Rl) comprises LMDH,
PGDC and BDH I; regulon 2 (R 2) comprises BADH and BDH II; benzoate 
oxygenase and cyclohexadienediol carboxylate dehydrogenase constitute 
regulon 3 (R 3) (Livingstone Sc Fewson, 1 9 7 2 ) . The term 'regulon' relates 
to a group of genes controlling related functions and regulated together
Figure 1 Metabolism of mandelate and benzylalcohol in A.calcoaceticus
Regulon 1
Regulon 2
Regulon 3
: L(+)-mandelate dehydrogenase (1)
D(-)-mandelate dehydrogenase (2) 
phenylglyoxylate decarboxylase (3) 
benzaldehyde dehydrogenase I (5)
: benzylalcohol dehydrogenase (4)
benzaldehyde dehydrogenase II (6)
: benzoate oxygenase (7)
cyclohexadienediol carboxylase dehydrogenase (8)
'Catechol pathway' enzymes = catechol-1,2-dioxygenase (9)
(+)-muconate lactonising enzyme (10)
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by an inducer or repressor (Maas & Clark, 1964).
IMDH, PGDC and BDH I are coordinately synthesised and are referred 
to as the 'mandelate enzymes' or R1 enzymes (Livingstone Sc Fewson, 1 9 7 2 ) . 
Phenylglyoxylate, the product of the first enzyme of the pathway (Figure 
1 ) is the primary inducer of R1 and the mandelate enzymes are specifically 
and gratuitously induced by thiophenoxyacetate (Livingstone Sc Fewson,
1972). 2-Phenylpropionate is a competitive inhibitor of induction and 
was used for the isolation of constitutive mutants (Fewson et al., 1978).
THIOPHENOXYACETATE 2-PHENYLPROPIONATE
C H,
a I -*
COOH CH “ C O O H
A.calcoaceticus, wild type NCIB 8250, has a dehydrogenase specific 
for L-mandelate and can therefore grow on the L isomer of mandelate but not 
on D-mandelate (Kennedy Sc Fewson, 1968a,b). However,mutants have been 
isolated which can grow on D-mandelate (Fewson et al., 1976; Hills Sc 
Fewson, 1983a). These mutants contain a novel D(-)-mandelate 
dehydrogenase (DMDH) in addition to the original LMDH (Hills Sc Fewson, 
1983a). A second wild type strain, EBF 65/65, shows the opposite 
pattern in that it can grown on D-mandelate but not on L-mandelate and 
mutants have been isolated from this strain which possess an LMDH as well 
as the original IMDH and can therefore grow on L-mandelate (Hills Sc 
Fewson, 1983a). It was shown that the novel enzymes were coordinately 
controlled with the pre-existing enzymes, i.e. they form part of R1 
(Hills Sc Fewson, 1983b).
The mandelate enzymes are repressed in the presence of benzoate, 
catechol and succinate. The latter two compounds also inhibited these 
enzymes but there is no evidence for feedback inhibition by the other 
intermediates of the pathway (Cook et al., 1975).
The mandelate pathway converges with the oxidation of benzyl alcohol 
at the level of benzaldehyde (Cook et al., 1975). The ability of both
benzaldehyde and benzyl alcohol to induce R2 is in contrast with the 
specificity of phenylglyoxylate as the inducer of the enzymes of the 
mandelate pathway.
The further metabolism of benzoate to catechol (Figure 1) involves 
the enzymes benzoate oxygenase and cyclohexadienediol carboxylate 
dehydrogenase which are often referred to as ’benzoate oxidase'
(Reiner, 1971; Reiner Sc Hegeman, 1971; Reiner, 1972). In NCIB 8250, 
catechol is converted via cis,cis-muconate and (+)-muconolactone to 
succinate and acetyl CoA (Figure 1) by the catechol branch of the 
p-ketoadipate pathway (Kennedy Sc Fewson, 1968b).
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1.3 Properties of the mandelate enzymes in A.calcoaceticus
Both LMDH and DMDH have been designated ’membrane-bound' (Hills & 
Fewson, 1983a) although it is not known whether they are outer or inner 
membrane enzymes. Experiments with crude extracts showed that LMDH 
and DMDH are NAD(P) independent, show absolute stereospecificity for 
their substrates and are inhibited by the opposite isomer (Hills St 
Fewson, 1983a). Both enzymes have similar dependence on temperature 
and pH and are inhibited by oxalate but not by several metal chelating 
agents. DMDH is much more susceptible to inhibition by HgC^ and 
£-chloromercuribenzoate and is much more heat-labile than LMDH 
(Hills & Fewson, 1983a).
In addition to the stereospecific mandelate dehydrogenases, a pair 
of stereospecific lactate dehydrogenases can be coordinately induced in 
A.calcoaceticus by either D(-) or L(+)-lactate (Fewson Si 0 'Donnell,1981; 
Allison et al., 1985a). All four dehydrogenases, although separable, 
have been found to be very similar to each other (Fewson St O'Donnell,
1981) e.g. all are membrane-bound and NAD(P) independent. Furthermore, 
D-lactate dehydrogenase (DLDH) and DMDH are strikingly similar, as are 
L-lactate dehydrogenase (LLDH) and LMDH (Fewson St O'Donnell, 1981; 
Allison et al., 1985a). This is illustrated by the heat-lability and 
sensitivity to inhibition by £-chloromercuribenzoate. The 
enzymes specific for the D enantiomer of lactate and mandelate are also 
more easily solubilised from membranes (Fewson Si O'Donnell, 1981;
Allison et al., 1985a).
None of the dehydrogenases was significantly solubilised by methods 
commonly used for the removal of peripheral proteins (Allison et al., 
1985a). However, all four enzymes were solubilised by detergents, 
especially Triton X-100 and Lubrol PX. The similarities between the 
enzymes specific for the D enantiomers of mandelate and lactate was
again shown by the selective solubilisation of these two enzymes by the
ionic.detergents cholate, deoxycholate and sodium dodecyl sulphate 
(Allison et al., 1985b). This treatment left LLDH and LMDH associated 
with the membranes and still in an active form. However, attempts to 
solubilise these enzymes with Triton X-100 after cholate extraction 
proved unsuccessful. Allison et al. (1985a,b) described the optimal 
conditions for the solubilisation of the four enzyme activities. The 
detergent: protein ratio was especially important since the enzymes were
not released if not enough detergent was added and the enzymes were 
inactivated if too much detergent was added. Maximal solubilisation of 
DMDH and DLDH from a 'wall + membrane’ fraction was achieved with 1.5mg 
cholate/mg protein and 0.5mg Triton X-100/mg protein was the optimal 
detergent concentration for solubilising LMDH and LLDH (Allison et al., 
1985b).
The four enzyme activities have been separated by DEAE-Sephacel 
ion exchange chromatography (Fewson & O'Donnell, 1981; Allison et al., 
1985b) and a purification scheme for DMDH and DLDH has been developed 
(Allison et al.,1985b). This purification involved cholate extraction 
from a 'wall + membrane' fraction, (NH^SO^ fractionation, gel filtration 
and ion exchange chromatography and chromatofocus ing. DLDH and DMDH were 
co-eluted from the Ultrogel AcA 34 gel filtration column (apparent Mr = 
130,000). Ion exchange chromatography of the pooled fractions from gel 
filtration separated the two enzymes, with DLDH eluting at a lower 
phosphate concentration (70-80mM) than DMDH (100-llOmM). The final 
purification of the two enzymes was achieved by chromatofocus ing.
The properties of the purified DMDH and DLDH were shown to be very- 
similar (Allison et al., 1985b). The apparent M^ of DLDH was 62,800 
whereas that of DMDH was 59,700. Both enzymes gave similar responses 
to pH and were sensitive to £-chloromercuribenzoate but metal chelating 
agents did not affect either activity. In addition, both enzymes were 
shown to contain non-covalently bound FAD as cofactor (Allison et al.,
1985b).
The second enzyme of the mandelate pathway is PGDC (Figure 1).
This enzyme catalyses the thiamin pyrophosphate (TPP) dependent, 
non-oxidative decarboxylation of phenylglyoxylate to benzaldehyde and 
remains in the soluble fraction obtained after differential 
centrifugation of bacterial extracts prepared by ultrasonic treatment 
(Kennedy 8c Fewson, 1968b). PGDC is an allosteric enzyme which 
exhibits negative cooperativity towards the coenzyme and ADP 
(Jamaluddin 8c Fewson, 1973). PGDC has been purified to homogeneity 
(Barrowman 8e Fewson, 1985) and is a tetrameric enzyme with an apparent 
subunit Mr of 58,000.
BADH, BDH I and BDH II are NAD+ dependent and all are 'soluble' 
enzymes (Kennedy 8e Fewson, 1968b). Experiments with crude extracts 
showed that BDH I and BDH II were shown to be sensitive to 
£-chloromercuribenzoate and N-ethylmaleimide and optimal activities 
were achieved at pH9.0-9.5 (Livingstone et al., 1972). BADH and BDH II 
have been purified to homogeneity and both are tetrameric enzymes with 
subunit Mr values of 39,700 and 55,000 respectively (Mackintosh, 1986; 
Mackintosh Sc Fewson, 1986). A purification scheme is currently being 
developed for BDH I which is also tetrameric with a subunit M^ of 
55,000 (personal communication, R.M. Chalmers).
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1.4 Mandelate metabolism in Pseudomonas putida
P.putida strain NCIB 9494, previously referred to as P.fluorescens 
A.3.12, has been shown to metabolise L-mandelate through the same 
sequence of metabolic intermediates as A.calcoaceticus (Gunsalus et al., 
1953a,b; Hegeman, 1966a,b,c; Omston & Stanier, 1966; Canovas et al., 
1967). In addition, P.putida, strain NCIB 9494, converts D-mandelate 
to L-mandelate by means of a racemase (Gunsalus et al., 1953a.b;
Hegeman et al., 1970; Hegeman & Kenyon, 1970; Maggio et al., 1975; 
Whitman et al., 1982), although Hegeman et al. (1970) have described 
another strain of P.putida which has a DMDH but has no racemase. As 
in A.calcoaceticus the LMDH of P.putida is membrane-bound (Gunsalus et 
al., 1953a,b) ; however, this enzyme has not been solubilised or purified.
P.putida synthesises three benzaldehyde dehydrogenases : one is
NAD+-linked, one is NADP+-linked (Gunsalus et al., 1953a,b) and the third 
is synthesised during growth on benzaldehyde (Stevenson & Mandelstam, 
1965). Metabolism of benzyl alcohol also seems to be via dehydrogenation 
to benzaldehyde as in A.calcoaceticus (Hegeman, 1966a) however, P.putida 
oxidises benzyl alcohol slowly by non-specific alcohol and aldehyde 
dehydrogenases which do not normally function in mandelate metabolism 
(Colins & Hegeman, 1984).
The mandelate pathway in P.putida is controlled by induction and 
repression as in A.calcoaceticus. However, R1 is non-specifically 
induced by either L-mandelate, D-mandelate or phenylglyoxylate (Stanier 
et al., 1964; Hegeman, 1966a,b,c; Higgins & Mandelstam, 1972). 
Repression is by benzoate, catechol and succinate (Mandelstam & Jacoby, 
1965; Stevenson & Mandelstam, 1965); since the repression mechanism can 
be activated independently by any one of these repressors, it was called 
a 'multisensitive repression mechanism'.
1.5 Enzyme Interactions
1.5.1 Metabolic compartmentation in prokaryotes and eukaryotes
Prokaryotes (cells without distinct nuclei) differ from eukaryotes 
(cells with nuclei separated from the cytoplasm by a membrane) in many 
respects but one striking difference is in the level of subcellular 
organisation. Eukaryotes contain subcellular organelles e.g. 
mitochondria and/or chloroplasts which effectively segregate enzymes 
and metabolites within the cell and the importance of this 
compartmentation in the regulation of cellular processes is well 
established (Srere8cEstabrook, 1978; Nover et al, 1980; Friedrich,
1984, 1985). Further compartmentation is also achieved in the eukaryotic 
cytoplasm by the presence of ^ multifunctional proteins e.g. the arom 
complex and fatty acid synthetase (Kirschner ScBisswanger 1976) and by 
the presence of stable multienzyme complexes e.g. pyruvate dehydrogenase, 
oc-ketoglutarate dehydrogenase and tryptophan synthase (Welch, 1977; 
Hammes, 1981). Although intracytoplasmic membranes have been observed 
in bacteria (Cota-Robles, 1966; Weigand et al., 1973; Kennedy 8c 
Finnerty, 1975) there are no subcellular organelles present and 
consequently bacteria lack the metabolic compartmentation such organelles 
confer on cells.
The degree of organisation of the prokaryotic cytoplasm is unknown 
but multifunctional proteins (Kirschner Se Bisswanger, 1976) and stable 
multienzyme complexes similar to those of eukaryotic systems have been 
isolated from bacteria e.g. pyruvate dehydrogenase from E.coli (Reed 8c 
Cox, 1970) and from Bacillus stearothermophilus (Packman Se Perham, 1982) 
and tryptophan synthase from E.coli (Miles, 1979). The enzymes of 
fatty acid synthesis are usually found as individual activities in 
bacteria but a single polypeptide chain with complete fatty acid synthesis 
activity has been isolated from Mycobacterium smegmatis (Wood et al., 
1978). The fatty acid oxidising (degradative) enzymes have been
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isolated as a stable five enzyme cluster from E.coli and other bacteria 
(Ottaway & Mowbray, 1 9 7 7 ).
There is also the possibility that metabolic compartmentation 
could be achieved in prokaryotes, and in eukaryotes, by the association 
of apparently 'soluble' sequential enzymes of a metabolic pathway in 
the form of transient enzyme complexes (Srere 8c Mosbach, 1 9 7 4 ; Friedrich, 
1984 , 1 9 8 5 ) . Friedrich (1 9 8 4 ) has outlined a model for 'dynamic 
compartmentation' involving such transient enzyme-enzyme complexes. In 
this model, consecutive enzymes may accomplish direct metabolite transfer 
(channeling) even if the complexes are very loose and the rate constants 
for both association and dissociation are high. The non-random 
distribution of enzymes in macrocompartments would favour collisions 
between functionally adjacent enzymes and hence augment the compartmenting 
effect. The flexibility of association of 'soluble' enzymes to meet the 
changing requirements of the cytoplasm could theoretically have greater 
advantage to the cell than other kinds of spatial compartmentation.
There is also the possibility that 'soluble' sequential enzymes associate 
weakly but not necessarily transiently.
1 .5 .2  Advantages of enzyme complexes
The organisation of enzymes which catalyse sequential reactions in 
stable or transient complexes could confer several advantages on the cell
Enhancement of catalytic activity could be brought about as a result 
of stabilisation of the active conformational state of each component 
enzyme. This is illustrated by tryptophan synthase of E.coli which 
consists of two polypeptide chains and the enzyme complex has the 
structure of c^/^* Separately the oC and ft subunits have distinct 
activities :
(Welch, 197 7 ; Hammes, 19 8 1 ; Friedrich, 1 9 8 4 ) .
a) Enhancement of catalytic activity
Indole 3-glycerol phosphate 
Indole + L-serine
> indole + D-glyceraldehyde 3-phosphate
> tryptophan
However, the overall activity of the complex (oc2^2^ ^0-100 fold
greater than the individual subunits (Creighton, 1970; Ginsberg &
Stadtman, 1970). Furthermore, mutants have been isolated with inactive 
oC and subunits in that they cannot catalyse their respective reactions 
but they have been shown to activate the complementary subunit, which 
suggests that a conformational change is induced (Yanofsky Sc Crawford, 1972; 
Miles, 1979).
Tryptophan synthase is one of the few good examples of complexes 
which show enhanced catalytic activity. The presence of unforeseen 
enzyme effectors in a multicomponent reaction could complicate the 
interpretation of experiments designed to illustrate enhanced catalytic 
activity due to enzyme-complex formation. Therefore, experiments which 
purport to demonstrate that the rate of a multistep sequence of reactions 
proceeds more rapidly than would be expected on the basis of the summation 
of the individual enzyme-catalysed reaction velocities should be regarded 
with some caution. Ottaway (1985) reinforced this need for scepticism 
when in a computer simulation he was unable to show a change in flux 
through a coupled enzyme system. This study involved a comparison 
of the reaction velocities of malate dehydrogenase and citrate synthase 
free in solution with that of the enzyme pair packed closely together in 
a particle and of the enzymes immobilised on an inert matrix (Ottaway,
1984, 1985).
b) Substrate channeling
The slow dissociation of an intermediate produced by one enzyme in 
a sequence could provide a high steady state concentration for the next 
enzyme and by keeping an intermediate in a limited environment, competition 
with other pathways could be minimised. Tryptophan synthase again provides 
a good example of this; indole, the product of the oc subunit reaction, 
cannot be detected as a free intermediate of the tryptophan synthase 
complex (Matchett, 1973).
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Evidence for substrate channeling in general, however, has been 
difficult to achieve; indeed Coggins & Boocock (1986) have been unable 
to find any direct evidence of substrate channeling in the arom complex 
of N.crassa from measurements of steady state levels of several 
intermediates. Indirect evidence for channeling in other systems 
comes from in vivo isotope tracer experiments (see 1.5.5.3; Shipley & 
Clark, 1972; Bhargava, 1985) but these are often limited by the 
resolution of the techniques used to detect labelled intermediates and 
by a limited knowledge of the effectors controlling a particular pathway. 
Futhermore, exogenously applied intermediary metabolites may be 
inaccessible to enzyme sites because of permeability barriers or they may 
be metabolised before they come in contact with the enzyme system under 
study.
c) Unstable or toxic intermediates
A suitable environment could be provided for unstable intermediates 
thereby protecting them from uncontrolled non-enzymic reactions e.g. 
decarboxylation, hydrolysis, hydration or oxidation. Furthermore, 
localisation of toxic intermediates would minimise their detrimental 
effects on the cell.
d) Decrease in transit and in transient time
The transit time is the time required for a metabolite to reach 
the next enzyme in a pathway and the transient time is the parameter 
which characterises the speed of attaining a (new) steady state (Welch, 
1977; Gaertner, 1978). The presence of enzyme complexes could decrease 
both the transit and the transient time as a result of direct metabolite 
transfer from one enzyme to another. This implies that the diffusion 
of an intermediate into the cellular space is a rate limiting factor. 
Indeed, by applying the kinetics of elementary collisions, Pollard 
(1963) concluded that for cells larger than 1pm [c.f. Acinetobacter 
dimensions 1.5-2.5 x 0.9-1.6pm (Baumann et al., 1968) J , the diffusional 
term becomes a limiting step for the accomplishment of metabolic processes
and consequently a submicroscopic order is required.
By contrast, the concentrations of the glycolytic enzymes have
been analysed in detail in the yeast Saccharomyces carlbergensis (Hess
-5 -4et al., 1969) and have been found to be in the range 10 -10 M, thus 
the catalytic sites are equimolar with many glycolytic intermediates.
Hess concluded from these data that the packing of the glycolytic 
enzymes in the cell is sufficiently dense to avoid any time delays by 
diffusion of intermediates, 
e) Coordinate regulation
Regulation of an entire multienzyme complex could possibly be 
achieved by a single effector acting at a single site. Furthermore, if 
the formation of a complex were necessary either to produce an enzyme 
species with any activity at all or to elevate the efficiency of a 
pathway to a physiologically useful level, then the ligand-controlled 
association or dissociation of the members of a complex could provide an 
additional mechanism for the control of the pathway.
Using a partially purified arom complex from N.crassa.Welch Se 
Gaertner (1976) presented evidence for coordinate activation of the five 
enzyme activities in the complex by DAHP (3-deoxy-D-arabino-heptulosonic 
acid 7-phosphate) which is the substrate of the first enzyme in the complex 
(Figure 2). However, Coggins Se Boocock (1986) were unable to achieve 
such an effect of coordinate activation with a highly purified arom 
pentafunctional polypeptide and were critical of the methods used by 
Welch Se Gaertner (1976).
Are enzyme complexes necessary for coordinate regulation? According 
to the theory of Kacser Se Bums (1973, 1979) and Kacser (1983) all 
enzymes in a pathway contribute to flux control and changes in the activity 
of any component of that pathway merely redistributes the effects of the 
other enzymes in the pathway. This implies that the enzymes of a given 
pathway could be coordinately regulated even in the absence of complex
17a.
Figure 2 Aromatic amino acid biosynthesis and metabolism of 
quinate and p-hydroxybenzoate
DAHP = 3-deoxy-D-arabino-heptulosonic acid 7-phosphate 
EPSP = 5-enolpyruvoylshikimate 3-phosphate
1, DAHP synthase 
3, 3-dehydroquinase 
5, shikimate kinase 
7, chorismate synthase
2, 3-dehydroquinate synthase; 
4, shikimate dehydrogenase;
6, EPSP synthase;
8, catabolic 3-dehydroquinase.
Enzymes 2 - 6  are present on the multifunctional arom polypeptide,
----- ►  biosynthetic pathway
 ►  catabolic hydroaromatic pathway
quinate
erythrose-^-phosphate + PEP
t
DAHP
p -hydroxy benzoate
' ' ' 2
3-dehydroquinate
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3-dehydroshikimate ^
protocatechuate
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1
1 5
i
shikimate 3-phosphate
i 6
EPSP
I
\i
♦
chorismate 
/ 1 \
/ 1 \
/  1 \
tyr, trp, phe
and other aromatic
compounds
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formation. Alternatively, if the activity of the 'rate limiting' 
enzyme was regulated then the enzyme pathway would be regulated.
1.5.3 Enzyme complexes - no advantage?
There is always the possibility that even although enzyme 
associations occur they may not confer any particular advantage on the 
cell. Enzyme associations could be evolutionary relics or a 
consequence of the process of enzyme synthesis. Another possibility 
is that enzyme interactions could be an inherent, but accidental, 
property of particular proteins and it could be that since enzyme 
interactions take place, the cell has found a use for them (Gould & 
Lewontin 1979).
1.5.4 Examples of 'soluble' enzyme interactions in eukaryotes
Evidence for the existence of weak enzyme interactions has been
difficult to find. This may be due to the lability of the putative 
enzyme clusters but it may also reflect the transient nature of their 
association or, of course, the fact that they do not exist. It should 
be kept in mind that attempts to isolate transient species e.g. enzyme- 
substrate complexes have shown that this is not an easy task, yet such 
complexes obviously exist (Hess & Boiteux, 1972).
The situation in eukaryotic cells is complicated by the existence 
of a microtubular lattice (MIL) which is an elaborate network of protein 
strands that connect with almost all cytoplasmic ultrastructure 
(Wolosewik & Porter, 1979; Porter & Tucker, 1981). It is argued that 
classical 'soluble' enzymes are not freely diffusible because they are 
integral components of the MTL (Clegg, 1981, 1984a,b; Masters, 1981).
Several investigators (e.g. Knull et al., 1974; Masters, 1981) 
have suggested that the subcellular distribution of some enzymes may not 
be invariant but it may be a dynamic characteristic which alters in 
response to the changing requirements of the cell. The term 
' anibiquitous' has been coined to describe the situation where the
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distribution of an enzyme between soluble and particulate forms may vary 
with the metabolic status of the cell (Wilson, 1981).
1.5.4.1 Glycolytic enzymes in muscle
Most glycolytic enzymes appear to be associated with actin filaments 
in skeletal muscle (Clarke & Masters, 1975; Walsh et al., 1981). The 
extent of enzyme binding and the catalytic properties of the enzymes 
have been demonstrated to be strongly influenced by their substrates, 
other proteins, pH, ATP, Ca , Mg and electrical stimulation suggesting 
that enzyme function in vivo may be regulated by their interactions with 
the structural proteins (Knull et al., 1980; Bronstein & Knull, 1981).
1.5.4.2 Glycolytic enzymes in red blood cells
A particle containing glycolytic enzyme activity has been isolated 
from broken cell ghosts (Fossel & Solomon, 1978). The glycolytic 
complex consisting of glyceraldehyde-3-phosphate dehydrogenase, mono- 
phosphoglycerate mutase and phosphoglycerate kinase was shown to interact 
with the inner membrane and the interaction of the complex with the 
membrane was responsive to the application of ouabain to the outer 
membrane surface.
1.5.4.3 Glycolytic enzymes in the yeast S.carlsbergensis 
Ultracentrifugation studies and kinetic studies on extracts of
S. carlsbergensis were carried out in an attempt to show interactions between 
the glycolytic enzymes (Hess & Boiteux, 1972). However, even with the 
high enzyme concentrations used (140mg ml )^, no aggregation of the 
enzymes was observed.
1.5.4.4 Trypanosome glycosome
The parasite Trypanosoma brucei consumes glucose at a rate 50 times 
that of most mammalian cells and this may be possibly due to the 
compartmentation of the glycolytic enzymes in an organelle called the 
glycosome (Opperdoes et al., 1977a,b; Opperdoes & Borst, 1977; Oduro 
et al., 1980). Pulse labelling experiments showed that the glycolytic
carbon flow in T.brucei goes through a compartment which is separated from 
the rest of the cell and involves approximately 20-30% of the total 
glycolytic intermediates (Visser et al., 1981). Crosslinking studies 
confirmed the close proximities of the glycolytic enzymes in the 
glycosome (Aman et al., 1985), yet Aman & Wang (1986) were unable to 
demonstrate any substrate channeling in a cross linked complex. After 
it had been reported that even when the glycosomal membrane had been 
destroyed all the enzymes in the complex remain tightly bound together 
(Musset & Opperdoes, 1983), Ottaway (1985) raised the question that if this 
is so then why is there a need for such a membrane?
1.5.4.5 Krebs cycle enzymes in rat liver mitochondria
Srere (1972) first proposed that the 'soluble' Krebs cycle enzymes 
exist as a multienzyme complex near, or on , the inner (matrix) side of 
the inner membrane of rat liver mitochondria. After being unable to 
demonstrate any high molecular mass aggregate of the Krebs cycle enzymes 
by studying mitochondrial extracts on sucrose density gradient 
centrifugation and gel filtration chromatography (Srere et al., 1978),
Srere and others have subsequently used a variety of techniques to 
demonstrate a Krebs cycle enzyme complex (Srere, 1985).
a) Swollen mitochondria
In swollen mitochondria, a drastic reduction in the rate of 
oxidation of a substrate would be expected since the mean free path 
between an intermediate and the next enzyme would be increased and the 
proposed Krebs cycle enzyme complex would be dissociated. MatlibSc Srere
(1976) demonstrated that by swelling mitochondria, at least a three 
fold increase in the mitochondrial volume was achieved and this resulted 
in a significant reduction in the rate of oxidation of substrates.
b) Crosslinking
A variety of chemical crosslinkers were used in intact mitochondria
to study matrix proteins (D'Souza & Srere, 1983). It was anticipated 
that if the Krebs cycle enzymes interact and are localised near the
surface of the inner membrane, chemical crosslinkers would stabilise such 
interactions. Indeed, disorganisation of matrix proteins, by either 
swelling mitochondria or by sonication, reduced the degree of crosslinking 
and it was concluded that the Krebs cycle enzymes are preferentially 
localised within the matrix of rat liver mitochondria next to the inner 
membrane (D1Souza Se Srere, 1983).
c) Studies with purified enzymes
Many workers have used purified enzymes to study enzyme interactions 
(Srere, 1985) e.g. specific interactions have been demonstrated between 
fumarase and malate dehydrogenase (Beekmans Se Kanarek, 1981), citrate 
synthase and malate dehydrogenase (Halper Se Srere, 1977), pyruvate 
dehydrogenase complex and citrate synthase (Sumegi et al., 1980) and 
succinate thlokinase and oc-ketoglutarate dehydrogenase complex (Porpaczy 
et al., 1983). Several techniques were used in these studies including 
chemical crosslinking of purified enzymes, enzyme interactions in 
polyethylene glycol and immobilised enzymes (see (d) and (e) below).
d) Use of polyethylene glycol
The presence of polyethylene glycol (PEG) in dilute solutions of 
globular proteins results in the proteins being sterically excluded from 
regions of the aqueous solvent occupied by the synthetic polymer thus 
proteins are confined to a reduced volume (Middaugh et al., 1 9 7 9 ; Knoll 
8c Hermans, 1 9 8 3 ) . By exploiting this property of PEG, Halper 8c Srere
(1 9 7 7 ) were able to demonstrate a specific interaction between purified 
citrate synthase and malate dehydrogenase.
e) Immobilised enzyme systems
An immobilised enzyme system of malate dehydrogenase and citrate 
synthase (either as co-immobilised separate enzymes or as aggregates 
immobilised to a particular support such as Sepharose beads) was shown 
to operate at a faster rate than the equivalent amounts of free enzymes 
(Koch-Schmidt et al., 1977).
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Being aware that many of the enzyme interactions illustrated here 
(1.5.4.5 c - e) were not observed at physiological ionic strength,
Srere (1 9 8 0 , 198 1 , 1982) argued firstly that we do not have an accurate 
assessment of ionic strength within the cell; and secondly, since 
cellular protein concentrations are quite high (20 -50% ) (Sols Sc Marco,
19 7 0 ; Ottaway Sc Mowbray, 1 97 7 ; Srere, 1 9 8 0 , 1982 , 198 4 , 1985 ) and 
since molecular crowding (Minton, 1981) can markedly affect weak protein 
interactions, these interactions are likely even at physiological ionic 
strength; and finally, the interactions are specific for enzymes of 
sequential metabolic reactions.
1.5.5 Examples of 'soluble* enzyme interactions in bacteria
Since bacteria lack compartmentation by subcellular organelles, 
enzyme complex formation could conceivably be an important method of 
metabolic compartmentation,
1.5.5.1 Aromatic amino acid biosynthesis and metabolism of quinate
The biosynthesis of the aromatic amino acids phenylalanine, tyrosine 
and tryptophan has a common stretch of reaction sequence consisting of 
seven enzyme steps (Figure 2 ) .  This pathway occurs in microorganisms 
and higher plants but is absent from animals. In fungi e.g. N.crassa, 
five of these enzyme activities (enzymes 2 -6  in Figure 2 ) are present on 
a single polypeptide chain (Berlyn et al., 1970; Lumsden Sc Coggins, 1977).
A bifunctional polypeptide with 3-dehydroquinase and shikimate 
dehydrogenase activities (enzymes 3 and 4 in Figure 2) has been found in 
plants (Berlyn et al., 1970; Polley, 1978). These enzymes (enzymes 
2-6 in Figure 2) were found to be separate in E.coli and five other bacteria 
which were studied (Berlyn 8c Giles, 1969).
However, it has been suggested that in A.calcoaceticus the 
regulatory mechanism necessary for the protection of biosynthetic 
intermediates (particularly 3-dehydroquinate and 3-dehydroshikimate) in
the presence of inducible enzymes catalysing their degradation (Figure 2)
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may involve a multienzyme complex of the biosynthetic enzymes analogous 
to those found in fungi (Ingledew et al., 1971). Evidence for this was 
somewhat indirect and came from mutants which had lost the inducible 
catabolic dehydroquinase (enzyme 8, Figure 2), although normal levels 
of the biosynthetic enzyme were present (Ingeldew et_al., 1971). The 
mutants were completely unable not only to grow on quinate but also to 
produce enough protocatechuate to induce the other enzymes of the 
hydroaromatic pathway when growing on succinate in the presence of quinate. 
Further indirect evidence of 3-dehydroshikimate channeling came from 
Tresguerres et al. (1972) who showed differential utilisation of exogenous 
and dehydroquinate-derived dehydroshikimate. Berlyn & Giles (1973), 
however, later reported that under conditions of sucrose density gradient 
centrifugation where the biosynthetic enzyme complex was readily 
demonstrable in N.crassa, the A.calcoaceticus enzymes were separable, 
but they admitted that physical compartmentation of the components of the 
two pathways could predominate but would probably be destroyed after 
disruption of the bacteria.
1.5.5.2 Enzymes of the ^ -ketoadipate pathway in P.putida
Metabolic compartmentation of -carboxy-cis,cis-muconate (Figure 2) 
has been suggested (Meagher et al., 1972) on the basis that exogenously 
supplied -carboxy-cis,cis-muconate induced the synthesis of an uptake 
system that was not induced by j$ -carboxy-cis,cis-muconate when it was 
supplied endogenously by the catabolism of £-hydroxybenzoate (Figure 2). 
This indirect evidence was somewhat substantiated when copurification of 
four enzymes of the ft -ketoadipate pathway (metabolism of protocatechuate 
to succinate and acetyl CoA, Figure 2) was observed on a DEAE cellulose 
column (Meagher et al., 1972). After exposure to ammonium sulphate, the 
four enzymes eluted from the column as. sharply defined zones of activity 
suggesting that a non-covalent enzyme aggregate exists but is destroyed 
by ammonium sulphate (Meagher et al., 1972).
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1.5.5.3 Organisation of the glycolytic enzymes in E.coli
Compartmentation of glycolytic metabolism in E.coli has been 
suggested on the basis of metabolic experiments using competing labelled 
and unlabelled substrates (McBrien & Moses, 1968; MacNab et al., 1973).
In the first of these experiments (McBrien Sc Moses, 1 9 6 8 ) ,  resting cultures, 
treated with chloramphenicol to prevent additional enzyme synthesis, 
were divided into several identical subcultures all supplied with the 
same mixture of glucose, galactose and lactose and each culture also 
received one of those sugars labelled with ^C. The cultures were found 
to exhibit differences both in their preference for labelled hexose and
in their metabolic product labelling patterns for the Krebs cycle
14 14 14intermediates C-citrate and C-succinate and the amino acid C-
glutamate (McBrien & Moses, 1968). In a later series of experiments
14(MacNab et al., 1973) the incorporation of C into protein amino acids 
was measured using cultures of growing bacteria. The purpose of these 
experiments was to investigate the possibility of the preferential 
metabolism of intermediates derived from maltose carbon (entering glycolysis 
at the level of hexose) compared with the glycerol carbon (joining 
glycolysis at the level of triose phosphate isomerase). Although maltose 
and glycerol were shown to be equivalent carbon sources, since they 
supported the. same growth rate and the same amount of carbon was required 
for growth in each case, more maltose carbon was incorporated into amino 
amino acids than glycerol carbon. These results indicated a substantial 
degree of channeling.
In an attempt to find more concrete evidence for the existence of a 
glycolytic enzyme complex, Mowbray & Moses (1976) undertook a study of 
these enzymes involving gentle disruption of the bacteria using lysozyme, 
followed by differential centrifugation and gel filtration chromatography 
of the extracts so formed. After differential centrifugation, 14-20?o 
of the glycolytic enzyme activities were recovered in the high speed
pellet although most of this activity dissociated on washing the pellet. 
Evidence of a high Mr aggregate of the glycolytic enzymes was obtained 
on gel filtration chromatography. However, in neither of these studies 
was any comparison with control enzymes (enzymes from unrelated parts 
of metabolism) included and therefore the possibility that these results 
are due to non-specific binding cannot be excluded.
Gorringe Sc Moses (1980) claimed to have reconstituted a high Mr 
particle, containing glycolytic enzyme activity, from a concentrated 
sample of the individual enzymes from a lysed spheroplast preparation. 
Throughput activity of the glycolytic pathway was demonstrated in this 
high Mr species although no throughput activity was observed for a sample 
of individual glycolytic enzymes at the same protein concentration. It 
was concluded from this that for throughput activity to be observed, 
not only had all the glycolytic enzymes to be present in sufficient 
quantity but they also had to be structurally integrated into a specific 
association.
However, Kingdon (1 9 8 4 ) was unable to repeat the results obtained 
on gel filtration chromatography reported by Mowbray Sc Moses (1 9 7 6 ) and 
Gorringe Sc Moses (1 9 8 0 ) and concluded that the enzyme complexes 
apparently observed were due to enzyme-cellular debris association and 
whole cell contamination of the experimental samples. Kingdon (1 9 8 4 ) was 
particularly critical of the throughput experiments on the glycolytic 
particle reported by Gorringe Sc Moses (1 9 8 0 )  ^ radiolabelled glucose was 
used in these studies, however most glucose appears intracellularly as 
glucose- 6 -phosphate having been transported across the bacterial membrane 
by the phosphotransferase system (Waywood Sc Sleeves, 198 0 ; Begley et al.,
1 9 8 2 ). The formation of pyruvate in these throughput experiments was 
monitored by the addition of aminotransferase and quantifying the amount 
of " ^ C -alanine formed by paper chromatography (Gorringe Sc Moses, 1 9 8 0 ) .
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However, Kingdon (1984) discovered that the labelled product observed
on the paper chromatograms was in fact ^C-lactate which had been produced 
by viable bacteria which contaminated the sample.
Nevertheless, in experiments involving sucrose density gradient 
centrifugation studies following in vivo protein crosslinking with 
dimethylsuberimidate (DMSI), there was evidence which suggested that a soluble 
enzyme-enzyme association occurs between triose phosphate isomerase, 
glyceraldehyde 3-phosphate dehydrogenase and a third unknown component 
with an apparent Mr of 150,000 (Kingdon, 1984). It was suggested that 
this complex might serve to reduce the intracellular concentration of 
the toxic glycolytic intermediate, glyceraldehyde 3-phosphate (Kingdon,
1984).
1.5.5.4 Association of the Krebs cycle enzymes in E.coli
Using the methodology of Mowbray Sc Moses (1976) and Gorringe Sc 
Moses (1980), Barnes Sc Weitzman (1986) and Weitzman 8c Barnes (1985) reported 
evidence for a high Mr aggregate of the Krebs cycle enzymes in E.coli.
The high Mj. species was isolated from lysed spheroplasts by gel filtration
chromatography in the presence of 20% (v/v) glycerol. Addition of 14%
(w/v) PEG or BSA (lOmg ml "S produced a 2-3 fold increase in the yield of 
the high Mr species from gel filtration chromatography; however, no high 
Mr species were detected in the absence of 20% (w/v) glycerol or in the 
presence of 1M KC1 and the yield of the high Mr species was reduced by
50% when the pH was changed from 7 .5  to 6 .5  or 8 .9  (Barnes 8c Weitzman,
1986). There was no evidence of a Krebs cycle enzyme aggregate when 
the bacteria were disrupted by sonication or in the French pressure cell.
As with the experiments on the glycolytic enzymes (Mowbray Sc Moses, 1976; 
Gorringe 8c Moses, 1980) the behaviour of control enzymes (from unrelated 
parts of metabolism) was not reported. However, Barnes 8c Weitzman 
(1986) did add lactate dehydrogenase (from rabbit muscle) to the bacterial 
lysate to check for non-specific binding and reported that this enzyme
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did not elute at a position corresponding to a high Similar results
indicative of a Krebs cycle enzyme aggregate were said to be obtained
with A.calcoaceticus, P.aeruginosa and B.subtilis (Weitzman Sc Barnes,
1 98 5 ; Barnes Sc Weitzman, 1 9 8 6 ) . Since Barnes Sc Weitzman (1 9 8 6 ) 
followed the protocols outlined by Mowbray Sc Moses (1 9 7 6 ) and Gorringe 
Sc Moses ( 1 9 8 0 ) ,  there is the possibility that these results are due to 
whole cell contamination of the experimental samples.
1.5.5.5 Association of the enzymes of the mandelate pathway in P.putida
Halpin et al. (1981) have reported evidence for the physical 
association of the enzymes of the mandelate pathway in P.putida on the 
basis of experiments involving the crosslinking reagent dimethylsuberimidate 
(DMSI). The strategy behind using crosslinking reagents in these studies 
is that if enzyme interactions exist it is hoped that the crosslinker 
would provide sufficient stabilisation to allow their isolation and 
characterisation.
When extracts from control and DMSI-treated bacteria were subjected 
to differential centrifugation, there was a 9-25 fold increase in the 
soluble enzyme activities recovered in the pellet fraction (where most of 
the LMDH activity was present)after DMSI treatment. In addition, when 
extracts from bacteria which had been treated with DMSI in vivo were 
subjected to gel filtration chromatography, an extra peak of enzyme 
activities appeared in the void volume which in control extracts had only 
LMDH activity. This was taken to indicate the presence of a high Mr 
aggregate of the mandelate enzymes although, again, these workers did not 
pay much attention to the need to follow the distribution of control 
enzyme in these gel filtration experiments (Halpin et al., 1981).
The crosslinked complex of the mandelate enzymes was also studied by
13C-NMR spectroscopy (Halpin et al., 1981). On oxygenation of the 
isolated complex, DL-[©C -^c]-mandelate was converted to[oc -benzoate;
£c*l -l^cj-phenylglyoxylate and(oC-^c]-benzaldehyde were also detected.
This confirmed that all the enzymes necessary for the metabolism of 
mandelate to benzoate were present in the high Mr material. However, 
it was also reported that in at least one experiment, [^c]-bicarbonate 
was detected after oxygenation of the-isolated complex suggesting that 
the enzymes of the 'catechol pathway' (Figure 1) were also present in the 
high Mr material. There is also the possibility that the mandelate 
enzymes as well as other unrelated 'soluble' enzymes had been randomly 
crosslinked since glutamine synthetase activity was detected in the 
isolated high Mr material, although Halpin et al. (1981) did not place 
any emphasis on this observation. The results presented by Halpin et al. 
(1981) are far from conclusive and it was not possible to determine 
whether the mandelate enzymes were complexed to each other or to other 
cellular components.
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1.6 Aims
The primary aim of this study was to determine whether or not the 
enzymes of the mandelate pathway in A.calcoaceticus exist as a multi- 
enzyme complex. If there was evidence for such a complex then the next 
objective would have been to isolate it and characterise it in terms of 
size, composition and kinetic properties; however, as it turned out, 
there was no sound evidence for the existence of a complex.
It was hoped that techniques such as gel filtration chromatography, 
density gradient centrifugation and ultracentrifugation would be useful
for testing whether there was evidence for co-purification of the mandelate
/
enzymes. For these co-purification studies it was thought that a gentle 
method of disruption would be necessary and so the first work that was 
undertaken was to develop a method for disrupting A. calcoaceticus after 
lysozyme treatment.
It was realised that it would be necessary to develop appropriate 
methods for assaying a range of enzymes and for crosslinking experiments 
either in vivo or using bacterial extracts.
A subsidiary aim was to purify LMDH with a view to raising antibodies 
against the enzyme which could be useful in identifying cross linked species 
or in inmunoprecipitation studies on the native complex. An additional 
reason for purifying LMDH was so that it could be characterised thus 
making it possible to compare further the stereospecific mandelate and 
lactate dehydrogenases.
CHAPTER 2 MATERIALS AND METHODS
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2.1 Materials
All reagents were the best grade available commercially. With the 
exceptions of the materials listed below, reagents were obtained from BDH 
Chemicals Ltd., Poole, Dorset, BH12 4NN.
Phenylene dimaleimide - Aldrich Chemical Co.Ltd., The Old Brickyard, New 
Road, Gillingham, Dorset SP8 4JL.
Bovine serum albumin (Fraction V) - Armour Pharmaceuticals Co.Ltd., 
Eastbourne, Sussex BN22 9AG.
HRP colour development reagent - Bio-Rad Laboratories Ltd., Watford, 
Hertfordshire.
Aldolase; lactate dehydrogenase; pyruvate kinase (all from rabbit muscle) - 
Boehringer Corp., Ltd., Lewes, East Sussex BN7 1LG.
Freund's complete and incomplete adjuvant - Difco Laboratories, Detroit, 
Michigan 48201, U.S.A.
D-Mandelic acid; L-mandelic acid; phenylglyoxylic acid - Fluorochem Ltd. 
(Fluka), Glossop, Derby SK13 9NU.
Ultrogel AcA34 and HA Ultrogel - LKB Instruments Ltd., 232 Addington Road, 
South Croydon, Surrey.
2-Phenylpropionicacid - K + K, Kodak Ltd., Kirby, Lancs L33 7UK.
Nutrient broth (CMl); nutrient agar (CM3); agar No.l - Qxoid Ltd., 
Basingstoke, Hants RC24 OPW.
DEAE Sephacel;' gel filtration calibration proteins; SDS PAGE calibration 
proteins; Percoll; density gradient marker beads; Polybuffer 74 - 
Pharmacia (Great Britain) Ltd., Prince Regent Road, Hounslow, Middlesex.
L-Glutamic acid.HCl - T.J. Sas and Son Ltd., London WC1.
HRP donkey anti-rabbit IgG; normal rabbit serum; normal donkey serum - 
Scottish Antibody Production Unit, Law Hospital, Carluke.
Aldehyde dehydrogenase (yeast); alcohol dehydrogenase (horse liver); 
Coomassie Brilliant Blue G250; deoxyribonuclease; 3-deoxy-2-keto-octonic 
acid; D,L-isocitric acid; lysozyme; Lubrol PX; NAD; NADP; NADH; PMS;
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phosphoenol pyruvate potassium salt; protein A-Sepharose; ribonuclease;
SDS PAGE calibration proteins; TPP (cocarboxylase); Triton X-100;
Tween 20 - Sigma Chemical Co.Ltd., Poole, Dorset BH17 7NH.
Dime thy lmalonimidate; dime thy lsuccinimidate; dime thy lglutarimidate ; 
dimethyladipimidate; dimethylpimelimidate; dimethylsuberimidate - gifts from 
Dr. J.R. Coggins, Department of Biochemistry, University of Glasgow. 
Anti-DMDH; anti-PGDC - gifts from Dr. I.D. Hamilton and Dr. M.M.
Barrowman, Department of Biochemistry, University of Glasgow.
2.2 Microbiological techniques
2.2.1 Microorganisms
The bacteria used in this work are listed in Table 1. All strains 
except mutant strains C1005, C1123 and C1219 were maintained in 10ml Qxoid
nutrient broth (CM1), stored at 4°C. Mutant strains C1005, C1123 and
C1219 were maintained in 10ml complex medium plus D,L-mandelate, instead 
of nutrient broth in order to maintain the selection pressure during storage 
and so avoid the outgrowth of non-constitutive revertants. Subcultures 
were made into Qxoid nutrient broth (CMl)or complex medium plus 
D,L-mandelate at 6-12 monthly intervals. In addition, constitutive strains 
were periodically replated on salts medium containing 2-phenylpropionate 
and phenylglyoxylate. Colonies were then picked off and cultured in complex 
medium plus D,L-mandelate and stored at 4°C.
2.2.2 Characterisation of bacteria
Characteristics of the various strains were checked with the aid of 
Qxi-Ferm and Entero diagnostic tubes (Roche Products Ltd., PO Box 8,
Welwyn Garden City, Herts AL7 3A7). Oxidase reactions (Cowan & Steel,
1965) and the appearance of colonies on nutrient agar were also examined.
2.3 Sterilisation
2.3.1 Moist heat
Heat-stable solutions were autoclaved. Media containing carbon 
sources were autoclaved at 109°C (except for complex media) and all other
32.
Table 1 
1.
NCIB 8250 
NCIB 8250 
NCIB 8250 
NCIB 8250 
NCIB 8250 
2.
NCIB 9494
Strains of bacteria
Acinetobacter calcoaceticus
Wild type strain, inducible for LMDH, PGDC and BDH I 
(Fewson, 1967b; Livingstone et al., 1972)
Mutant strain C1005 (previously HMM5) (NCIB 11339) 
constitutive for LMDH, PGDC and BDH I (Fewson et al., 1978)
Mutant strain C1219 (NCIB 11457), constitutive for LMDH, 
DMDH, PGDC and BDH I (Hills & Fewson, 1983a)
Mutant strain Cl123, constitutive for DMDH, PGDC, BDH I, 
no LMDH activity present (Hills & Fewson, 1983a)
Mutant strain C1408, constitutive for PGDC and BDH I, 
no LMDH or DMDH activities present (Hills & Fewson, 1983a)
Pseudomonas putida
Wild type strain (previously A3.12),inducible for the 
mandelate enzymes (Hegeman, 1966a)
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solutions at 109°C or 120°C for times established by Fewson (unpublished 
results). Efficiency of sterilisation was verified by using Browne's 
tubes (Type three, A. Browne Ltd., Chancery Street, Leicester).
2.3.2 v Dry heat
Pipettes were wrapped in either Kraft paper or placed in metal cannisters 
before sterilisation. Each sterilisation (160°C, 1.75h) was checked by 
including a Browne's tube (Type one).
2.3.3 Filtration
Volatile and heat-labile compounds were sterilised by filtration.
Large volumes of media were sterilised through Millipore filters (GSWPO 4700, 
0.2pm pore size; Millipore Ltd., Abbey Road, London). For volumes of 100ml 
or less, Nalgene disposable sterile filter units (0.2pm pore size; Sybron 
Corp., Rochester, N.Y., U.S.A.) were used.
2.3.4 Ethylene oxide
Plastic pipettes and other 'disposable' apparatus were sterilised with 
ethylene oxide. All items were sealed with polythene film and exposed to 
ethylene oxide (Anprolene) for 12h in a sterilising box (AN74; H.W. Anderson 
Products Ltd., Clacton-on-Sea, Essex). Sterilisation was verified by an 
Anprolene exposure indicator (AN85) or by a steritest unit- (AN80). All 
apparatus was aired for at least 24h prior to use to remove residual gas.
2.4 Media
2.4.1 Minimal medium containing mandelate
This medium was adapted from that used by Hegeman (1966a) and contained 
(gl-1) D,L-mandelate 1.52 (10nM); (NH,)2SO,, 1; H U O., 3.4; Na2HPO,, 3.55;
and 2ml Chel metals 1 Chel metals was prepared as follows.
Nitrilotriacetic acid (Chel) (80g) was dissolved in 1M NaOH (625ml) and the 
solution was adjusted to pH7.0 with 5M HC1. Salts were then added in the 
following order:- FeSO^; 7H2O, l.lg; Na2MoO^.21^0, 50mg; MnSO^^I^O, 50mg;
ZnSO^. 7H2 0 , 50mg; CuSO^.bh^O? 25mg; CoC^^HLpO, 25mg; and the solution was
made up to 11 with distilled water and autoclaved (Beggs & Fewson, 1977).
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The minimal medium containing mandelate was adjusted to pH6.9 with NaOH, 
made to the correct final volume with distilled water and autoclaved. 
Immediately before inoculation, sterile 2% (w/v) MgSO^. 7^0 (20ml l” )^ was 
added.
2.4.2 Basal medium
The basal medium contained 2g of KH^PO^ and lg ofCNH^^SO^ per litre, 
adjusted to pH7.0 with NaOH.
2.4.3 Salts medium
The salts medium contained 2g of K^PO^ and lg of (NH^^SO^ per litre, 
adjusted to pH7.0 with NaOH, and 20ml 2% (w/v) MgSO^. 7^0 per litre which 
was added after autoclaving, thus 5mM L-glutamate/salts medium refers to 
5mmol L-glutamate per litre of salts medium (Kennedy St Fewson, 1968a).
2.4.4 Nutrient broth
Nutrient broth (Oxoid CM1; 13g 1 )^ was dispensed in 10ml volumes in 
universal bottles for storage of cultures.
2.4.5 Complex medium
The complex medium (Allison et al., 1985a) contained (g l~^) :0xoid No.l 
nutrient broth, 26; K^PO^, 2; (NH^SO^, 1; L-glutamic acid. HC1, 0.9; 
MgSO^. 7^0, 0.4. This medium was supplemented with D,L-lactate (1.5g 1 )^ 
and/or D,L-mandelate (1.5g 1 )^ or phenylglyoxylate (0.75g 1” )^ as required, 
adjusted to pH7.0 with NaOH,made to the correct final volume with distilled 
water and autoclaved.
2.5 Agar plates
2.5.1 Nutrient agar plates
The agar (Oxoid CM3; 28g 1 )^ was boiled and stirred to dissolve it 
and then autoclaved. The sterile molten medium was cooled to 55°C and 
poured into petri dishes (9cm diameter - Sterilin Ltd., Teddington, 
Middlesex). Plates were left inverted for 24h at 30°C to dry.
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2.5.2 Agar plates containing defined media
Qxoid agar No'.l [ Lll; 1.5% (w/v)] was mixed with K^PO^ (2.0g l"^) 
and (NH^^SO^ (l.Og 1 in addition to the appropriate carbon source which 
had been adjusted to pH7.0 with NaOH and then autoclaved. If the carbon 
source was heat-labile it was sterilised by filtration and added to the 
sterile molten agar mixture at 55°C. Before pouring into the plates, 20ml 
27o (w/v) sterile MgSO^. 7^0 was added to each litre of medium. The plates 
were then dried at 30°C for 24h.
2.6 Optical density measurements
Optical densities (O.D.) of bacterial suspensions were estimated by 
measuring the OD^qq in a Pye Unicam SP30 Spectrophotometer (Pye Unicam 
Instruments Ltd., 576 West Harbour Road, Granton, Edinburgh EH5 1PP).
Dense suspensions were diluted with the appropriate medium so that the 
OD500 was always less than 0.6 when read in the spectrophotometer.
2.7 Growth of bacteria
2.7.1 General growth conditions
Culture volumes of 50ml or 500ml were grown in 250ml or 2 litre conical 
flasks, respectively, stoppered with polystyrene foam bungs (A.Sc J.Beveridge 
Ltd., 5 Bonnington Road Lane, Edinburgh EH6 5BP). The cultures were usually 
grown on a rotary shaker (M.K.V. Orbital Shaker, L.H. Engineering Co.Ltd., 
Stoke Poges) moving at about 120 rpm in rooms maintained at 23°C or 
30°C as appropriate.
Cultures of 4 litre volumes were grown in 10 litre flat-bottomed flasks 
each having a plug of non-adsorbent cotton wool through which passed a 
plugged glass pipette (10ml). The cultures were grown at 30°C under 
conditions of vigorous aeration produced by a 45mm polypropylene-coated 
magnetic bar stirring at approximately 300rpm on the apparatus described 
by Harvey et al. (1968). Air (400ml min )^ was passed through the glass 
pipette over the culture.
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Larger amounts of bacteria were grown in a 10 litre fermenter (Braun 
Biostat V., F.T. Scientific Instruments, Tewkesbury, Glos., UK) which 
contained 10 litres of complex medium and 50ml of sterile 1% (v/v) poly 
(propylene glycol) 2025 as antifoam. A 20 litre reservoir containing the 
same medium was connected to the fermenter. The fermenter was operated 
at 23°C or 30°C as appropriate‘with an aeration rate of 4 litres of sterile 
air min  ^and stirring at setting 2.5 (approx. 350 rpm). After 16h 
growth, when the apparent OD of the culture at 50Cnm was at least 2.0,
9 litres of the culture was harvested and 9 litres of fresh medium was 
added to the fermenter from the reservoir. After another period of growth, 
this process was repeated.
2.7.2 Growth of A.calcoaceticus, mutant strain C1005 on complex medium 
Inocula were prepared by aseptically transferring 0.1ml of a stock
culture into 50ml of medium (in 250ml flasks) and growing at 23°C with shaking 
for 48h or at 30°C with shaking for 24h. These cultures were used as inocula 
(2.5%, v/v) for 400ml of medium (in 2 litre conical flasks) which were then 
incubated on an orbital shaker at 120 rpm for 24h at 23°C or 16h at 30°C.
These cultures were then either harvested or used to inoculate the fermenter 
containing 101 of complex medium.
2.7.3 Growth of wild type A.calcoaceticus NCIB 8250 on 5mM succinate/salts 
medium
A stock nutrient broth culture was inoculated (0.2%, v/v) into. 50ml 
succinate/salts medium (in a 250ml conical flask) and grown for 24h at 30°C. 
All of this culture was then inoculated into 4 litres of 5mM succinate/salts 
medium in a 10 litre flat-bottomed flask, plugged with non-adsorbant cotton 
wool and grown under conditions of vigorous aeration for 16h at 30°C.
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2.7.4 Growth of P.putida NCIB 9494 on minimal mandelate medium
A stock nutrient broth culture was inoculated (0.2%, v/v) into 50ml 
of minimal medium containing mandelate and grown for 24h at 30°C with 
shaking. This culture was used as the inocula (2.5%, v/v) for 400ml of 
medium (in 2 litre flasks) which were incubated at 30°C with shaking.
These cultures were harvested when the OD^qq of the culture reached 0.8 
(after about 5h).
2.8 Harvesting and storage of bacteria
Cultures were harvested by centrifugation in 750ml polypropylene 
bottles (maximum volume 500ml; 69650, MSE Ltd., Buckingham Gate, London)
at 5200rpm for 20 min at 4°C in an MSE Mistral 6L centrifuge. Each pellet 
was resuspended in ice-cold, sterile basal medium and recentrifuged in a 
50ml polypropylene centrifuge tube (59407, MSE) at 12,000g for 30 min at 
4°C in an MSE 18 centrifuge. The supernatant was decanted and the 
washed bacterial pellet was either used immediately or stored at -20°C 
until required.
2.9 Disruption of bacteria
2.9.1 Ultrasonic disruption
Bacteria were resuspended in an appropriate buffer (usually 0.05M 
potassium phosphate buffer, pH7.5) to a final concentration of 0.25g wet 
weight ml Five-seven ml were placed in a 10ml vial and positioned in 
a chilled brass holder (Holms & Bennett, 1971). This was screwed onto the 
horn of a 13mm probe of the Dawe Soniprope (Type 7532A; Dawe Instruments 
Ltd., London) and lowered into an ice-water slurry. A.calcoaceticus was 
disrupted at .a current of 80W for 5 x 30s periods alternated with cooling 
periods of 30s. P.putida was also disrupted at a current of 80W but for 
3 x 30s periods alternated with cooling periods of 30s. The homogenate 
was centrifuged at 15,000g for 20 min at 4°C in an MSE Highspeed 18 
centrifuge to remove intact bacteria and debris. The supernatant was stored 
at -20°C.
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2.9.2 French press disruption
Bacteria were resuspended in an appropriate buffer to a final
concentration of 0.5g wet weight ml  ^and disrupted by two or four passages
through the French Press (Cat. No.4-3398A, Aminco, Silver Spring, Maryland,
-2USA) at a pressure of 98MPa (14,300 lb in ). The homogenate was 
centrifuged at 15,000g for 20 min at 4°C in an MSE 18 highspeed centrifuge 
to remove intact bacteria and debris.
2.9.3 Disruption by lysozyme treatment
2.9.3.1 This method was slightly modified from that of Scott et al; (1976). 
Freshly harvested bacteria were washed three times in 0.05M Tris/HCl buffer, 
pH7.8 and resuspended (50mg wet wt ml )^ in about 200ml of 0.05M Tris/HCl 
buffer, pH7.8 containing 0.6M sucrose. The suspension was incubated with 
lysozyme (lOmg/g wet wt) for 150 min at 23°C before lysis of the spheroplasts 
by the addition of 10 volumes of cold distilled water. Deoxyribonuclease 
(2mg/g original wet wt) was added to decrease the viscosity. After the 
mixture had been stirred for 90 min at 4°C, intact bacteria were removed
by centrifugation at 15,000g for 20 min at 4°C in an MSE 18 Highspeed 
centrifuge.
2.9.3.2 Alternatively, after incubating the bacterial suspension with 
lysozyme for 150 min at 23°C (Methods 2.9.3.1), the spheroplasts were 
harvested by centrifuging at 15,000g for 20 min at 4°C in an MSE 18 Highspeed 
centrifuge. The spheroplasts were washed once by resuspension/ 
centrifugation in 0.05M Tris/HCl buffer, pH7.8 containing 0.6M sucrose.
The spheroplast sludge was homogenised for 45s at top speed on a Potter 
Elvenhjem homogeniser, then a crystal of deoxyribonuclease was added and 
the homogenate was incubated at 23°C for 5 min. The homogenising and 
deoxyribonuclease treatment, was repeated twice (Mowbray Sc Moses, 1976). 
Finally, intact bacteria were removed by centrifuging at 15,000g for 20 min 
at 4°C in an MSE 18 Highspeed centrifuge.
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2.10 Separation of outer and inner membranes
This method was adapted from that described by Scott et al. (1976). 
Freshly harvested bacteria (lOg) were disrupted by lysozyme treatment 
(Methods 2.9.3.1). Membranes were collected from the resulting low speed
supernatant by centrifuging at 65,000g (25K rpm, 10 x 100ml Prepsin rotor)av .. _
for 120 min at 4°C and were resuspended in 0.05M potassium phosphate buffer,
pH7.5 containing deoxyribonuclease and ribonuclease (O.lmg of each/g
original wet wt). After the mixture had been stirred for 30 min at 4°C,
the membranes were collected as before and washed twice by resuspension/
centrifugation and were resuspended in a small volume (approx. 12ml) of
0.05M potassium phosphate buffer, pH7.5 containing 20pg of chloramphenicol
ml"^. Centrifugation of this crude membrane fraction at top-speed
(approx. 15,000g) in an Eppendorf 3200 centrifuge for 10 min resulted in the
sedimentation of the cytoplasmic membranes and the outer membranes remained
in the supernatant fraction. The cytoplasmic membranes were washed once by
resuspension/centrifugation, and were resuspended in 0.05M potassium
phosphate buffer, pH7.5 containing 20pg of chloramphenicol ml ^. The
outer membranes were recovered from the pooled supernatant fractions by
centrifuging at 65,000g for 120 min and were resuspended in 0..05M potassiumav
phosphate buffer,pH7.5 containing 20pg of chloramphenicol ml
2.11 Preparation of 'wall + membrane' fractions
2.11.1 The low speed supernatant resulting from bacterial disruption
(Methods 2.9) was centrifuged at 105,000g (40K rpm, Ti50 rotor) for 60 minav
at 4°C and the pellet washed three times by resuspension and centrifugation 
in the appropriate buffer.
2.11.2 Alternatively, the low speed supernatant was centrifuged at
165,000g (40K rpm, Ti60 rotor or 50K rpm, Ti50 rotor) for 150 min at 4°Cav
and the pellet washed twice by resuspension and centrifugation.
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2.12 Toluene treatment of intact bacteria in the presence of 
polyethylene glycol (PEG)
Intact bacteria were treated with toluene 'according to the method 
described by Beggs & Fewson (1977) except that buffers contained 8.5?0
(w/v) PEG (Matlib et al., 1977). Bacteria (3.8ml; 0.8g wet wt ml ^ ) were
pipetted onto 200pl 4% (v/v) toluene in ethanol. The mixture was vortexed 
for 30s and incubated at 27°C in a water bath for 90 min.
2.13 Electron microscopy
All electron microscopy was carried out by Mr. I. Montgomery,
Physiology Department, University of Glasgow. Membrane fractions were 
negatively stained with 1.5% phosphotungstic acid (pH7.0). After incubating 
for 1 min at room temperature, excess fluid was removed and the grids were 
air dried.
2.14 Crosslinking with dimethylimidates
Crosslinking was carried out by the method developed by Dr.J.R. Coggins 
(Personal communication and Coggins, 1978).
2.14.1 Stock solutions
(a) TNM buffer, pH8.0 (0.05M Triethanolamine.HCl buffer, pH8.0 
containing 0.1M NaCl and 0.01M MgCl2 ).
■(b) 0.4M NaOH.
(c) 2 x TNM buffer (0.1M Triethanolamine.,HCl buffer, pH8.0 containing 
0.2M NaCl and 0.02M MgCl2).
(d) Dissolving mix: this was prepared by mixing 1 volume of 0.4M NaOH
and 1 volume of 2 x TNM buffer.
(e) 0.1M stock dimethyl imidate solution: the solid dimethyl imidates
were stored at -20°C and since these reagents are very hygroscopic, the 
stock bottles were allowed to reach room temperature for approx lh and the 
bottles were not opened for longer than necessary. A small amount of the 
dimethyl imidate was transferred to a stoppered bottle, weighed accurately 
and an appropriate volume of dissolving mix (d) was added to give a 0.1M
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solution. ' Prepared this way, the pH of the stock solution was pH8.0.
The dimethyl imidate’ solution was used immediately or within 5 min of 
preparation.
2.14.2 Crosslinking aldolase with DMSI
A sufficient volume of 0.1M DMSI (Methods 2.14.1) was added to a 
solution of aldolase (l-2mg ml in TNM buffer, pH8.0, to give a final 
DMSI concentration of 6mM. The mixture was incubated for 60 min at 23°C 
with gentle swirling. The crosslinked species obtained were examined by 
SDS PAGE (Methods 2.21.1).
2.14.3 Crosslinking intact bacteria with dimethylimidates
This method was based on that described by Halpin et al. (1981). 
Exponentially growing bacteria (after approx.5h growth) were harvested and 
washed once with TNM buffer, pH8.0 and resuspended in the same buffer (0.3g 
wet wt ml )^. The crosslinker (0.1M; Methods 2.14.1) was added to give a 
final concentration of 6mM. The bacterial suspension was incubated for 60 
min at 23°C with gentle swirling. In some experiments potassium 
phosphate buffer, pH7.5 was used instead of TNM buffer, pH8.0; in this 
case the same volume of the 0.1M dimethyl imidate solution was added every 
15 min over the 60 min incubation period.
2.14.4 Crosslinking a French press homogenate with DMSI or DMPI 
(dimethylpimelimidate)
Freshly harvested bacteria were resuspended in TNM buffer, pH8.0 to 
a final concentration of 0.5g wet wt ml An appropriate volume of 0.1M
DMSI or DMPI (Methods 2.14.1) was added to the bacterial suspension to give 
a final concentration of 6mM, after which the bacterial suspension was passed 
through the French press (Methods 2.9.2). The same volume of a 0. 1M 
solution of DMSI or DMPI was added to the resulting homogenate which was 
passed through the French press again. When all the French pressing had 
been completed, a further volune of the 0.1M solution of DMSI or DMPI was 
added to the. French press homogenate which was then incubated at 23°C for
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60 min with gentle swirling. In experiments where the bacteria were 
resuspended in potassium phosphate buffer, pH7.5 instead of TNM buffer, 
pH8.0, the crosslinking of the French press homogenate was carried out as 
above but the same volume of the 0.1M solution of DMSI or DMPI was added 
every 15 min throughout the 60 min incubation period. Unbroken bacteria 
and debris were removed by centrifuging at 15,000g for 20 min at 4°C in 
an MSE 18 Highspeed centrifuge.
2.15 Crosslinking with phenylene dimaleimide (PPM)
2.15.1 Crosslinking intact bacteria with PPM
Exponentially growing bacteria (after approx. 5h growth) were harvested, 
washed once with 0.1M potassium phosphate buffer, pH7.5 containing lOOpM 
thiamin pyrophosphate (TPP; cocarboxylase), 2mM MgSO^ and ImM EDTA and 
resuspended (0.3g wet wt ml )^ in the same buffer. PDM was added to a 
final concentration of lOOpM and the bacterial suspension was incubated at
23°C for 30 min. The reaction was terminated by the addition of
dithiothreitol (DTT) to a final concentration of 200pM. The bacteria were 
washed once with 0.1M potassium phosphate buffer, pH7.5 containing lOOpM 
DTT, lOOpM TPP, 2mM MgSO^ and ImM EDTA and disrupted by sonication 
(Methods 2.9.1).
2.15.2 Cross linking a French press homogenate with PDM
Freshly harvested bacteria were washed once with 0.1M potassium 
phosphate buffer, pH7.5 containing lOOpM TPP, 2mM MgSO^ and ImM EDTA and 
resuspended (0.5g wet wt ml )^ in the same buffer. PDM was added to the 
bacterial suspension to a concentration of lOOpM before the bacteria were 
disrupted by two passages through the French pressure cell (Methods 2.9.2). 
When the French pressing was complete, more PDM was added and the samples 
were incubated at 23°C for 30 min. The reaction was terminated by the 
addition of DTT to a final concentration of 200pM. Unbroken bacteria and 
debris were removed by centrifuging at 15,000g for 20 min at 4°C in an MSE 18 
Highspeed centrifuge.
43.
2.16 Percoll density gradient centrifugation
2.16.1 Stock solutions
(a) Percoll
(b) 2.5M sucrose in 0.5M potassium phosphate buffer, pH7.5
(c) 0.25M sucrose in 0.05M potassium phosphate buffer, pH7.5
(d) Stock Percoll solution : a solution was prepared by adding 18ml 
of Percoll (a) to 2ml 2.5M sucrose in 0.5M potassium phosphate buffer, 
pH7.5 (b).
2.16.2 Method
A 20% Percoll solution was prepared by making 22,2ml of the stock Percoll
solution (d) to 100ml. One ml of sample was layered onto 20ml of this 20%
Percoll solution in a Ti60 polycarbonate centrifuge tube. The samples were
then centrifuged for 30 min at 64,000g (30K rpm, Ti60 rotor) after whichav
lml fractions were collected from the top of the self-generated gradient. 
Density gradient marker beads were included in each run in a separate tube 
to calibrate the density gradient formed.
2.17 Enzyme assays
Enzymes were generally assayed in plastic 1cm light-path cuvettes in a 
Unicam SP8/100 spectrophotometer with an in built chart recorder. The 
temperature of an external cuvette holder and of the spectrophotometer 
cuvette carriage was maintained at 27°C by an attached heating unit. The 
reaction components, except the substrate, were added to the cuvettes which 
were standing in the external cuvette holder. Micropipettes (Eppendorf 
Marburg Mikropipet, V.A. Howe and Co.Ltd., London Wll) were used to dispense 
volumes less than lml. The components of the reaction mixture were mixed 
using 'plumpers' (Calbiochem, San Diego, California 92112). The reactions 
were initiated by the addition of substrate and mixing. Upto 4 cuvettes 
could be placed in the spectrophotometer and the absorbance measured 
sequentially at 10-15s intervals for upto 5 min by means of a programmed 
cuvette changer. Different volumes of enzyme samples were usually assayed
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to check the linearity of the assay. Enzyme assays were all carried out in 
duplicate for each sample.
Enzyme units are defined as pmol substrate converted min ^; specific 
activities are given as units of enzyme per mg protein.
2.17.1 Mandelate dehydrogenases
LMDH and DMDH were assayed by following the phenazine methosulphate 
(PMS)-dependent reduction of 2,6-dichlorophenolindophenol (DCIP) at 600nm 
as described by Hills Sc Fewson (1983a) and Allison et al. (1985b). A 
decrease in A^qq of 7.18 units was taken to correspond to the oxidation of 
lpmol of substrate at pH7.5.
The enzyme was assayed in reaction mixtures containing (total volume
3ml):
200pmol (2ml of 0.1M) potassium phosphate buffer, pH7.5 
200nmol (0.1ml of 2mM) DCIP 
lpmol (0.1 of lOmM) PMS
lQmg[ 0.1ml of 10% (w/v)] bovine serum albumin (BSA) 
enzyme sample (usually 50pl)
1.5pmol (0.1ml of 15mM) L-mandelate or 6pmol (0.1ml of 60mM)
D-mandelate adjusted to pH7.5, to initiate the reaction.
The same assay conditions were used to assay the IMDH of P.putida 
except that 12.5pmol (0.1ml of 125mM) L-mandelate, adjusted to pH7.5, was 
added to initiate the reaction.
2.17.2 Lactate dehydrogenases
DLDH was assayed in the same way as DMDH (Methods 2.17.1) except that 
6pmol (0.1ml of 60mM) D-lactate was used as substrate.
The assay procedure for LMDH activity (Methods 2.17.1) was modified to 
measure T.T.PH by replacing L-mandelate with 1.5pmol (0.1ml of 15mM) L-lactate 
as substrate and lowering the amount of BSA in the cuvette from lOmg to lmg 
in order to obtain maximal activity.
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2.17.3 Direct assay for PGDC activity
PGDC activity was measured by following the disappearance of 
phenylglyoxylate at 334nm (Hegeman, 1966a). A decrease in of 0.0272 
units corresponded to the decarboxylation of lpmol of phenylglyoxylate.
The enzyme was assayed in reaction mixtures containing (total volume
3ml):
500pmol (lml of 0.5M) potassium phosphate buffer, pH6.0
30nmol TPP (0.1ml of 300pM in 0.25M potassium phosphate buffer, pH7.0)
enzyme sample (usually 0.1M)
7.5pmol (0.1ml of 75mM) phenylglyoxylate, adjusted to pH6.0, to initiate the 
reaction .
2.17.4 Indirect,aldehyde dehydrogenase linked, assay for PGDC activity 
PGDC activity was measured by coupling the formation of benzaldehyde to
the reduction of NAD, catalysed by yeast aldehyde dehydrogenase (Barrowman 
Sc Fewson, 1985). NAD reduction was measured at 340nm; an increase of
2.07 units corresponded to the decarboxylation of lpmol of phenylglyoxylate.
The enzyme was assayed in reaction mixtures containing (total volume 
3. 0ml):
200pmol (2ml of 0.1M) potassium phosphate buffer, pH7.0 
6pmol (0.1ml of 60mM) NAD
200nmol TPP (0.1ml of 2mM in 0.25M potassium phosphate buffer, pH7.0)
1 unit yeast aldehyde dehydrogenase (added in 0.1ml in ImM DTT) 
enzyme sample (usually 50pl)
15pmol (0.1ml of 150mM) phenylglyoxylate, adjusted to pH7.0, to initiate the 
reaction.
The activity of each batch of aldeyhyde dehydrogenase was checked by 
measuring the rate of reduction of NAD in the presence of 3mM benzaldehyde.
It was also checked that aldehyde dehydrogenase was present in non-rate 
limiting concentrations for a given sample by measuring the rate of reduction 
of NAD in the presence of increasing concentrations of aldehyde dehydrogenase.
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2.17.5 Indirect, alcohol dehydrogenase linked, assay for PGDC activity 
This alternative indirect assay of PGDC activity was modified from the
method described by Ullrich (1970) for pyruvate decarboxylase. Here PGDC 
activity was measured by coupling the formation of benzaldehyde to the 
oxidation of NADH catalysed by horse liver alcohol dehydrogenase.
The enzyme was assayed in reaction mixtures containing (total volume 
3.0ml):
lmmol (2ml of 0.5M) potassium phosphate buffer, pH6.0 
0.5pmol (0.1ml of 5mM) NADH
17pg horse liver alcohol dehydrogenase (0.1ml of a 0.5mg protein ml  ^solution) 
200nmol TPP (0.1ml of 2mM in 0.25M potassium phosphate buffer, pH7.0) 
enzyme sample (usually 50pl)
15pmol (0.1ml of 150mM) phenylglyoxylate, adjusted to pH6.0, to initiate the 
reaction.
It was checked that the horse liver alcohol dehydrogenase was present in 
non-rate limiting concentrations for a given sample bymeasuring the rate of 
oxidation of NADH in the presence of increasing concentrations of alcohol 
dehydrogenase. Care was also taken to include a minus substrate blank to 
compensate for any NADH oxidase activity present in the sample.
2.17.6 BDH of A.calcoaceticus
BDH activity was measured by following the reduction of NAD at 340nm 
(Beggs & Fewson, 1977). An increase of 2.07 units corresponded to the oxidation 
of lpmol of benzaldehyde.
The enzyme was assayed in reaction mixtures containing (total volume 
3. 0ml):
200pmol (2ml of 0.1M) sodium pyrophosphate buffer, pH9.0 
6pmol (0.1ml of 60mM) NAD 
50pmol (0.1ml of 0.5M) KC1 
enzyme sample (usually 50pl)
0.3pmol (0.1ml of 3niM) benzaldehyde to initiate the reaction.
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2.17.7 NAD(P) dependent BDH's of P.putida
NAD and NADP dependent BDH activities were measured by following the 
reduction of NAD(P) at 340nm (Hegeman, 1966a). An increase of 2.07 units 
corresponded to the oxidation of lpmol of benzaldehyde.
The enzyme was assayed in reaction mixtures containing (total volume 
3. 0ml):
200pmol (2ml of 0.1M) Tris/HCl buffer, pH8.0 
2.5pmol (0.1ml of 25mM) NAD or NADP 
enzyme sample (usually 50pl)
3pmol (0.1ml of 30mM) benzaldehyde to initiate the reaction.
2.17.8 Mandelate racemase
This method was modified from that described by Hegeman (1966a).
Mandelate racemase activity was assayed as for DMDH activity (Methods 2.17.1) 
but in addition, a sufficient quantity (approx.3mg protein) of a 'wall + 
membrane' fraction of mutant strain C1005 which had been grown on complex 
media supplemented with D,L-mandelate (Methods 2.11.2) was added to give 
non-rate limiting amounts of LMDH. D-mandelate was added (0.1ml of 125mM) 
to initiate the reaction.
2.17.9 Catechol-1,2-dioxygenase
Catechol-1,2-dioxygenase activity was measured by following the 
production of cis, cis-muconate at 260nm in quartz cuvettes (Hegeman, 1966a). 
An increase in ^2^0 **• ^  units corresponded to the conversion of lpmol
of catechol to cis, cis-muconate.
The enzyme was assayed in reaction mixtures containing (total volume 
3. 0ml):
200pmol (2ml of 0.1M) potassium phosphate buffer, pH7.5 
4pmol (0.1ml of 40mM) EDTA
0.3pmol (0.1ml of 3mM) catechol (freshly prepared).
The reaction was initiated by addition of an enzyme sample (usually lOpl).
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2.17.10 Isocitrate dehydrogenase
Isocitrate dehydrogenase (ICDH) activity was assayed by the method of 
Borthwick et al. (1984) by following the reduction of NADP at 340nm. An 
increase in A-^q of 2.07 units corresponded to the oxidation of lpmol of 
isocitrate.
The enzyme was assayed in reaction mixtures containing (total volume 
3.0ml):
450pmol Tris/HCT buffer, pH7.5; 1.5pmol MnC^ (2ml of 225mM Tris/HCl buffer, 
pH7.5 containing 0.75mM MnC^)
1.2pmol (0.1ml of 12mM) NADP 
7.5pmol (0.1ml of 75mM) isocitrate.
The reaction was initiated by the addition of an enzyme sample (usually 20pl).
2.17.11 NADH oxidase
NADH oxidase activity was measured by following the oxidation of NADH 
at 340nm (Kennedy 81 Fewson, 1968b). A decrease in A^q of 2.07 units 
corresponded to the oxidation of lpmol of NADH.
The enzyme was assayed in reaction mixtures containing (total volume 
3.0ml):
50pmol (0.5ml of 0.1M) sodium pyrophosphate buffer, pH7.0
500nmol NADH (0.1ml of 5mM in 0.05M sodium pyrophosphate buffer, pH7.0).
The reaction was initiated by the addition of an enzyme sample (usually 50pl).
2.17.12 Glutamine synthetase
Glutamine synthetase was assayed by the pyruvate kinase and lactate 
dehydrogenase coupled procedure described by Kingston et al. (1968). In 
this method, the ADP produced by glutamine synthetase is converted to ATP 
by reaction with phosphoenol pyruvate (PEP) catalysed by pyruvate kinase.
The pyruvate thus produced is reduced by NADH in the presence of lactate 
dehydrogenase. The overall reaction was monitored by the oxidation of 
NADH at 340nm. A decrease in A ^ q of 2.07 units corresponded to the 
oxidation of lpmol of NADH and thus to the formation of lpmol of glutamine.
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• The enzyme was assayed in reaction mixtures containing (total volume 
3.0ml):
150pmol imidazole.HC1 buffer, pH7.0; 150pmol MgC^; 30pmol KC1; 120pmol 
NH^Cl; 300pmol. glutamic acid (2ml of 75mM imidazole HC1, pH7.0 containing 
75mM MgCH^, 15mM KC1, 60mM NH^Cl, 0.15M glutamic acid), 
lpmol (0.1ml of 30mM) NADH.
3pmol (0.1ml of 30mM) PEP 
22.8pmol (0.1ml of 228mM) ATP 
75pg pyruvate kinase (in 50pl)
150pg lactate dehydrogenase (in 50pl) .
The reaction mixture was allowed to equilibrate at 30°C for 10 min during 
which time traces of ADP and pyruvate would be consumed and about 0.lpmol NADH 
would be oxidised. When a stable baseline was reached, an enzyme sample was 
added to initiate the reaction.
2.18 3-Deoxy-2-keto-octonic acid determinations
3-Deoxy-2-keto-octonic acid (KDO) was measured by the thiobarbituric 
acid method of Keleti & Lederer (1974) as described by McDougall et al. 
(1983),
2.18.1 Stock solutions
(a) 0.05M H2S04
(b) acid periodate: 0.1M NalO^ in 0.2M HC1. This solution was
stored in a dark bottle.
(c) sodium arsenite:4% sodium arsenite (w/v) in 0.5M HC1
(d) thiobarbituric acid.’ a 0 .6% (w/v) solution was made as required 
by dissolving in boiling distilled water. The solution was allowed to cool 
to room temperature before use.
(e) butan-l-ol/HCl [95:5 (w/v)].
2.18.2 Method
Samples (0.2ml) and the standard KDO (0.323mg ml "*)and 2-deoxy-ribose 
(0.26mg ml "Ssolutions were incubated with ^ SO^ [(a); 0 .2ml] for 20 min at
50.
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100 C. The samples were al loured to reach toom temperature and 0.2ml acid
periodate (b) was added and incubated for 10 min. Sodium arsenite [(c);
0 .8ml] was then added and the samples were shaken until the yellow colour
was discharged. Thiobarbituric acid [(d); 3.2ml] was added and after shaking,
the solution was heated to 100°C for 10 min. After cooling, 4ml of butan-l-ol/
HC1 (e) was added and mixed. The samples were centrifuged at 1200g for 5 min
in an MSE Mistral 2L centrifuge at 4°C and the upper layer was removed by a
Pasteur pipette. The absorbance was measured at 508nm and 552nm. The
molar absorption coefficients (l.mol ^cm )^ were 3.46 x 10^ at 552nm and
6.88 x 10^ at 508nm for KDO and 2.42 x lO^at 552nmand 2.81 x 10^ at 508nm
for 2-deoxyribose.
2.19 pH measurement
The pH values of most solutions were determined \asing a direct reading 
pH meter (Model 7010; E.I.L. Ltd., Cumbernauld, Glasgow G67 1AG) connected 
to a combined glass electrode (224; Probion Ltd., Glenrothes, Fife KY6 3AE).
The pH values of small volumes were measured with a pH meter (Model PHM84; 
Radiometer, Copenhagen) fitted with an assembly containing microelectrodes.
2.20 Protein estimation
The method of Lowry et al. (1951) or Bradford (1976) was used to estimate 
the protein contents of samples using BSA as standard. Protein elution from 
columns was followed by measuring the A2gQ of the eluant.
2.21 Sodium dodecylsulphate polyacrylamide gel electrophoresis
(SDS PAGE)
These methods are based on Davis (1964) as modified by Hayes and Wellner 
(1969) and by Lumsden and Coggins (1977).
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2.21.1 Phosphate buffer method
2.21.1.1 Stock solutions
(a) 1M sodium phosphate buffer, pH6.5: a solution was prepared 
containing 81. Og Na2HP0^ 1  ^plus 59.3g Nal^PO^ 1 ^, the pH was checked and 
adjusted if necessary.
(b) 20% (w/v) SDS: the solution was stored , at 30°C.
(c) Acrylamide-bisacrylamide solution : 28g acrylamide and 0.735g
NN methylene bisacrylamide were made to 100ml with distilled water. This 
solution was stored at room temperature and used within one month.
(d) Running buffer: a solution of 0.1M sodium phosphate buffer, pH6.5 
containing 0.1% (w/v) SDS was prepared and stored at room temperature.
2.21.1.2 Gel plates
Glass plates (dimensions 9.5 x 20.cm and 10 x 20cm) were washed in 
Decon 75 to ensure they were free of silicon grease, then rinsed with distilled 
water. The plates were assembled using 1.5mn teflon spacers and silicon 
grease and placed into a home-made gel-making manifold suitable for making 
upto 4 gels at a time.
2.21.1.3 Preparation of gels [ 5%(w/v)]
A solution was prepared containing(additions in this order): 35ml
acrylamide-bisacrylamide stock solution (c); 141ml distilled water; 20ml
1M sodium phosphate buffer, pH6.5 (a); 1ml 20% SDS solution (b); lOOpl 
NjNjN'N'-tetramethylenediamine (TEMED) and 150mg anrnonium persulphate. The 
solution was de-gassed and poured into the gel-making manifold and 4 x 24 
track teflon combs were placed on top. The poured gels were allowed to 
polymerise, stored at 4°C and used within one week.
2.21.1.4 Preparation and loading of samples
Protein solutions were mixed with the following dissolving buffer:
0.25ml 20% (w/v) SDS; 50pl 2-mercaptoethanol; 1.0ml glycerol; 50pl 1M sodium
phosphate buffer, pH6.5; 0.1ml 0.5% (w/v) Bromophenol Blue; made to 5ml
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with distilled water. A volume of dissolving buffer at least equal to the 
protein solution was used; the maximum sample size was 35pl per track.
The dissolved protein samples were heated to 100°C for 5 min before loading 
onto the gel. Once the electrophoresis apparatus had been assembled and 
both reservoirs had been filled with running buffer, the samples were loaded 
onto the gel using a micropipette.
2.21.2 Electrophoresis conditions and sample running
The samples were electrophoresed at 80mA per slab gel which were cooled 
by circulating an ice/water slurry around the electrophoresis apparatus.
The electrophoresis was stopped when the dye had almost reached the bottom of 
the gel. The gel was then stained for protein (Methods 2.21.3).
2.21.3 Protein staining
The gels were stained with 0.1% (w/v) Coomassie Brilliant Blue G-250
in methanol/acetic acid/^O (50:10:40 by volume) for lh at 60°C. The gels
were destained with methanol/acetic acid/^O (10:10:80 by volume) at 60°C.
2.21.4 Tris/HCl buffer method (discontinuous SDS slab gels)
2.21.4.1 Stock solutions
(a) A solution was prepared containing 36.6g Tris and 0.23ml TEMED, the 
pH was adjusted to pH8.8 with concentrated HC1 and the volume was made to 
100ml with distilled water and stored at room temperature.
(b) Electrode buffer: 6g Tris; 28.8g glycine and 10ml 20% (w/v)
SDS were made to 21 with distilled water and stored at room temperature.
(c) Acrylamide-bisacrylamide solution: 28g acrylamide and 0.735g
NN methylene bisacrylamide were made to 100ml with distilled water. This 
solution was stored at room temperature and used within one month.
(d) A solution was prepared containing 19.2ml 0.1M Tris/HCl buffer, 
pH6 .8 ; 0.8ml 20% (w/v) SDS; and 0.05ml TEMED.
(e) 20% (w/v) SDS: the solution was stored at 30°C.
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2.21.4.2 Gel plates
Gel plates were prepared as described in Methods 2.21.1.2.
2.21.4.3 Preparation of gels
(a) Separating gel [ 12.5% (w/v)]
A solution was prepared containing: 25ml solution (a) Tris/HCl,
TEMED buffer, pH8 .8 ; 89.3ml acrylamide-bisacrylamide solution (c) (the
amount of solution (c) was adjusted as appropriate for lower percentage 
gels); 1ml 20% (w/v) SDS (e) and 82.2ml distilled water. This solution 
was degassed at room temperature before the addition of 150mg ammonium 
persulphate. The gel mixture was poured into the gel making manifold, 
overlayed with propan-2-ol and allowed to polymerise for 30 min. The layer 
of propan-2-ol was then washed off with distilled water and the top of the 
gels were blotted dry with filter paper.
t
(b) Stacking gel f 5.9% (w/v)]
A solution was prepared containing: 17.5ml acrylamide-bisacrylamide
solution (c); 10ml solution (d) containing Tris/HCl buffer, SDS, TEMED 
pH6.8 and 55ml distilled water. The solution was degassed before the 
addition of 150mg anmonium persulphate. The gel mixture was poured on top 
of the separating gel and 4 x 24 track teflon combs or 4 x single track 
combs (for prep.gels) were placed on top. The gels were left to polymerise 
for 30-60 min, stored at 4°C and used within one week.
2.21.4.4 Sample preparation
The sample buffer was prepared as follows: 1.5g SDS, 8g sucrose and
lOOpg pyronium Y was added to 10ml of 0.5M Tris/HCl buffer, pH8 .8 . The 
samples were mixed in the following way: 80pl of sample, 25pl 0.2M DTT
and lOpl of sample buffer. The sample was denatured by heating to 100°C 
for 5 min. The maximum sample volume was 35pl per track (or 1.5ml for single 
track prep, gel) and all samples were loaded onto the gel using a micropipette.
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2.21.4.5 Electrophoresis conditions and sample running 
Conditions were as described in Methods 2.21.2.
2. 21.5 Molecular mass calibration on SDS PAGE
Molecular mass estimations from SDS PAGE were made by calibrating gels 
with proteins of known Mr. A calibration kit (Pharmacia, Sigma or BDH) 
was used for this purpose and a typical standard curve obtained is shown 
(Figure 3A).
2.21.6 Gel scans
Gels were scanned using an LKB 2202 Ultroscan Laser Densitometer.
A typical gel scan of calibration proteins is shown in Figure 3B.
2.21.7 Photography
Gels were photographed by members of staff at the Medical Illustration 
Unit, University of Glasgow.
2.22 Immunob 1 otting method
This method is based on that described by Towbin et al. (1979) as 
modified by Batteiger et al. (1982).
2.22.1 Stock solutions
(a) Transfer buffer: a solution was prepared containing 0.19M glycine;
0.025M Tris; 0.02% (w/v) SDS and 20% (v/v) methanol.
(b). Blocking buffer: a solution of 0.02M Tris buffer, pH7.2
containing 0.15M NaCl and 0.5% (v/v) Tween 20 was prepared and stored at 
room temperature.
(c) First incubation buffer: a solution of 0.02M Tris buffer, pH7.2
containing 0.15M NaCl, 0.5% (v/v) Tween 20 and 5% (v/v) normal donkey serum 
was prepared as required.
(d) Second incubation buffer: a solution of 0.02M Tris buffer, pH7.2
containing 0.15M NaCl and 5% (v/v) normal donkey serum was prepared as 
required.
(e) Chloronapthol stain: a solution of 30mg HRP colour development
reagent in 10ml methanol, 50ml lOmM Tris buffer, pH7.2, 150pl 4% (v/v)
Figure 3 Standard curve of relative molecular mass calibration of
A sample of calibration proteins was subjected to SDS PAGE (Methods 
2.21.4) on 12.5% gels. A standard plot of log-^ Q Mr against values 
allowed calibration of a set of SDS gels (A) and a typical gel scan (B) 
is shown.
The calibration proteins used were (from Pharmacia) -
SDS PAGE
Protein Mr
Phosphorylase b 
Bovine serum albumin
94,000
67,000
Ovalbumin 45,000
Carbonic anhydrase 
Soybean trypsin inhibitor 
oc -Lactalbumin
30,000
20,100
14,400
log
 
M
r
55.
5-0
4-8
4-6
4-2
100-60-4
Rf value
B
START
«-------------------------- -TRACKER DYE
56.
H2O2 was mixed immediately before use.
2.22.2 Immunoblotting conditions
SDS PAGE was carried out (Methods 2.21.4). When electrophoresis was 
complete, the protein was transferred to 0.45p nitrocellulose paper (Anderman 
and Co., Kingston Upon Thames, Surrey, KT2 6NH) using a Bio-Rad Trans-blot 
cell containing transfer buffer (a). The transfer was run at 350mA for 
4h after which the nitrocellulose paper was placed in blocking buffer (b) 
and incubated at 4°C for at least 16h. The nitrocellulose paper was then 
transferred to the 'first incubation buffer' (c) to which the antibody of 
interest was added (usually a 1:200 dilution of the antibody). This was 
incubated at 23°C for 90 min after which the nitrocellulose paper was washed 
4 x 12 min in 0.02M Tris buffer, pH7.2 containing 0.15M NaCl and 0.5% (v/v) 
Tween 20 and then washed 1 x 12 min in 0.02M Tris buffer, pH7.2 containing 
0.15M NaCl. The nitrocellulose paper was placed in the 'second incubation 
buffer' (d) to which a 1:1000 dilution of HRP donkey anti-rabbit IgG was 
added and incubated at 23°C for 90 min. The nitrocellulose paper was 
washed 5 x 12 min in 0.02M Tris buffer, pH7.2 containing 0.15M NaCl, after 
which it was placed in the chloronapthol stain (e) for approx. 2 min and then 
washed in excess distilled water. The nitrocellulose paper was then dried 
and stored.
2.23 Column chromatography
2.23.1 Apparatus
The glassware and adaptors of the columns used were obtained from LKB 
Instruments Ltd. and Pharmacia Ltd. Solutions were pumped through the 
column using a 'varioperpex' peristaltic pump (LKB Instruments Ltd.) and the 
eluants collected with an automatic fraction collector (Model 7000 
Ultrarac, LKB Instruments Ltd.).
2.23.2 Column chromatography media
All column chromatography material was prepared and treated as advised 
by the instruction booklet of the appropriate manufacturer.
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2.23.3 Relative molecular mass estimations from gel filtration
Molecular mass estimations were made by gel filtration on columns 
calibrated with proteins of known molecular mass.
2.24 Purification of IMDH
All steps in the purification procedure were carried out at 4°C.
2.24.1 Preparation of a 'wall + membrane' fraction
Frozen bacteria [ 70g of mutant strain C1005 which had been grown on
complex medium plus D,L-mandelate (Methods 2.7.2)] were resuspended in 0.05M
potassium phosphate buffer, pH7.5 (0.5g wet wt ml and were disrupted by
four passages through a French pressure cell (Methods 2.9.2). The resulting
homogenate was centrifuged at 165,000g (40K rpm, Ti60 rotor) for 150 minav
and the pellet was washed twice by resuspension/centrifugation (Methods 
2.11.2) and resuspended to a final volume of 70ml. This fraction was either 
used immediately or stored at -20°C.
2.24.2 Preparation of Triton extract
The 'wall + membrane' fraction was diluted to 20mg protein ml  ^and
10% (w/v) Triton X-100 was added to a final concentration of 0.5mg of
detergent per mg of protein. The suspension was stirred gently for 30 min
and then centrifuged at 165,000g (40K rpm, Ti60 rotor) for 120 min.av
Ethanediol was added to the supernatant (' Triton extract') to a final 
concentration of 20% (v/v) and the Triton extract was then either used 
immediately or stored at -20°C.
2.24.3 Ion exchange chromatography I
The Triton extract was applied to a column of DEAE-Sephacel (20cm long 
x 5.2cm diam.) which had been equilibrated with 0.02M potassium phosphate 
buffer, pH7.5 containing 0.1% (w/v) Triton X-100, 100pm DTT and 20% (v/v) 
ethanediol. The column was washed (2-3 column volumes) with the same buffer 
containing 0.1M NaCl to remove unbound material. Protein was eluted by 
applying a linear gradient of 0.1-0.25M NaCl in the same buffer (total 
volume 2 1) at 60ml h  ^and fractions were collected at 6 min intervals.
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The A^gQ of the eluent was monitored and fractions were assayed for LMDH 
activity. Conductivities were measured with a radiometer (Copenhagen, 
Denmark) type CDM 2e conductivity meter.
2.24.4 Ammonium sulphate fractionation
Solid (NH^^SO^ (specially low in heavy metals for enzyme work) was
added to the pooled ion exchange fractions to give 15% saturation. When all
the (NH^SO^ had dissolved, the solution was stirred for 30 min before
centrifuging at 65,000g „ (25K rpm, 10 x 100ml Prepspin rotor) for 30 minav
at 4°C. More (NH^^SO^ was added to the resulting supernatant to give 30% 
saturation and the solution was again stirred at 4°C for 30 min and 
centrifuged as before. The floating material was then resuspended in 0.02M 
potassium phosphate buffer, pH7.5 containing 0.05% (w/v) Triton X-100, 
lOOpM DTT and 10% (v/v) ethanediol.
2.24.5 Gel filtration chromatography
The 15-30% (NH^^SO^ fraction of the ion exchange pool was applied to 
a. column of Ultrogel AcA-34 (71cm long x 5.2cm diam.) which had been 
equilibrated with 0.02M potassium phosphate buffer, pH7.5 containing 0.05% 
(w/v) Triton X-100, lOOpM DTT and 10% (v/v) ethanediol. Protein was eluted 
with the same buffer at 60ml h  ^and fractions were collected every 10 min. 
Fractions containing LMDH activity were pooled.
2.24.6 Ion exchange chromatography II
Pooled fractions from the gel filtration column were applied to a 
second column of DEAE-Sephacel (5cm long x 2.6cm diam.) pre-equilibrated 
with 0.02M potassium phosphate buffer, pH7.5 containing 0.05% Triton X-100, 
lOOpM DTT and 10% (v/v) ethanediol. The column was washed (2-3 column 
volumes) with the same buffer containing 0.1M NaCl. A linear gradient of 
0.1-0.25M NaCl was applied (total volume 400ml) at 20ml h and fractions 
were collected every 6 min. Fractions containing LMDH activity were pooled, 
ethanediol was added to a final concentration of 20% (v/v) and the pool was
stored at -20°C.
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2.25 Analysis of flavin in purified enzyme
The flavin content of LMDH was analysed as described by Allison 
et al. (1985b). This method involves extraction of non-covalently bound 
flavin by trichloroacetic acid (TCA). After addition of the ice cold 
TCA [final concentration 10% (v/v)] , the solution was incubated at 4°C 
for 15 min before centrifuging at 15,000g for 10 min. The protein 
precipitate was re-extracted with TCA in the same way. The combined 
extracts (supernatants) were extracted twice with 4 volumes of diethylether 
to remove the TCA. Residual diethylether was removed from the aqueous 
layer under a stream of The extract was neutralised by addition of
0.5ml of 1M potassium phosphate buffer, pH7.5 and made to a final volume 
of 3ml with 0.1M potassium phosphate buffer, pH7.5. The emission spectrum 
of the sample in a 3ml quartz cuvette was recorded in a Perkin-Elmer 
3000 fluorescencei spectrophotometer (exciting at 450nm) and compared with 
standard solutions of FAD and FMN.
2.26 Raising antiserum to LMDH
The recovery of LMDH at the final stage of the purification was poor
\
and so a modified version of the method of Mikara & Blobel (1980) was used 
to produce protein for injection. In this method a less purified sample 
may be used by first running on a SDS polyacrylamide gel and cutting out 
the band corresponding to the enzyme.
2.26.1 Concentration of gel filtration pool
The pooled fractions from the gel filtration column (Methods 2.24.5) 
were treated with (NH^^SO^ (Methods 2.24.4) to yield a 15-30% saturated 
fraction which was resuspended in 5-10ml of 0.02M potassium phosphate buffer, 
pH7.5 containing 0.05% (w/v) Triton X-100, lOOpM DTT and 10% (v/v) 
ethanediol.
2.26.2 Preparing LMDH for injection
The 15-30% (NH^^SO^ fraction (1.5ml) was applied to a single track
12.5% SDS gel (Methods 2.21.4). The gel was then stained with Coomassie
Blue (Methods 2.21.3) and destained (Methods 2.21.3).
The band corresponding to LMDH was cut out of the gel and washed in
distilled ^ 0  until the pH of the wash was 7.0. The gel was ground in 
liquid N2 and the powder was immediately transferred to the barrel of a 
2ml syringe. Distilled ^ 0  (0.5ml approx.) was added and the sample was 
sonicated for 3 x 30 sec using the microtip probe of the Dawe Soniprobe 
(Type 7332A; Dawe Instruments Ltd., London). An equal volume of Freund's 
complete adjuvant was added and the sonication was repeated. The emulsion 
was then injected into 1ml syringes. Subsequent samples were prepared 
with Freund's incomplete adjuvant.
2.26.3 Injection of rabbit and preparation of serum
This stage was carried out by Dr. I.D. Hamilton. A rabbit weighing 
4kg (approx.) was injected subcutaneously at several sites with the
equivalent of lOOpg (total) of LMDH. After 5 weeks a further lOOpg was
injected and a booster injection was given 2 weeks later. After a further 
two weeks, 50ml (approx.) of blood was collected from the r abb ids ear vein.
Blood samples were allowed to clot at room temperature and left 
overnight at 4°C. The serum was pipetted off and centrifuged at 15,000g for 
10 min to remove red blood cells. One ml samples were stored at -20°C.
2.26.4 Adsorption of LMDH antiserum
A sonic extract (Methods 2.9.1) (lOmg protein ml )^ of strain 8250 grown 
5mM succinate/salts medium (Methods 2.7.3) (i.e. containing no detectable 
LMDH activity) was denatured by boiling in the presence of 1.3% (w/v) SDS 
and 45mM DTT for 5 min. An equal volume of this denatured extract was 
incubated with LMDH antiserum for 4h at 23°C after which the sample was 
centrifuged in an Eppendorf 3200 centrifuge for 5 min. The supernatant 
(adsorbed antiserum) was stored in 1ml samples at -20°C.
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2.27 Antibody enzyme inhibition studies
Appropriate concentrations of enzyme extracts (lOOpl) were incubated 
with appropriate dilutions of antisera (lOOpl) for lh at 23°C. Enzyme samples 
were also incubated with buffer or normal rabbit serum as controls. The 
samples were centrifuged for 5 min in an Eppendorf 3200 centrifuge and 
enzyme activities were measured in the supernatants.
2.28 Immunoprecipitation studies
Appropriate concentrations of enzyme extracts (lOOpl) were incubated 
with undiluted antisera (lOOpl) or with normal rabbit serum or buffer as 
controls for lh at 23°C. Protein A-Sepharose (lOOpl) was added and the 
samples were incubated for a further hour at 23°C before immunocomplexes 
were precipitated by centrifuging for 5 min in an Eppendorf 3200 centrifuge.
2.29 Statistical methods
Means and standard deviations, correlation coefficients (r) and the 
Students t-test were calculated using a Casio fx-180P calculator (Casio 
Computer Co. Ltd.). All results are quoted as means + standard deviations 
with the number of determinations in parentheses.
2.30 Determination of kinetic constants
The Michaelis constant of LMDH for L-mandelate was determined by
measurement of initial velocities of enzyme activities with a range of
substrate concentrations. The Enzpack computer programme (Williams, 1985)
was used to calculate the K by the ’direct linear' method.m J
2.31 Glassware
2.31.1 General glassware
All growth flasks were cleaned before use by autoclaving in Hemosol 
solution (approx lOg 1 Meinecke and Co., Baltimore, USA). The glassware 
was thoroughly rinsed with tap water and then with distilled water before 
drying in an oven. Other glassware was washed in Hemosol, rinsed and 
dried.
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2.31.2 Pipettes
All pipettes were cleaned by soaking in 'Kirbychlor' disinfectant 
solution (H.and T. Kirby and Co.Ltd., Meldenhall, Suffolk) then in Hemosol 
solution followed by thorough rinsing in tap and deionised water and drying 
in an electrically heated pipette drier. All pipettes were plugged with 
non-absorbant cotton wool.
2.32 Safety
Bacterial cultures were killed by autoclaving before disposal. Any 
bacterial spillage was swabbed with 10% (v/v) propan-l-ol. All other 
precautions taken in the interest of safety were as described in the 
University of Glasgow Safety Handbook.
CHAPTER 3 RESULTS
Section 3.1 Separation of outer and inner membranes of 
A.calcoaceticus and location of lactate and 
mandelate dehydrogenases
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3.1.1 Introduction
Although the mandelate and lactate dehydrogenases of A.calcoaceticus 
strain NCIB 8250 have been designated as membrane-bound (Fewson & 
O'Donnell, 1981; Hills 8s Fewson, 1983a) it was not known whether these 
enzymes are inner or outer membrane proteins. Miura & Mizushima (1968) 
first demonstrated the separation of outer and inner membranes of E.coli 
after treating the bacteria with lysozyme. Subsequently, methods have 
been developed combining French press disruption with lysozyme treatment 
and sucrose density gradient centrifugation (Schnaitman, 1970; Thornley 
et al., 1973). Purified outer membranes have also been obtained by 
selectively solubilising the cytoplasmic membrane with detergents 
(De Pamphilis & Adler, 1971 a and b; Schnaitman, 1971). Since active 
enzymes were required in this present study, these latter methods 
involving digestion of the cytoplasmic membrane were not suitable.
Previous attempts to achieve lysis of A. calcoaceticus NCIB 8250 
by lysozyme had been unsuccessful (personal communications Prof. C.A. 
Fewson; Dr. L.M. Fixter). Separation of outer and inner membranes 
of Acinetobacter has been reported in strain H01-N after lysozyme 
treatment (Scott et al., 1976) and in strain MJT/FS/199A by a 
combination of French press disruption and lysozyme treatment (Thornley 
et al., 1973). However, this latter strain is oxidase positive and 
should probably be excluded from the genus Acinetobacter (McDougall 
et al., 1983). Nonetheless, it was thought that a combination of these 
methods might prove useful.
3.1.2 Separation of outer and inner membranes of A.calcoaceticus 
NCIB 8250
Preliminary attempts to separate outer and inner membranes of
A. calcoaceticus NCIB 8250 by combining French press disruption with 
lysozyme treatment as described by Thornley et al. (1973) were 
unsuccessful and so a method for lysozyme treatment of A. calcoaceticus
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NCIB 8250 was developed based on that described by Scott et al. (1976).
a) Time course for lysozyme treatment of strain C1219
Freshly harvested bacteria were incubated with lysozyme (Methods 
2.9.3.1) and samples were taken immediately and at various time intervals 
upto 150 min. The OD^qq and the ICDH activity released on diluting the 
samples in the absence and presence of 0.6M sucrose was measured (Figure 
4). ICDH is a cytoplasmic enzyme and therefore if any activity is 
released this indicates that disruption of bacteria has taken place.
Addition of lysozyme to the bacterial suspension had an immediate 
effect. Approx. 50% of the total cell lysis (based on ICDH released 
when the samples were diluted in cold distilled water) took place 
virtually immediately (Figure 4B). Since there was very little change 
in the OD^qq and since no ICDH was released when the samples were diluted 
in buffer containing 0.6M sucrose, it can be concluded that the 
spheroplasts formed as a result of lysozyme treatment are stable over 
the 150 min incubation period. Similar time course profiles were obtained 
for other mutant strains of A.calcoaceticus derived from the wild type 
strain NCIB 8250 (results not shown).
b) Investigation of centrifugation conditions required to separate 
outer and inner membranes
Attempts were made to separate the outer and inner membranes; NADH 
oxidase was used as a marker for the inner membrane and KDO was used as 
an outer membrane marker (Figure 5A).
The outer membrane remained in the supernatant and most of the inner 
membrane sedimented under the conditions of centrifugation used (Figure 5A); 
upto 70% NADH oxidase was recovered in the pellet whereas 95?0 KDO remained 
in the supernatant. The supernatant (outer membrane fraction) was 
contaminated with 30% of the inner membrane whereas the pellet fraction 
(inner membrane) showed little contamination (5%) by the outer membrane.
More inner membrane was sedimented when the sample was centrifuged for
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Figure 4 Time course for lysozyme treatment of mutant strain C1219 
Bacteria (mutant strain C1219) were treated with lysozyme (lOmg 
per g wet wt) in the presence of 0.05M Tris/HCl buffer, pH7.8 containing 
0.6M sucrose (Methods 2.9.3.1). Samples were taken over the 150 min
incubation period and were diluted in cold distilled water (--  ) or in
0.05M Tris/HCl buffer, pH7,8 containing 0.6M sucrose (--- ). The OD^qq
(A) of the bacterial suspension was measured before (• ) and after (o ) 
the addition of lysozyme. The ICDH activity (B) in the supernatants, 
obtained when the diluted samples were centrifuged for 5 min in an 
Eppendorf 3200 centrifuge, was measured before (4 ) and after (a ) the 
addition of lysozyme.
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Figure 5 Optimising the centrifugation times for separation of outer and 
inner membranes
Freshly harvested bacteria (mutant strain C1219) grown on complex 
media) were treated with lysozyme (Methods 2.9.3.1) and a crude membrane 
fraction was prepared (Methods 2.10) and centrifuged in an Eppendorf 3200 
centrifuge for various times. The pellets and supernatants were assayed 
for NADH oxidase, KDO and protein (A) and subjected to SDS PAGE on a 10% 
gel (Methods 2.21.4). Approx. 50pg protein was loaded on each track.
The gel was stained with Coomassie Blue (B) and standard proteins of 
known molecular mass (M) obtained from BDH Chemicals Ltd. were used to 
calibrate the gel:- ovotransferrin, M^ 77,000; albumin, Mr 67,000; 
ovalbumin, Mr 45,000; chymotrypsinogen A, Mr 25,700; myoglobin,
Mr 17,200 and cytochrome c, M^ 12,300. S = supernatant (outer membrane); 
P = pellet (inner membrane). Numbers refer to time of centrifugation 
(min).
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A. Centrifugation 
time 
(min)
Fraction
NADH
oxidase
KDO
(% of total)
Protein
1 supernatant 35 98 80
pellet 65 2 20
2 supernatant 36 98 80
pellet 64 2 20
5 supernatant 36 95 74
pellet 64 5 26
10 supernatant 30 95 76
pellet 70 5 24
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longer than 10 min, however, this resulted in a greater contamination of 
the inner membrane by the outer membrane (results not shown).
c) SDS PAGE of outer and inner membranes
The membrane fractions were analysed by SDS PAGE (Figure 5B). The 
outer and inner membranes showed different patterns on SDS PAGE although 
the patterns obtained were not altered by varying the time of centrifugation. 
The outer membrane fractions (supernatants) were dominated by four major 
proteins with apparent Mr values of 44,000, 28,000, 22,000 and 13,000. 
Cytoplasmic (inner) and outer membranes were separated in subsequent 
experiments by centrifuging for 10 min (Methods 2.10).
d) Analysis of outer and inner membrane fractions by electron 
microscopy
The outer and inner membrane fractions were examined by electron 
microscopy using the negative staining technique (Methods 2.13). The 
outer membrane fractions were a homogeneous suspension of open f C 1 
structures (Figure 6A) whereas the cytoplasmic membrane fractions were 
composed of larger fragments and vesicles of various sizes (Figure 6B).
3.1.3 Location of DMDH, LMDH, DLDH and LLDH
Outer and inner membrane fractions were prepared from mutant strain 
C1219, Each fraction was assayed for the four dehydrogenases - DMDH,
LMDH, DLDH and LLDH as well as for NADH oxidase and KDO (Table 2).
All four dehydrogenases showed the same pattern as NADH oxidase in 
terms of both percentage distribution and specific activities (Table 2); 
65-75% of the enzymes were located in the inner membrane fraction and 
so it can be concluded that DMDH, LMDH, DLDH and LLDH are cytoplasmic 
membrane proteins.
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Figure 6 Electron micrographs of outer and inner membranes
Membrane fractions were negatively stained with 1.5% phospho- 
tungstic acid, pH7.0 (Methods 2.13). After incubating at room 
temperature for 1 min, excess fluid was removed and the grids were air 
dried. A = outer membrane. B = inner membrane.
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Table 2 Distribution of lactate dehydrogenases and mandelate 
dehvdrogenses in the outer and inner membranes
Component Specific activity %  of total enzyme units
(munits per mg protein) KDO or protein
inner outer inner outer
membrane membrane membrane membrane
LMDH 1078 358 66 34
DMDH 252 59 74 26
LLDH 469 151 67 33
DLDH 890 281 68 32
NADH oxidase 183 66 65 35
KDO 5.4pg ml-1 104pg ml“^ 5 95
Protein 3.1 mg ml*"-*- 5.08pg ml--*- 40 60
Bacteria (mutant strain C1219 which had been grown on complex
media supplemented with D,L-lactate and D,L-mandelate) were treated with 
lysozyme (Methods 2.9.3.1) and outer and inner membrane fractions were 
prepared (Methods 2.10). Each fraction was assayed for LMDH, DMDH, 
LLDH, DLDH, NADH oxidase, KDO and protein and the results were expressed 
in terms of both specific activities and percentage of totals.
Section 3.2 Purification of L-mandelate dehydrogenase
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3.2.1 Introduction
Many preliminary experiments attempting to purify IMDH were carried
out in conjunction with the work on the purification of DMDH and DLDH 
by Drs. M.J. O'Donnell and N. Allison (also Allison et al., 1985b).
Neither IMDH nor LLDH had been purified to homogeneity, partly because 
of problems resulting from their sensitivity to high salt concentrations 
and low pH values.
3.2.2 Preliminary experiments on IMDH purification
IMDH was taken through purification stages which were based on those
for DMDH and DLDH (Allison et al., 1985b) but modified accordingly.
IMDH was solubilised from a 'wall + membrane' fraction by Triton X-100 
extraction (Methods 2.24.2) and the resulting Triton extract was treated 
with (NH^^SO^ (Methods 2.24.4). The 15-30% saturation (NH^SO^ fraction 
was resuspended in 0.02M potassium phosphate buffer, pH7.5 containing
0.17o (w/v) Triton X-100, lOOpM DTT and 10% (v/v) ethanediol and applied 
to a 1.4 1 gel filtration column (71cm long x 5.2cm diam.) of Ultrogel 
AcA 34 which had been equilibrated with the same buffer. Fractions 
containing IMDH activity were pooled and applied to a column (15cm long x 
2.6cm diam.) of DEAE Sephacel which had been equilibrated with 0.02M 
potassium phosphate buffer, pH7.5 containing 0.05% Triton X-100, lOOpM 
DTT and 20% (v/v) ethanediol. The column was washed (1-2 column volumes) 
with the same buffer before IMDH activity was eluted by a linear gradient 
of 0-250mM NaCl (total volume 500ml) at a flow rate of 20ml h
The pooled fractions from the ion exchange column were dialysed 
against 0.02M piperazine.HC1 buffer, pH5.7 containing 0.05% Triton X-100, 
100pM DTT and 5% (w/v) ethanediol. This dialysis resulted in a loss of 
50% of the IMDH activity. The IMDH sample was applied to the Pharmacia 
fplc Mono P chromatofocusing column which had been equilibrated with the 
same piperazine buffer. IMDH activity was eluted from the column by a 
1:8 dilution of Polybuffer 74, pH3.6 containing 0.05% Triton X-100, lOOpM DTT
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and 5% (v/v) ethanediol at a flow rate of 60ml h The pH of the 
fractions collected was immediately raised by the addition of lOOpl of 
1M potassium phosphate buffer, pH7.5. There was poor recovery (20%) 
of IMDH from this column and this may have been due to the instability 
of the enzyme at its isoelectric point.
The purification was monitored by SDS PAGE (Figure 7). It can be 
seen that unlike the DMDH and DLDH, this purification scheme did not 
result in a homogeneous preparation of IMDH. Three major protein bands 
were observed in the Mono P pool and these have apparent Mr values of 
66,000, 44,000 and 27,000. The possibility that IMDH is a multicomponent 
enzyme such as succinate dehydrogenase (Hederstedt & Rutberg, 1981) was 
discounted in preliminary experiments which showed that it was possible 
to separate these three proteins to some extent.
3.2.3 IMDH purification scheme
Since chromatofocusing proved unsuitable for purifying IMDH, it was 
necessary to investigate other methods for the final stage of the 
purification. The order of the purification scheme was altered so that 
gel filtration became the penultimate step thus avoiding the need to 
dialyse the sample'at this stage.
a) Triton X-100 extraction
A 'wall + membrane' fraction was prepared (Methods 2.11.2) from 70g 
of frozen bacteria, mutant strain C1005 grown on complex media 
supplemented with D,L-mandelate (Methods 2.7.2), and the protein 
concentration was adjusted to 20mg ml ^. IMDH was solubilised by Triton 
X-100 (Methods 2.24.2); 60-70% of the starting IMDH activity was
solubilised in this way and a 3-4 fold purification was achieved.
b) Ion exchange chromatography I
The Triton X-100 extract was applied to a column of DEAE Sephacel 
(Methods 2.24.3) and the elution profile is shown in Figure 8. The 
recovery from the column was 30-50% and a 3 fold purification was achieved.
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Figure 7 Gel scans of an SDS polyacrylamide gel of the ion exchange 
and Mono P IMDH pools 
The pooled fractions containing LMDH activity from an ion exchange 
column and that from the fplc Mono P column (see text for details) were 
subjected to SDS PAGE (Methods 2.21.4) on 10% gels. Proteins of known 
molecular mass (from Sigma) were used to calibrate the gel:- phosphory- 
lase b, Mr 97,400; albumin, Mr 67,000; ovalbumin, Mr 45,000; carbonic 
anhydrase, Mr 30,000; trypsin inhibitor, Mr 20,100. The gels were 
stained with Coomassie Blue and scanned (Methods 2.21.6).
A. gel scan of the ion exchange IMDH pool (approx. 50pg protein loaded).
B. gel scan of the Mono P IMDH pool (approx. lOpg protein loaded).
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Figure 8 Ion exchange chromatography I of LMDH
A Triton X-100 extract (Methods 2.24.2) was applied to an ion 
exchange column (20cm long x 5.2cm diam.) of DEAE Sephacel which had been 
equilibrated with 0.02M potassium phosphate buffer,pH7.5 containing 0.1?o 
(w/v) Triton X-100, lOOpM DTT and 20% (v/v) ethanediol. The column was 
washed (2-3 column volumes) with the same buffer containing 0.1M NaCl 
before IMDH activity (O ) was eluted by applying a linear gradient (X) 
of 0.1 - 0.25M NaCl (total volume 21) at a flow rate of 60ml h  ^ (Methods 
2.24.3). Fractions were collected every 10 min and the A^gQ (4 ) of the 
eluant was monitored.
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c) Ammonium sulphate fractionation
The pooled flections fxoro the ion exchange column wexe txeated with 
(NH^^SO^ (Methods 2.24.4) in oxdex to concentxate the sample befoxe 
applying to the gel filtxation column. The xecovexy of LMDH activity 
in the xesulting 15-30% satuxation (NH^^SO^ fxaction was vexy vaxiable 
(25-80%). This was pxobably due to Txiton X-100 being concentxated 
duxing the pxoceduxe causing inactivation of the enzyme. Nonetheless, 
a 2-3 fold purification was achieved at this stage.
d) Gel filtxation chxomatogxaphy
The 15-30% satuxation (NH^^SO^ fxaction was subjected to gel filtxation 
chxomatogxaphy on a column of Ultxogel AcA 34 (Methods 2.24.5). The 
elution pxofile is shown in Figure 9 and an example of a calibxation curve 
of the column is shown in Figure 10. IMDH activity eluted at a position 
coxxesponding to an appaxent Mr of 300,000. The xecovexy of LMDH activity 
fxom this column was appxox. 607o and a 2 fold purification was achieved.
e) Monitoxing the purification by SDS PAGE
The purification was monitoxed at this stage by SDS PAGE (Figure 11).
The gel filtxation pool was much purex than the ion exchange pool obtained 
in the pxeliminaxy expeximents (Figure 7A). Although thexe wexe sevexal 
contaminants in the gel filtxation pool, thexe was a majox band with an 
appaxent Mr of 44,000 and pxesumably this is IMDH (see also Figure 18).
The majox contaminant has an appaxent Mr of 66,000.
f) Testing methods fox the final stage of the LMDH purification
1. Mono Q fplc column
The pooled fxactions fxom a gel filtxation column wexe applied to 
the Mono Q fplc column which had been equilibxated with 0.02M potassium 
phosphate buffex, pH7.5 containing 0.05% (w/v) Txiton X-100, lOOpM DTT and 107 
(v/v) ethanediol. Aftex washing the column with 2 column volumes of the 
same buffex, the IMDH activity was eluted by a lineax gxadient of 0.05M
NaCl. The fxactions with IMDH activity wexe analysed by SDS PAGE (xesuits
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Figure 9 Gel filtration chromatography of LMDH
A 15-30% saturation (NH^^SO^ fraction (Methods 2.24.4) was applied 
to a 1.41 column (71cm long x 5.2cm diam.) of Ultrogel AcA 34 which had 
been equilibrated with 0.02M potassium phosphate buffer, pH7.5 containing 
0.05% (w/v) Triton X-100, lOOpM DTT and 10% (v/v) ethanediol (Methods 
2.24.5). LMDH activity (O ) was eluted by the same buffer at a flow 
rate of 60ml h”  ^and the ^SQ (* ^ t^ ie eluant was monitored.
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Figure 10 Calibration curve of AcA 34 (1.41) gel filtration column
The Ultrogel AcA 34 gel filtration column (71cm long x 5.2 cm diam.) 
was calibrated with proteins of known molecular mass in the presence (A  ) 
and absence (O) of 0.057o (w/v) Triton X-100.
The proteins used were:-
Mr
thyroglobin 669,000
ferritin 440,000
catalase 232,000
aldolase 158,000
BSA 67,000
ovalbumin 45,000
chymotrypsinogen 
cytochrome c
25,000
12,300
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Figure 11 SDS PAGE of the LMDH purification
A sample was taken at each stage of the IMDH purification (Methods
2.24) and subjected to SDS PAGE (Methods 2.21.4) on a 12.5% gel which 
was stained with Cocmassie Blue (A). Approx. 50pg of protein (or lOyg 
in the case of the gel filtration pool) was loaded per track. The gel 
was calibrated with proteins of known molecular mass (M) from Pharmacia:- 
phosphorylase b, Mr 94,000; bovine serum albumin, Mr 67,000; ovalbumin, 
Mr 45,000, carbonic anhydrase, Mr 30,000; soyabean trypsin inhibitor,
Mr 20,100 and oC-lactalbumin, M^ 14,400. WM = 'wall + membrane' fraction;
TE = Triton X-100 extract; IE = ion excahnge pool; AS = 15-30%
saturation ammonium sulphate fraction, GF = gel filtration pool which 
had been concentrated 10 fold (Methods 2.26.1). The gel scan of the
IMDH gel filtration pool is shown (B).
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not shown) and the contaminating band with an apparent Mr of 66,000 was 
present in all fractions across the peak. Varying the gradient and 
changing the pH to 6.5 did not allow purification of IMDH.
2. Adsorption chromatography using hydroxyapatite (HA) Ultrogel
At the same time as these experiments on IMDH purification were 
carried out, Dr. N. Allison was working on the LLDH purification. This 
enzyme had been purified to 807o homogeneity using HA Ultrogel at the final 
stage of the purification. Preliminary experiments with IMDH on a column 
of HA Ultrogel were carried out by Mr. A. Scott. Better recovery of 
activity was obtained when the chromatography was run at pH6.5 and so in 
these experiments the gel filtration column was equilibrated and run in 
0.05M MES buffer, pH6.5 containing 0.05% (w/v) Triton X-100, lOOpM DTT 
and 10% (v/v) ethanediol. The IMDH gel filtration pool was applied to a 
column of HA Ultrogel equilibrated with the same buffer and IMDH activity 
was eluted from the column by a linear gradient of O-lOOmM K^PO^. When 
the fractions were analysed by SDS PAGE (results not shown) it was seen 
that although the contaminating proteins eluted at a lower K^PO^ 
concentration (15mM) than the IMDH activity (30mM), the major band was 
also present in the fractions containing IMDH activity (due to trailing). 
Attempts to manipulate the gradient so that the contaminants could be 
washed from the column (by washing with 15mM fG^PO^) before eluting the 
IMDH activity were unsuccessful. This was because when the column was 
washed with buffer containing 15mM K^PO^, both the contaminating proteins 
and the IMDH eluted at higher K^PO^ concentrations (75mM and 90mM 
respectively) than previously observed. In addition, there were two 
peaks of IMDH activity. This irreproducible behaviour on the HA Ultrogel 
may indicate that more than one mechanism is involved in separation on 
this column e.g. the HA Ultrogel may also be behaving as an ion exchanger.
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3. Ion exchange chromatography II
An LMDH gel filtration pool was subjected to ion exchange 
chromatography on a column of DEAE Sephacel (Figure 12). There was 
good recovery (607o) of LMDH activity from this column, although, in an 
effort to obtain a purer sample, only 40% of the activity was pooled. 
The pool containing LMDH activity was concentrated (Methods 2.26.1) 
and subjected to SDS PAGE (Figure 13). Since there was very little 
protein in this final sample, concentration by ammonium sulphate 
precipitation resulted in a substantial loss of protein owing to the
difficulty in recovering the floating material (see Methods 2.24.4).
TMAlternative methods of concentrating the sample e.g. using Minicon - B 
macrosolute concentrators (Amicon Corporation, Danvers, M.A. 01923, 
USA) were also unsatisfactory possibly because Triton-protein 
micelles adhered to the membranes of these concentrators.
As much as possible of the concentrated ion exchange II LMDH pool was 
applied to the SDS polyacrylamide gel shown in Figure 13A and it can be 
seen from the gel scan (Figure 13B) that there was some contamination 
of the LMDH. The procedure outlined in Methods 2.24 resulted in the 
purification of LMDH almost to homogeneity and the purification is 
summarised in Table 3.
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Figure 12 Ion exchange chromatography II of IMDH
A gel filtration pool of IMDH (Methods 2.24.5) was applied to a 
column (5.0cm long x 2.6cm diam.) of DEAE Sephacel which had been 
equilibrated with 0.02M potassium phosphate buffer, pH7.5 containing 
0.05% (w/v) Triton X-100, lOOpM DTT and 10% (v/v) ethanediol. The 
column was washed with 2-3 column volumes of the same buffer containing 
0.1M NaCl before LMDH activity (O ) was eluted by applying a linear 
gradient (X) of 0.1 - 0.25M NaCl (total volume 500ml) at a flow rate of 
20ml h~^ (Methods 2.24.6). The ^80 ^  ^  eltiant was monitored.
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Figure 13 SDS PAGE of the gel filtration and ion exchange II LMDH pools 
The pools from a gel filtration (Methods 2.24.5) and ion exchange II 
column (Methods 2.24.6) were subjected to SDS PAGE (Methods 2.21.4) on a 
12.5% gel which was calibrated with Pharmacia molecular mass proteins (M).
A. Coomassie Blue stained gel; GF = gel filtration LMDH pool;
IE II = ion exchange II LMDH pool. Both samples were concentrated 
(Methods 2.24.4) 10 fold before applying (approx. lOpg and 4pg protein 
respectively) to the gel.
B. Gel scan of the ion exchange II IMDH sample.
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Section 3.3 Characterisation of purified L-mandelate 
dehydrogenase
3.3.1 Introduction
The properties of the purified IMDH were studied to allow a comparison 
with those of the purified IMDH, DLDH and LLDH.
3.3.2 Relative molecular mass
Analysis of the purified IMDH by SDS PAGE gave an apparent Mr of 
44,000 + 800 (n=20). Gel filtration of the purified sample on a column 
(30cm long x 0.7cm diam.) of Ultrogel AcA 34 which had been calibrated 
with proteins of known molecular mass gave an apparent Mr of 64,000 
(average of two determinations).
3.3.3 The effect of pH on IMDH activity
The enzyme has a fairly broad pH range with the half maximal activity 
at pH5.2 and pH8.95 (Figure 14). The optimum pH of the purified IMDH is
pH7.5.
3.3.4 Determination of K-----------------m
The Km of the purified IMDH was calculated by measuring the activity 
at different substrate concentrations (Methods 2.30). For convenience 
the results are illustrated as direct plots and as Lineweaver-Burk plots 
(Figure 15). Using the Direct Linear plot on the Enzpack computer 
programme (Williams, 1985), the calculated Km was 186 + 19pM (n=3).
3.3.5 The effect of substrates on IMDH activity
IMDH was found to be completely stereospecific for its substrate i.e. 
L-mandelate but not D-mandelate was oxidised by this enzyme. Neither 
D-lactate nor L-lactate gave detectable rates of DCIP reduction even at 
a final concentration of 2mM.
D-mandelate inhibited IMDH activity only at high concentrations 
(^ . lOmM) and only when L-mandelate was present at a low concentration 
e.g. when L-mandelate was present at a concentration of lOOpM, lOmM 
D-mandelate inhibited IMDH by 36% and 20mM D-mandelate inhibited IMDH 
by 60%. L-lactate and D-lactate did not affect IMDH activity even at
84.
Figure 14 The effect of pH on IMDH activity
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The pH of the LMDH assay was varied over the range pH5.1 to pH9.6 
by adjusting the pH of the phosphate buffer. The absorption coefficient 
for DCIP was determined at each pH and used in the calculation of rates. 
The percentage of the maximum activity is plotted against the actual pH 
of the reaction mixture.
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Figure 15 Determination of Km of purified LMDH
An example of the results obtained when LMDH activity was determined 
at six different substrate concentrations is plotted as a direct plot 
(A) and as a Lineweaver-Burk plot (B) which has a correlation coefficient 
of 0.997.
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concentrations of 20mM in the presence of lOOpM L-mandelate.
3.3.6 The effect on LMDH activity of reagents which react with
sulphydryl groups
The effect on LMDH activity of various thiol group inhibitors is shown 
in Table 4. Iodoacetate had no effect on the enzyme activity. The 
enzyme was slightly more sensitive to inhibition by N-ethylmaleimide than 
iodoacetamide. LMDH was completely inhibited by lOpM mercuric chloride 
whereas 30pM p-chioromercuribenzoate inhibited the enzyme by 53%.
3.3.7 The effect on LMDH activity of metal chelating reagents
and related compounds
LMDH was unaffected by the metal chelators EDTA and 2,2' -bipyr idyl 
at the concentrations tested (Table 5). Similarly, azide and cyanide did 
not effect enzyme activity.
3.3.8 Analysis of flavin
The difference spectrum of pure LMDH with and. without substrate 
(Figure 16) showed a peak at 400rm with a shoulder between 420 and 460nm. 
Addition of dithionite produced almost exactly the same effect as 
substrate (Figure 16).
Treatment of the purified LMDH with cold TCA (Methods 2.25) resulted 
in an extract whose emission fluorescence spectrum (exciting at 420rm) 
was identical to that of standard solutions of FAD and FMN (Figure 17).
The emission fluorescence spectrum of the standard solutions and of the 
TCA extract of LMDH was abolished by the addition of dithionite. The 
addition of a small crystal of Na/ja naja snake venom to the standard 
solution of FAD resulted in a 9 fold increase in the fluorescence at 
520nm (Figure 17A) corresponding to the conversion of FAD to FMN by the 
phosphodiesterase in the snake venom (Bessey et al., 1949). However, 
the Naja naja snake venom had no effect on the emission fluorescence 
spectrum of the standard solution of FMN or of the TCA extract of LMDH 
(Figure 17B,C). This suggests that FMN is the flavin prosthetic group
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Table 4 The effect on LMDH activity of reagents which react with
sulphydryl groups
Inhibitor Concentration %  activity remaining
(mM)
N-ethylmaleimide 1 64
5 23
Iodoacetamide 5 66
10 31
Iodoacetate 5 101
10 98
Mercuric chloride 0.001 50
0.01 0
p-Chloromercuribenzoate 0.03 47
0.3 24
The inhibitors were preincubated with the enzyme and phosphate 
buffer (total volume 2.5ml) for 10 min at 27°C before addition of the 
remaining reaction components. The inhibitor concentration refers to 
the final concentration in the assay.
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Table 5 The effect on LMDH activity of metal chelators and related 
components
Potential inhibitor 
EDTA
2,2*-bipyridyl
KCN
NaN3
Concentration
(mM)
1
4
10
10
% activity remaining
98
97
102
101
The potential inhibitors were preincubated with the enzyme and 
phosphate buffer (total volume 2.5ml) for 10 min at 27°C before the 
addition of the remaining reaction components. The concentration refers 
to the final concentration in the assay.
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Figure 16 -Difference spectrum of purified LMDH
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The difference spectrum of the purified enzyme was obtained by 
measuring absorption spectra thus -
Reference cell Sample cell
LMDH + 6pmol L-mandelate LMDH —
LMDH + 6pmol L-mandelate LMDH + dithionite--------
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Figure 17 The emission fluorescence spectra of standard solutions of 
FAD and FMN and of a TCA extract of LMDH 
The emission fluorescence spectra, exciting at 420nm (Methods
2.25) of a standard solution (0.25pM) of FAD (A) and of a standard 
solution (lpM) of FMN (B) and of a TCA extract of LMDH (C) is shown (o ). 
The effects of the addition of dithionite (X) and of Naja naja snake 
venom ( A) are shown.
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of LMDH.
3.3.9 Preparation of antiserum against LMDH
The recovery of LM)H at the final stage of the purification was poor 
and so a less purified sample (a concentrated gel filtration pool) was 
used to prepare the antigen (Methods 2.26). The sample was run on a 
12.5% SDS polyacrylamide preparative gel (Methods 2.26.2; Figure 18) 
and the band corresponding to LMDH was cut out and treated as described in 
Methods 2.26.2.
3.3.10 Antibody - enzyme inhibition studies
Studies to investigate possible enzyme inhibition by the antiserum 
raised against LMDH were carried out on sonic extracts of mutant strain 
C1219 and of mutant strain C1005 and on the purified enzyme (Methods 2.27). 
However, under conditions which resulted in 73% inhibition of DMDH by 
anti-DMDH and 95% inhibition of PGDC by anti-PGDC, no inhibition of LMDH 
was observed in crude extracts or of the purified enzyme by the antiserum 
raised against LMDH.
3.3.11 Imnunoblots of extracts from various A ,calcoaceticus strains
with anti-LMDH
Extracts from non-induced strain NCIB 8250 (no LMDH activity present), 
induced strain NCIB 8250 (IMDH activity present), mutant strain C1005 
(LMDH activity present), mutant strain C1219 (LMDH activity present), 
mutant strain C1123 (no LMDH activity present) and mutant strain C1408 
(no LMDH activity present) were blotted with antiserum raised against 
IMDH (Figure 19A).
There was a band with an Mr value of approx. 44,000 in extracts of 
induced NCIB 8250, mutant strain G005 and mutant strain C1219 i.e. 
those extracts with LMDH activity but not in the other extracts which had 
no LMDH activity. In addition there was a major contaminating band 
(M = 61,000) in all extracts as well as a few other minor contaminants.
Figure 18 LMDH preparative gel used to prepare the LMDH antigen 
A concentrated gel filtration pool of LMDH (Methods 2.26.1) 
containing 250pg of protein in 1.5ml was run on a 12.5% preparative 
gel (Methods 2.26.2) which was stained with Coomassie Blue to reveal the 
band pattern shown. The band corresponding to LMDH was cut out of the 
gel and ground in liquid The resulting powder was prepared for
inj ection (Methods 2.26.2).
91.
LU
>
Q
CC
LU
—I
'ir
93a.
Figure 19 Immunoblots of sonic extracts from various strains of 
A.calcoaceticus with anti-LMDH 
Sonic extracts from strain 8250 grown on succinate (Methods 
2.7.3) and from strains 8250, C1005, C1219 and C1123 grown on complex 
media supplemented with D,L-mandelate and from mutant strain C1408 
grown on complex media supplemented with phenylglyoxylate were subjected 
to SDS PAGE on 12.5% gels (Methods 2.21.4) and subsequent immunoblotting 
with anti-LMDH (Methods 2.22) before (A) and after (B) adsorption of 
the anti-LMDH with non-induced extract (Methods 2.26.4). NI = non­
induced; I = induced. The positions of standard molecular mass 
proteins (Pharmacia) are indicated. These were run alongside the 
extracts but were stained for protein (not shown).
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Since the contaminating bands were present in the blot of the 
non-induced 8250 extract it was hoped that the anti-LMDH could be 
adsorbed using this extract. In initial experiments, anti-LMDH was 
incubated with a non-induced extract from NCIB 8250 grown on succinate 
(Methods 2.7.3); however, there was no change in the immunoblotting 
pattern observed after this treatment. When the non-induced extract was 
first denatured and then incubated with anti-LMDH (Methods 2.26.4), only 
one band, corresponding to LMDH, was detected on immunoblots of extracts 
from induced NCIB 8250, mutant strain C1005 and mutant strain CL219 
(Figure 19B). So, although the antiserum raised against LMDH does not 
inhibit activity (Results 3.3.10), it gives a positive reaction on 
immunoblotting extracts with IMDH activity.
Section 3.4 Development of PGDC assay
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3.4 Development of PGDC assay
During the course of this study, problems were encountered with the 
PGDC assay procedure. In some cases the correlation between results 
using the direct PGDC assay (Methods 2.17.3) and the yeast aldehyde 
dehydrogenase-linked PGDC assay (Methods 2.17.4) was very poor. When 
NADH oxidase activity was present in the samples, the PGDC value obtained 
with the aldehyde dehydrogenase-linked assay was much lower than that 
obtained with the direct PGDC assay. This was probably a result of NADH 
oxidase consuming the NADH produced during the coupled aldehyde 
dehydrogenase reaction (Figure 20A).
An alternative assay was therefore developed involving coupling 
PGDC activity with horse liver alcohol dehydrogenase by a modification 
of the method described by Ullrich (1970) for pyruvate decarboxylase.
The use of horse liver alcohol dehydrogenase in a coupled assay has several 
advantages:
a) the coupled reaction involves the oxidation of NADH (Figure 20A) 
and it should therefore be possible to correct for NADH oxidase activity 
in samples by including a minus substrate (phenylglyoxylate) cuvette as 
a control.
b) this coupled reaction is measured at pH6.0 (the optimum pH for PGDC) 
at which pH the NADH oxidase activity is decreased (Figure 20B).
c) the equilibrium favours benzyl alcohol formation, especially at 
low pH.
Since potassium phosphate is a poor buffer at pH6.0, PGDC activity 
was measured in potassium phosphate buffer, pH6.0 and in MES buffer, pH6.0; 
nevertheless a higher PGDC activity was obtained in the presence of 
potassium phosphate buffer.
The concentrations of potassium phosphate buffer, NADH, TPP, 
phenylglyoxylate and alcohol dehydrogenase were varied systematically and 
the assay condition described in Methods 2.17.5 resulted in maximal PGDC
Figure 20
A. Mechanism of ind irec t PGDC assays.
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For each set of samples, the assays were carried out with 0.5, 1.0 
and 2.0 times the amount of alcohol dehydrogenase in the assay to ensure 
that the alcohol dehydrogenase was present in non-rate limiting 
concentrations. In most cases, this was only true when the extract to 
be assayed was diluted. When alcohol dehydrogenase was present in non-rate 
limiting concentrations, the assay rate was proportional to the amount of 
enzyme extract added and the assay was linear with respect to time upto 
approx. 10 min.
The reproducibility of the alcohol dehydrogenase-linked PGDC assay 
was studied by assaying different volumes of a given sample. For example 
in an experiment using a sonic extract of mutant strain C1005 grown on 
complex media supplemented with D,L-mandelate, a value for PGDC activity 
of 926 + 26 enzyme units ml  ^ (n=6) was obtained by the alcohol 
dehydrogenase-coupled assay. In addition, the same sample was assayed 
by the direct PGDC assay procedure (Methods 2.17.3) and a value of 
976 _+ 31 enzyme units ml  ^ (n=6) was obtained, illustrating a good 
correlation between the two assay procedures.
Section 3.5 Enzyme interactions in the mandelate pathway
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3.5.1 Crosslinking intact Pseudomonas putida with DMSI
Halpin et al. (1981) claimed to have evidence for an association 
between the mandelate enzymes of P.putida and so as a first step, some 
of the experiments described in this paper were repeated and expanded.
P.putida were treated with DMSI in the presence of TNM buffer, pH8.0 
as described by Halpin et al. (1981) and in Methods 2.14.3. In addition, 
aldolase was treated with DMSI at the same time but separately to check 
that the crosslinking reagent was working. After disrupting the bacteria 
by sonication the extracts were analysed by high speed centrifugation as 
specified by Halpin et al. (1981). Table 6 shows the results obtained 
from control and DMSI treated P.putida. In these experiments catechol-1, 
2-dioxygenase (CO) was used as a control 'soluble' enzyme from a separate 
but related part of metabolism (Figure 1) and isocitrate dehydrogenase 
(ICDH) and glutamine synthetase (GS) were used as control 'soluble' 
enzymes from unrelated parts of metabolism. Furthermore, GS served as 
an example of an enzyme with a high Mr (i.e. 600,000) whereas ICDH was an 
example of an enzyme with a lower Mr (i.e. 100,000). Halpin et al. (1981) 
also used GS as a control enzyme but they assayed cis, cis-muconate 
lactonising enzyme (Figure 1) instead of CO.
In general, DMSI did not affect the total specific activities of the 
enzymes, although IMDH was slightly inhibited (Table 6). There was a 
5-50 fold increase in the specific activities of the 'soluble' enzymes of 
the mandelate pathway present in the high speed pellet after DMSI treatment. 
However, this was not a specific effect since the specific activities of 
CO, ICDH and GS in the pellet were also increased by the same extent 
(Table 6). No increase in the specific activities of the enzymes in the 
pellet was observed after EMSI treatment of stationary phase bacteria 
(results not shown).
The results reported by Halpin et al. (1981) are shown in Table 7 and 
it can be seen that these data are similar to those shown in Table 6.
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Table 6 Crosslinking intact P.putida with DMSI
Enzyme Total specific 
activity 
(munits/mg protein)
Specific activity 
in pellet 
(munits/mg protein)
%  recovered 
in pellet
Control DMSI Control DMSI Control DMSI
LMDH 309 247 661 622 95 97
Mandelate-
racemase 433 408 2.2 100 0.2 9.4
PGDC 215 248 2.9 13.3 0.6 2.1
NAD-BDH 79 76 ND ND ND ND
NADP-BDH 49 56 0.8 7.3 0.7 5
CO 498 499 2.7 40 0.2 3.1
ICDH 524 412 2.9 33 0.3 3.1
GS 25 33 2.3 18 4.2 22
Protein — 45 38
P.putida was grown on minimal mandelate media (Methods 2.7.4), 
harvested in late exponential phase and treated with DMSI in the presence 
of TNM buffer, pH8.0 (Methods 2.14.3). After disrupting the bacteria by 
sonication (Methods 2.9.1), the extracts were centrifuged at 105,000gav 
(40K rpm, Ti50 rotor) for 60 min and the ’high speed pellets’ so formed 
were washed three times by resuspension/centrifugation. The pellets, 
supernatants and washes were assayed for enzyme activity so that the 
results could be expressed in terms of the percentage of the total enzyme 
activity recovered. The total specific activities (here and in all 
subsequent experiments) were derived from the addition of the enzyme 
units and protein recovered in the pellet, supernatant and washes of each 
sample. ND = not detectable.
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Table 7 Results of Halpin et al. (1981) for the crosslinking of
intact P.putida with DMSI
Enzyme Specific activity in pellet
(munits/mg protein)
Control DMSI .
LMDH 746 629
Mandelate-racemase 8 178
PGDC 2 18
cis «cis-muconate-
lactonising enzyme 2 23
GS 0 32
The pellet was obtained from sonic extracts from control and DMSI 
treated bacteria by centrifuging at 100,000g for 60 min.
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An 11-32 fold increase in the specific activities of the control enzymes 
(cis, cis-muconate lactonising enzyme and GS) was reported but no emphasis 
was placed on this (Halpin et al., 1981).
Halpin et al. did not express their results in terms of total percent 
of enzyme, nor did they provide sufficient information in this paper so 
that the percentages could be calculated. When the results from my 
experiments were expressed in this way (Table 6) it can be seen that the 
amount of the 'soluble' mandelate enzymes recovered in the pellet fraction 
after DMSI treatment (2-9%) is very small in relation to the amount of IMDH 
(97%) present.
Halpin et al. (1981) also analysed sonic extracts from control and 
DMSI treated P.putida by gel filtration chromatography on Ultrogel AcA 22. 
Similar experiments were repeated (Figure 21) but Ultrogel AcA 34 was used 
because of its higher resolving power. Mandelate-racemase and PGDC 
elution profiles (Figure 21) from control extracts showed two peaks of 
activity, one corresponding to the reported (280,000 and 90,000 
respectively) and in the case of mandelate-racemase, a lower Mr peak 
(200,000) was observed whereas a higher M^ peak of PGDC activity (200,000) 
was observed. These multiple peaks of enzyme activity may be due to the 
buffer conditions used i.e. TNM buffer, pH8.0 which was used to allow 
comparison with the results reported by Halpin et al. (1981). The 
sharpness of the NAD-BDH peak (Figure 21) indicates that the column itself 
was satisfactory. All the enzymes assayed (except NAD-BDH) showed higher 
Mr species after DMSI treatment although only mandelate-racemase, PGDC 
and CO gave sharp peaks with high Mr values. With the exception of 
NAD-BDH, the enzymes eluted over a broad range of Mr values after DMSI 
treatment.
3.5.2 Crosslinking intact A.calcoaceticus
Although only non-specific crosslinking was observed in P.putida a 
series of experiments was carried out with A. calcoaceticus in the hope
102a.
Figure 21 Gel filtration chromatography of extracts from control and 
DMSI treated,P.putida 
Sonic extracts from control (o— o) and DMSI (•■ •) treated 
bacteria (Methods 2.14.3) were applied to a 1.41 column (71cm long x 
5.2cm diam.) of Ultrogel AcA 34 which had been equilibrated with TNM 
buffer, pH8.0. Enzyme activities were eluted by the same buffer at a 
flow rate of 60 ml h The column was calibrated with proteins of 
known Mr values and the elution position of four are indicated i.e. 
thyroglobin, Mr = 669,000; ferritin, Mr = 440,000; aldolase,
M^ = 158,000 and ovalbumin, Mr = 43,000. The elution volume of Blue 
Dextran (approx. Mr = 2,000,000) was taken to indicate the void volume.
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that specific crosslinking could be achieved.
A. calcoaceticus, mutant strain C1005, was treated with DMSI, 
disrupted by sonication and analysed by high speed centrifugation. The 
results obtained for A.calcoaceticus (Table 8) were similar to those for P. 
putida (Table 6) and LMDH (total specific activity) was inhibited by the 
DMSI treatment. There was an approx. 10 fold increase in the specific 
activity of PGDC recovered in the pellet and this corresponded to 1% of 
the total activity. However, as with P.putida the specific activities 
of the 'soluble'enzymes were also increased (Table 8) and the increase 
was observed only in exponentially growing bacteria.
Experiments which are summarised below were undertaken to try to 
achieve specific crosslinking (results not shown).
a) Different strains of A.calcoaceticus (strain 8250, mutant strains 
C1219 and C1123 ) gave similar results.
b) Different dimethylimidates (structures R-tG^) -R) i.e. 
diuKthylmaloaiiiiidate (n=i); aimethyisuccinimidate (n=2);
dime thy lglutarimidate (n=3); dimethyl adipimidate (n=4); DMPI (n=5) 
and DMSI (n=6), all of which crosslink lysine residues, were studied.
In addition, the effect of PDM which crosslinks sulphydryl groups was 
also investigated. No specific crosslinking was observed and in all 
cases LMDH (total specific activity) was inhibited. Slightly more of 
the 'soluble' enzymes (approx. 37o in the case of PGDC) were recovered in 
the pellet after crosslinking with DMPI than with any of the other 
crosslinkers.
c) Slightly more crosslinking (upto 6% PGDC associated with the 
pellet) was observed after bacteria had been treated with toluene in 
the presence of 8.5% (w/v) PEG (Methods 2.12). A 3-20 fold increase 
in the specific activities of the 'soluble' enzymes in the pellet was 
also observed in stationary phase bacteria after toluene/PEG treatment.
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Table 8 Crosslinking A.calcoaceticus mutant strain C1005 intact 
bacteria with DMSI
Enzyme Total specific
activity 
(munits/mg protein)
Specific activity 
in pellet 
(munits/mg protein)
%  recovered 
in pellet
Control DMSI Control DMSI Control DMSI
LMDH
PGDC
BDH
CO
ICDH
GS
Protein
90
166
86
82
157
53
63
166
79
175
166
63
184
0.7
ND
12
6
10
200
8.0
ND
49
27
28
57
O.l'l
ND
4.2 
3.5
5.2 
18
63
1.0
ND
5.6
3.2
8.8
20
A.calcoaceticus mutant strain C1005, grown on complex media
supplemented with D,L-mandelate, were harvested in late exponential phase
and treated with DMSI in the presence of TNM buffer, pH8.0 (Methods
2.14.3). After disrupting the bacteria by sonication (Methods 2.9.1)
the extracts were centrifuged at 105,000g (40K rpm, Ti50 rotor) for
av
60 min and the pellets were washed three times by
resuspension/centrifugation. All the fractions were assayed for enzyme 
activity. ND = not detectable.
107.
d) There was no evidence for specific crosslinking even in the 
presence of substrates and cofactors for the enzymes of the mandelate 
pathway. In these experiments bacteria were treated with toluene/PEG 
in an attempt to allow the substrates and cofactors to enter the 
bacteria.
3.5.3 Enzyme distribution in high speed centrifugation fractions 
after disruption of A.calcoaceticus by different methods
Since no specific crosslinking between the mandelate enzymes was 
observed it was necessary to investigate alternative methods of examining 
enzyme interactions. The effect of different methods of disruption on 
the enzyme distribution in high speed centrifugation fractions was studied, 
a) Ultrasonic disruption
When bacteria were disrupted by sonication, 50-60% LMDH was 
recovered in the pellet fraction whereas 4% (or less) PGDC, BDH, CO and 
ICDH and approx. 30% GS was present in this fraction (Figure 22A). 
d ) disruption by lysozyme treatment
When bacteria were disrupted by lysozyme treatment, 94% LMDH and 
0-17% of the ’soluble' enzymes PGDC, BDH, CO and ICDH were recovered in 
the pellet fraction with 30% GS (Figure 22B).
c) Effect of number of times through the French pressure cell
Bacteria were disrupted by passing through the French pressure cell
1.2.3 or 4 times (Figure 23). When bacteria were passed through the 
French press once or twice, 97% LMDH, 40-55% PGDC, 3-15% BDH, CO and ICDH 
and 40% GS were recovered in the pellet fraction, whereas when bacteria 
were passed through the French press 3 or 4 times, 95% LMDH and approx.
20% PGDC still remained in the pellet with 3-8% BDH, CO and ICDH and 40%
GS.
The presence of deoxyribonuclease or Mg++ did not alter these 
enzyme distributions. Approx. 30-40% GS sedimented irrespective of the 
method of. disruption [this illustrated the behaviour of a high Mr
108a
Figure 22 The effect of sonication and lysozyme treatment of
A.calcoaceticus on the enzymes recovered in the high 
speed pellet
Bacteria (mutant strain C1005 grown on complex media supplemented
with D,L-mandelate) were disrupted by sonication (Methods 2.9.1) or by
lysozyme treatment (Methods 2.9.3.2) and the extracts (3ml) were
centrifuged at 165,000g (50K rpm Ti50 rotor) for 150 min. The 'highav
speed pellet' so formed was washed twice by resuspending in 0.05M 
potassium phosphate buffer, pH7.5 to the original volume (3ml) and 
centrifuging. The results are expressed in terms of percentage of 
total enzyme activity recovered in the washed high speed pellet after 
sonication (A) and after lysozyme treatment (B). ND = not detectable, 
enzyme activities in both samples were similar, .l
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Figure 23 The effect of disrupting bacteria in the French pressure cell 
on the enzymes recovered in the high speed pellet 
Bacteria (mutant strain C1005 grown on complex media supplemented 
with D,L-mandelate) were disrupted by passing through the French 
pressure cell 1, 2, 3 or 4 times (Methods 2.9.2) and the extracts (3ml), 
were centrifuged at 165,000g (50K rpm,Ti50 rotor) for 150 min. The
3  V
high speed pellets were washed twice by resuspending in 0.05M potassium 
phosphate buffer, pH7.5 to 3ml and centrifuging. The results are 
expressed in terms of percentage of total enzyme activity recovered 
in the washed high speed pellet.
The total enzyme activities in all samples were similar.-
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protein (600,000) under the conditions of centrifugation used].
3.5.4 Effect of protein concentration on enzyme sedimentation
Since the protein concentration may be important for enzyme 
interactions, an experiment was undertaken to investigate this variable. 
In the previous experiment (Figure 23), the high speed pellets were 
washed by resuspending to the original volume (i.e. 3ml). As 50-60% 
of the total protein was recovered in the pellet fraction, this procedure 
involved dilution and so in the following study the pellets were washed 
by resuspending to half the original volume (i.e. 1.5ml) in an effort 
to maintain the high protein concentration.
The protein concentration of the French press homogenate had little 
effect on the amount of LMDH and NADH oxidase recovered in the pellet 
(Figure 24); approx. 98% of these two enzymes sedimented at the highest 
protein concentration (60mg ml )^ and 86% at the lowest protein 
concentration (3mg ml )^. However, the protein concentration had a 
remarkable effect on the amount of PGDC recovered in the pellet; at 
a protein concentration of 60mg/ml ^, 92% PGDC was recovered in the 
pellet fraction, whereas at a protein concentration of 3mg ml  ^only 
22% PGDC was recovered in this fraction. The distribution of the 
other enzymes also varied with the protein concentration of the French 
press homogenate (from highest to lowest protein concentration), BDH,
56 to 9%; ICDH,58 to 34%; CO, 30 to 9%; GS, 54 to 32% and protein,
i
50 to 30%. These results may illustrate a specific interaction of 
PGDC with the membrane and therefore possibly with LMDH at high protein 
concentrations. If the amount of ICDH (58%) recovered in the pellet 
fraction is taken as a measure of non-specific binding, then possibly,
34% of the total PGDC interacts specifically (at a protein concentration 
of 60 mg ml )^ with, the membrane fraction. Bacteria resuspended to 
lg ml  ^were difficult to handle and so in future experiments bacteria
111a.
Figure 24 The effect of the protein concentration of the French press
homogenate on the enzymes recovered in the high speed pellet
Bacteria (mutant strain C1005 grown on complex media supplemented
with D,L-mandelate) were washed once in 0.05M potassium phosphate
buffer, pH7.5 and resuspended to a concentration of (g wet wt ml
1, 0.5, 0.25, 0.125, 0.0625 and 0.03 in the same buffer. The bacteria
were disrupted by two passages through the French pressure cell (Methods
2.9.2) and the protein concentration of the resulting French press
homogenates was determined. The homogenates (3ml) were centrifuged at
165,000g (50K, Ti50 rotor) for 150 min and the high speed pellets wereav
washed twice by resuspending to 1.5ml and centrifuging. The percentage 
of the total enzyme activity recovered in the high speed pellet is 
plotted against the protein concentration of the homogenate.
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were resuspended to 0. 5gml which resulted in French press homogenates 
with a protein concentration of 30-40mg ml ^.
3.5.5 The effect of disrupting bacteria in different buffers
The buffer system used in the previous French press experiments 
(Results 3.5.3 Sc 3.5.4) was 0.05M potassium phosphate buffer, pH7.5.
Some loss of PGDC activity was observed when assays were carried out 
on successive days and so it was necessary to investigate different buffer 
systems with a view to stabilising PGDC activity. The buffer systems 
tested are shown in Table 9 , and the effect of addition of lOOpM TPP, 
lOOpM DTT, 2mM MgSO^ and lmM EDTA was studied. These reagents were 
chosen since it had been necessary to include them in all buffers used 
during PGDC purification (Barrowman Sc Fewson, 1 9 8 5 ).
LMDH activity was not much affected by the presence of TPP, DTT,
MgSO^ and EDTA but the specific activity of LMDH was always lower at 
pH6.0. The highest LMDH specific activity was obtained with 0.02M 
potassium phosphate buffer, pH7.5. The highest total PGDC specific 
activity was obtained with either 0.05M potassium phosphate buffer, 
pH6.0 or 0.1M potassium phosphate buffer, pH7.5 both in the presence of 
TPP, DTT, MgSO^ and EDTA. In all cases the presence of TPP, DTT,
MgSO^ and EDTA resulted in higher total specific activities of PGDC.
The total specific activity of ICDH was variable and showed no 
particular pattern.
In all cases (except 0.02M potassium phosphate buffer, pH7.5) the 
presence of TPP, DTT, MgSO^ and EDTA resulted in a higher PGDC specific 
activity in the pellet with 0.1M potassium phosphate buffer, pH7.5 
containing TPP, DTT, MgSO^ and EDTA giving the highest PGDC specific 
activity in the pellet.
A very high percentage (80%) of protein was recovered in the pellets 
at 0.02M potassium phosphate buffer, pH6.0 which would account for the 
low specific activities of PGDC and ICDH in the pellets in the presence
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of this buffer (Table 9). This is probably due to a high degree of 
non specific binding at this concentration of phosphate and pH.
Except for this buffer, the percentage of protein recovered in the pellet 
was more or less constant at 40-50%.
The percentage of LMDH recovered in the pellet was unaffected by 
the buffer conditions whereas the percentage of PGDC recovered in the 
pellet varied from 47% (0.1M potassium phosphate buffer, pH7.5) to 87% 
(0.02M potassium phosphate buffer, pH6.0 containing TPP, DTT, MgSO^ and 
EDTA). The percentage of ICDH recovered in the pellet varied from 
25-56%. In order to maximise both IMDH and PGDC specific activities 
and the percentage of PGDC in the pellet, 0.1M potassium phosphate 
buffer, pH7.5 containing lOOpM TPP, lOOpM DTT, 2mM MgSO^ and ImM EDTA 
was the buffer chosen to use in future experiments.
3.5.6 The effect on enzymes recovered in the pellet of different 
washing conditions
High speed pellets were washed with various solutions described in 
Table 10. It was hoped that a washing condition would be found which 
would preferentially wash ICDH from the pellets while leaving PGDC bound 
to the membranes.
In all cases 70-73% of the total PGDC activity was recovered in the 
pellet before washing and the total specific activities of the three 
enzymes remained constant irrespective of the washing condition. MgC^ 
and EDTA had no effect on the percentage of PGDC and ICDH recovered in 
the pellets whereas after washing with NaCl, KC1 or buffer at pH6.0 
(Table 10), a further 10-18% of the total PGDC was washed from the membrane 
(compared with the control) leaving approx. 60% of the total PGDC still 
associated with the membrane fraction. EGTA treatment washed approx.
30% more PGDC from the pellet. Molar potassium phosphate at pH6.0,
7.5 and 8.5 washed a further 30% ICDH from the high speed pellet leaving 
12-19% ICDH still associated with this fraction. Molar phosphate also 
washed more PGDC from the membrane leaving only 18-35% PGDC associated
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Table 10 The effect of washing the high speed pellet with
different conditions
%  of total recovered in pellet 
LMDH PGDC ICDH Protein
Buffer A 97 73 38 40
Buffer A + 0.2M NaCl 97 57 34 40
Buffer A + 0.5M KC1 97 63 37 38
Buffer A + 0.2M MgCl2 97 72 32 39
Buffer A + 0.02M EDTA 96 75 39 40
Buffer A + 0.02M EGTA 96 44 35 36
Buffer A but with 1M potassium 
phosphate, pH6.0 92 35 18 36
Buffer A but with 1M potassium 
phosphate 87 28 19 29
Buffer A but with 1M potassium 
phosphate, pH8.5 81 18 12 24
Buffer A but at pH6.0 94 55 35 43
Buffer A but at pH8.5 96 68 46 45
Bacteria (mutant strain C1005 grown on complex media supplemented 
with D,L-mandelate) were harvested and washed once with Buffer A (i.e. 
0.1M potassium phosphate buffer, pH7.5 containing lOOpM TPP, lOOpM DTT, 
2mM MgSO^ and ImM EDTA) and resuspended to 0.5g wet wt ml 1 in the 
same buffer. The bacteria were disrupted by two passages through the 
French pressure cell (Methods 2.9.2) and the resulting homogenates 
(11 x 3ml) were centrifuged at 165,000gav (50K rpm, Ti50 rotor) for 150 
min. The pellets were resuspended to 1.5ml in one of the listed buffers 
(all of which contained lOOpM TPP, lOOpM DTT, 2mM MgS04 and ImM EDTA) 
and incubated for 30 min at 4°C after which the high speed 
centrifugation was repeated. Results are expressed in terms of 
percentage of total recovered in the pellet after washing.
with this fraction. The amount of ICDH recovered in the pellet was 
unaffected by the other washing conditions (Table 10).
These results were rather surprising since the conditions used are 
methods well established for washing extrinsic proteins from membranes 
and so it was expected that more ICDH would have been washed from the 
pellets under these conditions. It may be that more exhaustive washing 
conditions were required.
In an attempt to wash the high speed pellets more thoroughly, they 
were washed with increasing concentrations of NaCl by resuspending in the 
appropriate buffer to half the starting volume (1.5ml) or to 2.5 times 
the starting volume (7.5ml) (Table 11). By increasing the NaCl 
concentration in the wash to l.QM approx. 20% more ICDH and PGDC were 
washed from the pellet leaving 19% and 52% respectively still associated 
with the membrane fraction (Table 11A). When the pellet was washed with
2.5 times the starting volume of the control buffer (Table 11B), a further 
50% of PGDC and 40%, ICDH was washed from the pellet, leaving 23% and 
7% respectively still associated with the membrane fraction. Washing 
with 2.5 times the starting volume of 0.2M NaCl and 0.5M NaCl did not 
release more PGDC compared with the control but 1.0M NaCl resulted in 
a further 10% PGDC being washed from the high speed pellet (Table 11B).
That more PGDC can be washed from the membrane by diluting the pellet 
(by washing in 2.5 times the starting volume) is consistent with the 
observation that the association of PGDC with the membrane is dependent 
on a high protein concentration (Figure 24). In all these experiments 
(Results 3.5.3-3.5.6) with French press homogenates, there was always 
more PGDC (6-40%) than ICDH associated with the membranes and so 
experiments were carried out to investigate the nature of the association 
of PGDC with the membrane fraction.
3.5.7 Analysis of French press homogenates by Percoll gradient 
centrifugation
A Percoll gradient was chosen such that the membranes would sediment
117.
Table 11 The effect of washing high speed pellets with different
buffer volumes and increasing NaCl concentrations
1. Wash % of total recovered in pellet
LMDH PGDC • ICDH Prote
Buffer A 93 76 47 43
Buffer A + 0.2M NaCl 92 70 38 42
Buffer A + 0.5M NaCl 92 63 26 36
Buffer A + 1.0M NaCl 92 52 19 29
2. Wash % of total recovered in pellet
LMDH PGDC ICDH Prote
Buffer A 94 23 7.5 25
Buffer A + 0.2M NaCl 95 23 7.2 23
Buffer A + 0.5M NaCl 96 22 4.6 20
Buffer A + 1.0M NaCl 94 12 3.2 20
Bacteria (mutant strain C1005 grown on complex media supplemented 
with D,L-mandelate) were washed and resuspended to 0.5g wet wt ml-'1' in 
Buffer A (i.e. 0.1M potassium phosphate buffer, pH7.5 containing lOOpM 
TPP, lOOpM DTT, 2mM MgSO^ and ImM EDTA) and disrupted by two passages 
through the French pressure cell (Method 2.9.2). The resulting 
homogenates (8 x 3ml) were centrifuged at 165,000gav (50K rpm, Ti50 
rotor) for 150 min. The pellets were washed twice by resuspending to 
either 1.5ml (1) or 7.5ml (2) in Buffer A or Buffer A containing 0.2, 0.5 
or 1.0M NaCl.
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in the Percoll gradient in situ leaving the soluble protein in the 
buffer layer above the gradient. The enzyme profiles obtained when a 
French press homogenate was subjected to density gradient centrifugation 
are illustrated in Figure 25.
LMDH and NADH oxidase activities peaked at a density of approx.
1.05 whereas PGDC, ICDH and CO remained in the buffer layer with only 
some activity sedimenting to positions of higher density. There was 
no evidence of co-migration of LMDH and PGDC. Essentially similar 
profiles were obtained when high speed pellets and supernatants were 
treated in the same way (results not shown). That no co-migration 
of LMDH and PGDC was observed may have been due to dilution of the sample 
in the Percoll solution and so a similar experiment was carried out where 
the Percoll gradient was run in the presence of a high speed supernatant 
(30mg protein ml "*") from a non-induced strain (8250) which had been 
grown on complex media. This was to try to mimic the conditions in 
the bacteria as far as possible with a view to protein concentration, 
pH and ionic strength. However, a similar enzyme profile was observed 
(results not shown).
3.5.8 Gel filtration chromatography of a French press homogenate
A French press homogenate (Figure 26) and high speed pellets (results 
not shown) were analysed by gel filtration chromatography. Essentially 
the same elution profiles were obtained with these two samples. LMDH 
eluted close to the void volume whereas PGDC and ICDH eluted at a position 
corresponding to a lower apparent Mr (although these two enzymes were 
not separated on this column). No co-elution of PGDC with the LMDH 
activity was observed.
There was the possibility that LMDH and PGDC associate in some way 
but may have dissociated due to dilution during the gel filtration 
chromatography. With this in mind, experiments were carried out
whereby the column was equilibrated and run in the presence of BSA 
(30mg ml 1) or in the presence of 20% (v/v) glycerol. However, no
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Figure 25 Percoll density gradient centrifugation of a French press 
homogenate
After bacteria (mutant strain C1005 grown on complex media 
supplemented with D,L-mandelate) had been disrupted by two passages 
through the French pressure cell (Methods 2.9.2), the resulting homogenate 
was layered on a solution of 20% Percoll and density gradient centrifug­
ation was carried out (Method 2.16). The gradient was calibrated by 
density gradient marker beads and 1ml fractions were collected from the 
top of the tube and assayed for enzyme activity and protein.
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Figure 26 Gel filtration chromatography of a French press homogenate 
Bacteria (mutant strain C1005 grown on complex media supplemented 
with D,L-mandelate) were disrupted by passing through the French pressure 
cell twice (Methods 2.9.2) and the resulting homogenate was applied to 
a column (30cm long x 0.7cm diam.) of Ultrogel AcA 34 equilibrated with
0.1M potassium phosphate buffer, pH7.5 containing lOOpM TPP, lOOpM DTT, 
2mM MgSO^ and ImM EDTA. Enzyme activity was eluted with the same buffer 
at a flow rate of 4ml h  ^and fractions were collected every 7.5 min.
The column was calibrated with proteins of known Mr values and the 
elution positions are indicated i.e. thyroglobulin, M^ = 669,000; 
aldolase, Mr = 158,000 and cytochrome c, Mr = 12,300. The elution 
volume of Blue Dextran (approx. Mr = 2,000,000) was taken to be the 
void volume.
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evidence for the co-elution of LMDH and PGDC was observed (results not 
shown).
3.5.9 The effect of PEG on the association of PGDC with the 
membrane fraction
PEG is thought to promote specific enzyme interactions by mimicking 
the high protein concentration in the cell (e.g. Halper & Srere, 1977) 
and so the effect of PEG on the association of PGDC with the membrane 
fraction was studied. French press homogenates were prepared from 
bacteria which had been resuspended in the presence or absence of 14%
(w/v) PEG (M 6,000) and the homogenates were centrifuged at 165,000g
jl av
(50K rpm, Ti50 rotor) for 150 min. In the control samples (no PEG 
present) approx. 70% PGDC was recovered in the high speed pellet; 
by contrast only 35% PGDC was recovered in the pellet fraction when PEG 
was present and so it can be concluded that PEG interferes with, rather 
than promotes the association of PGDC with the membrane.
3.5.10 Development of methods for crosslinking French press 
homogenates with dime thy limidates
Since such a high percentage (approx. 70%) of PGDC can be associated 
with the membrane fraction after disruption of the bacteria in the 
French pressure cell, it was thought that by crosslinking the French 
press homogenate, any enzyme interaction might be trapped and so 
facilitate the study of such interactions. The earlier crosslinking 
experiments in vivo (Results 3.5.2) were carried out in the presence of 
TNM buffer, pH8.0; however the PGDC tetramer is known to dissociate at 
this high pH (Barrowman, 1981) and so a method for crosslinking with 
the dimethylimidates at a lower pH was developed,
a) Crosslinking aldolase
The dimethylimidate crosslinkers (DMSI and DMPI) require a high pH 
(^  pH8.0) for maximal activity. An experiment was carried out comparing 
the crosslinking of aldolase by DMSI and DMPI in the presence of TNM 
buffer, pH8.0 and in the presence of phosphate buffer, pH7.5 (Figure 27).
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Figure 27 Crosslinking of aldolase
Aldolase was treated with the crosslinking reagents DMSI (S) and 
DMPI (P) in the presence of TNM buffer, pH8.0 or phosphate buffer, pH7.5 
(Methods 2.14.2) with either 1 (SI,PI) or 4 (S4,P4) additions of the 
crosslinker over the 60 min incubation period. The samples were run 
on 5% phosphate SDS polyacrylamide gels (Methods 2.21.1) which were 
stained with Coomassie Blue. Approx. 5pg of protein was applied to 
each track. C = control.
!Z3,
LU
>-
a
DC
LU
Q-
cn
55
Q.
(/)
1—
CO
o
in
Xa
*_
a>H—*♦—
3
A
d>
flj
.ca
to
o
O
CO
Xa
k.
a)
»+—V^-
3
A
Z
I-
124.
Crosslinking of aldolase took place after one addition of the 
reagents (DMSI and DMPI) in the presence of phosphate buffer, pH7.5 
but less trimer and tetramer were formed than when the reaction was 
carried out at pH8.0 (Figure 27). However, when DMSI and DMPI were 
added 4 times over the 60 min incubation period (to compensate for the 
short half life of the reagents), an equivalent amount of cross linking 
was observed at pH7.5 as that obtained with one addition of the reagents 
at pH8.0. This showed that cross linking with the dimethyl imidates was 
possible at pH7.5.
b) Crosslinking the French press homogenate
Freshly harvested bacteria (mutant strain C1005 grown on complex 
media supplemented with D,L-mandelate) were treated with DMSI and DMPI 
during the prepartion of French press homogenates (Methods 2.14.4).
After incubating with the cross linker (which was added every 15 min for 
lh) the French press homogenates were subjected to high speed 
centrifugation (Methods 2.11.2).
There was no increase in the amount of PGDC recovered in the pellet 
fraction after treating with DMSI or DMPI. When the pellets were 
washed by resuspending to half the original volume of the homogenate, 
approx. 70% of the total PGDC and 40% ICDH was recovered in- the high 
speed pellets of control and treated samples. When the pellets were 
washed by diluting to 2.5 times the original volume, 36% PGDC and 6%
ICDH remained associated with the membrane fractions of control samples 
whereas 44% PGDC and 6% ICDH was recovered in the pellet fraction of the 
crosslinked homogenate.
c) Analysis of cross linked French press homogenates by immunoblotting
Control and crosslinked French press homogenates were analysed by
immunoblotting with anti-IMDH, anti-EMDH and anti-PGDC as described in 
Figure 28.
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Figure 28 Imnunoblots of control and crosslinked extracts
French press homogenates (prepared from mutant strains C1005 and
Cl 123 grown on complex media supplemented with D,L-mandelate) were
treated with DMSI and DMPI (Methods 2.14.4) in the presence of 0.05M
potassium phosphate buffer, pH7.5. The homogenates were centrifuged at
165,000g (50K rpm, Ti50 rotor) for 150 min and the pellets,av
supernatants and French press homogenates were run on 7.5% SDS poly­
acrylamide gels and subsequently inmunoblotted (Methods 2.22) with 
anti-LMDH, anti-DMDH and anti-PGDC.
(1) fractions from strain C1005 blotted with anti-LMDH
(2) fractions from strain C1123 blotted with anti-DMDH
(3) fractions from strain C1005 blotted with anti-PGDC
C = control; S = DMSI; P = DMPI
The positions of Pharmacia molecular mass standards which had been 
stained for protein (not shown) are indicated.
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In the control (uncrosslinked) samples there were bands 
corresponding to LMDH, DMDH or PGDC whereas in the cross-linked samples 
there were bands with high apparent Mr values. In all cases DMSI and 
DMPI gave similar results. In the anti-LMDH blot (Figure 28.1) there 
were bands with apparent Mr values of 140,000 (this band was not always 
detected and sometimes appeared in the control sample), 100,000 and 40,000 
(equivalent to LMDH). In the anti-DMDH blot (Figure 28.2), there was a 
band with an apparent Mr value of 66,000 (equivalent to DMDH) in the 
control sample; however there was no band with this Mr value in the 
cross linked sample but there was one with a slightly higher Mr value 
(68,000). This may be due to intra-molecular crosslinking of the 
DMDH. In addition there was a smear in the cross linked samples which 
may indicate that DMDH was crosslinked to species of various Mr values.
In the anti-PGDC blot (Figure 28.3) bands with apparent Mr values of
135,000, 120,000, 98,000 and 56,000 (equivalent to PGDC) were detected.
A similar blotting pattern with anti-PGDC was obtained with extracts 
from mutant strain Cl005 (LMDH and PGDC activities present) and mutant 
strain C1123 (DMDH and PGDC activities present). PGDC is reported to 
be a tetramer (Barrowman & Fewson, 1985), however there was no evidence 
for trimers or tetramers of PGDC being formed on cross linking. The 
band with an apparent Mr of 120,000 may be a dimer of PGDC.
3.5.11 Crosslinking a French press homogenate from mutant strain CL408 
and a washed 'wall + membrane* fraction from mutant strain Cl005 
There was a band with an apparent Mr of 100,000 on the anti-LMDH blot 
of the crosslinked sample and a band with an apparent Mr of 98,000 on the 
anti-PGDC blot of the same sample. If there was an LMDH-PGDC cross linked 
species this would have an expected Mr of 102,000 (by addition of the 
reported Mr values of LMDH and PGDC i.e. 44,000 and 58,000 respectively). 
The following experiment was carried out to investigate the possibility
that the band with an approx. Mr value of 100,000 was a cross linked hybrid
of LMDH and PGDC. French press homogenates from mutant strain C1005 
(LMDH and PGDC present) and from mutant strain C1408 (no LMDH activity; 
PGDC activity present) and a 'wall + membrane' fraction from mutant 
strain CL005 (LMDH activity, no PGDC activity present) were treated 
with DMSI and immunoblotted with anti-LMDH and anti-PGDC (Figure 29).
The crosslinked French press homogenate from mutant strain C1408 
showed a similar pattern to that from mutant strain C1005 in the anti- 
PGDC blot (Figure 29B) even although there was no positive band in the 
anti-LMDH blot of the C1408 sample (Figure 29A). The crosslinked 
washed 'wall + membrane' fraction showed a similar pattern to the 
French press homogenate of mutant strain Cl005 in the anti-LMDH blot 
even although there was no positive band in the anti-PGDC blot of the 
washed 'wall + membrane' sample from C1005. It can therefore be 
concluded that LMDH and PGDC were crosslinked to other protein species 
but not to each other.
3.5.12 Gel filtration chromatography of control arid DMSI treated 
extracts
Control and DMSI treated French press homogenates were analysed by 
gel filtration chromatography (Figure 30). In samples treated with DMSI, 
there were two peaks of 'soluble' enzyme activity, one corresponding to 
the control activity and a second species with a higher Mr which eluted 
close to the void volume. LMDH activity eluted in the void volume in 
both control and DMSI treated samples. These results confirm the 
non-specificity of the crosslinking reaction since high Mr species, 
co-eluting with LMDH activity, were obtained with the control enzymes 
(CO and ICDH) as well as the 'soluble' mandelate enzymes.
3.5.13 Confirmation of crosslinking in vivo
Confirmation that the crosslinking reagent DMSI can penetrate 
exponential phase bacteria (mutant strain C1005) was obtained by 
subjecting sonic extracts from control and DMSI treated bacteria (in the
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Figure 29 Immunoblots of control and crosslinked homogenates from 
mutant strains Cl005 and C1408 and of a crosslinked 
'wall + membrane* fraction frommutant strain Cl005 
Bacteria (mutant strain Cl005 grown on complex media supplemented 
with D,L-mandelate) were disrupted by sonication (Methods 2.9.1) and a 
'wall + membrane' fraction was prepared (Methods 2.11.2) and washed 
thoroughly until no PGDC activity was detected. This 'wall + membrane' 
fraction and French press homogenates from strains C1005 (grown on 
complex media supplemented with D,L-mandelate) and C1408 (grown on 
complex media supplemented with phenylglyoxylate) were treated with 
DMSI (Methods 2.14.4) and immunoblotted (Methods 2.22) with anti- 
LMDH (A) or anti-DMDH (B). C = control; D = DMSI; WM = 'wall + 
membrane' fraction.
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Figure 30 Gel filtration chromatography of control and DMSI extracts 
Control (o— o) and DMSI (•■-■ •) treated French press homogenates 
(Methods 2.14.4) from mutant strain C1005 (grown on complex media 
supplemented with D,L-mandelate) were applied to a gel filtration column 
(30cm long x 0.7cm diam.) of Ultrogel AcA 34 equilibrated with 0.1M 
potassium phosphate buffer, pH7.5 containing lOOpM TPP, lOOpM DTT, 2mM 
MgSO^ and ImM EDTA. Enzyme activity was eluted with the same buffer at 
a flow rate of 4ml h  ^and fractions were collected every 7.5 min. The 
column was calibrated with proteins of known Mr values and the elution 
positions are indicated i.e. thyroglobulin, Mr = 669,000; aldolase,
Mr = 158,000 and cytochrome c, Mr = 12,300. The elution volume of 
Blue Dextran (approx. Mr = 2,000,000) was taken as the void volume.
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presence of 0.1M potassium phosphate buffer, pH7.5 containing lOOpM 
TPP, 200pM DTT, 2pM MgSO^ and ImM EDTA) to immunoblotting with anti-LMDH 
and anti-PGDC. A similar pattern to that of the immunoblots of cross- 
linked French press homogenates from strain C1005 was obtained (results 
not shown).
3.5.14 Crosslinking intact bacteria and French press homogenates 
with PPM
The failure to crosslink IMDH and PGDC with the dimethylimidate 
crosslinkers could have been due to the absence of suitably positioned 
lysine residues on each protein and so the effect of PDM, which cross­
links sulphydryl groups, was studied.
Intact bacteria and French press homogenates from mutant strain 
C1005 were treated with PDM (Methods 2.15.1 and 2.15.2) after which 
extracts were immunoblotted with anti-LMDH and anti-PGDC. However, 
there was no evidence of species with higher Mr values even although PDM 
inhibited IMDH activity by approx. 40% (results not shown).
3.5.15 Immunoprecipitation of French press homogenates
French press homogenates from mutant strain C1005 and mutant strain 
C1219 were subjected to immunoprecipitation by anti-LMDH, anti-DMDH and 
anti-PGDC (Table 12). No IMDH activity was precipitated by anti-LMDH 
whereas only 27% DMDH and 0-5% PGDC remained in the supernatant after 
incubating extracts with anti-DMDH and anti-PGDC respectively. Neither 
anti-DMDH nor anti-PGDC had any effect on the other enzyme activities 
i.e. IMDH or PGDC in the case of anti-DMDH and DMDH or IMDH in the case 
of anti-PGDC.
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Table 12 Immunoprecipitation of French press homoRenates
Addition % of starting enzyme activity
LMDH DMDH PGDC
C1005 C1219 C1005 C1219 C1005 C121'
Buffer 100 100 ND 100 100 100
Normal rabbit serum 96 91 ND 100 89 76
anti-LMDH 96 105 ND 115 113 105
anti-DMDH 96 105 ND 27 93 76
anti-PGDC 96 96 ND 108 ND 5,
Bacteria (mutant strains C1005 and C1219 grown on complex media
supplemented with D,L-mandelate) were disrupted by two passages through 
the French pressure cell (Methods 2.9.2) and the homogenates (lOOpl) were 
incubated with an equal volume of antisera (anti-LMDH, anti-DMDH or 
anti-PGDC) or with normal rabbit serum or buffer as controls for 60 min 
at 23°C. Protein A-Sepharose (lOOpl) was added and the samples were 
incubated for a further 60 min at 23°C before immunocomplexes were 
precipitated by centrifuging for 5 min in an Eppendorf 3200 centrifuge 
(Methods 2.28). The supernatants so formed were assayed for enzyme 
activities and the results are expressed as a percentage of the enzyme 
activities of the control (+ buffer) sample before centrifuging.
ND = not detectable.
CHAPTER 4 DISCUSSION
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4.1 Separation of outer and inner membranes and location of the
lactate and mandelate dehydrogenases of A.calcoaceticus
A method for disrupting A.calcoaceticus strain NCIB 8250 following 
lysozyme treatment was developed for several reasons. Firstly, lysozyme 
. disruption of bacteria is generally regarded as a gentle method and 
minimises fragmentation of membranes (Mowbray Se Moses, 1976; Scott et al., 
1976) and so it was thought that this method would be useful' in the study 
of enzyme interactions (3.5.3). Secondly, it was hoped that lysozyme 
treatment and subsequent separation of the outer and inner membranes 
could be used as a starting point for purifying IMDH. However, it 
became apparent that because of the time scale and large volumes that 
would have been required (during lysis of spheroplasts; see Methods 
2.9.3.1) this method was inappropriate for the initial stages of the LMDH 
purification. Finally, inner and outer membrane separation was required 
for the location of the lactate and mandelate dehydrogenases.
That the outer and inner membranes of A. calcoaceticus were 
substantially separated was confirmed by enzyme distribution studies 
(Figure 5) as well as by analysing the membrane fractions by SDS PAGE 
(Figure 5) and electron microscopy (Figure 6). SDS PAGE of the outer 
membrane showed four major proteins (Figure 5) with Mr values of 44,000,
28,000, 22,000 and 13,000. This is similar to the banding pattern of 
the outer membrane of P. aeruginosa in. which the four major outer membrane 
proteins have M'values of 37,000, 35,000, 21,000 and 17,000 (Hancock & 
Nikaido, 1978). On the other hand, in E.coli (Schnaitman, 1970), 
Salmonella typhimurium (Osborn et al., 1972) and Proteus mirabilis 
(Hasin et al., 1975) there is one predominant outer membrane protein 
with an Mr of 44,000. The electron micrographs of the inner and outer 
membranes (Figure 6) were similar to those obtained by Scott et al. (1976) 
for Acinetobacter sp. strain H01-N and by Schnaitman (1970) for E.coli.
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The lactate and mandelate dehydrogenases were principally located 
in the cytoplasmic membrane (Table 2) which is known to be involved in 
many cellular functions including selective permeation and active 
transport, electron transport, oxidative phosphorylation, and the 
biosynthesis of phospholipids, peptidoglycans and proteins (Salton, 1971).
4.2 Purification and characterisation of LMDH
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The purification of integral membrane proteins is not an easy task 
and many workers have encountered difficulties relating to solubilising 
proteins which retain their biological activity and native structure 
while avoiding aggregation of proteins into non-physiological entities 
(Helenius 8c Simons, 19 7 5 ; Tanford 8c Reynolds, 1976 ; Baines Se Poole, 
1 9 8 5 ) . The long standing problem of succinate dehydrogenase from E.coli 
is an example of such a protein system where conventional purification 
methods have been unsuccessful. However, structural information has 
been obtained indirectly using mutants (Spencer Se Guest, 1974) and 
imnunological methods (Owen 8c Candon, 1982) and more recently from the 
nucleotide sequence of the genes coding for succinate dehydrogenase 
(Wood et al., 1984 ; Darlison Se Guest, 1 9 8 4 ) . The purification of LMDH 
( 3 .2 )  was not without problems and indeed the final purification was not 
entirely satisfactory because the yield was low and the final material was 
not completely homogeneous.
In the preliminary experiments on the purification, a three component 
system was observed on SDS PAGE and each component was present in almost 
equal amounts (Figure 7B). There were two possibilities for this:
(1) unrelated proteins with similar solubility properties had been 
purified together or (2) the incorporation of these three polypeptides 
into a single micelle reflected a structural-functional relationship 
between these polypeptides in the intact membrane (Tanford 8c Reynolds, 
1976) as is the case for succinate dehydrogenase (Hederstedt 8c Rutberg, 
1 9 8 1 ).
Tanford 8c Reynolds (1 9 7 6 ) suggested that if detergent is present in 
excess, such that there are more detergent micelles than polypeptide 
chains, then detergent complexes containing one polypeptide chain per 
particle would predominate unless there are attractive forces that cause
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two or more polypeptide chains to remain associated. Although it was 
possible to separate these three components (Figure 7B) in the purification 
scheme reported in Section 3.2.2, such that they were no longer present 
in equal ratios, it was not possible [ even though several methods were 
studied (3.2.3.b)] to purify LMDH completely (Figure 13) and there was 
always some contamination by the polypeptides with Mr values of 66,000 
and 27,000 in the final LMDH preparation. It may be that these two 
polypeptides are components of LMDH in its native environment. Evidence 
for this is that (1) LMDH is inactivated by high Triton X-100 concentrations 
especially during the initial solubilisation from the membrane (Allison 
et al., 1985b), (2) the recovery of LMDH activity after ammonium sulphate 
precipitation (3.2.3.c) was variable (25-80%) probably because Triton 
X-100 was concentrated during the process and (3) the inability to 
completely purify LMDH (Figure 13). The inactivation of LMDH by high 
Triton X-100 concentrations may be due to the three components (Figure 7B) 
being separated into different micelles and indeed since the recovery of 
LMDH was very low (1.1%; Table 3), the activity in the final preparation 
may be due to the small amounts of the 66,000 and 27,000 polypeptides 
present (Figure 13).
One possible method for testing whether the polypeptides with M^ 
values of 66,000 and 27,000 are involved in LMDH activity would be to 
raise antibodies against these components to see if the antibodies could 
affect LMDH activity (or 'L-mandelate oxidase’ activity in the membranes 
and other properties). However, this sort of experiment could only be 
interpreted if positive results were obtained since the antibodies 
may not affect the LMDH activity for other reasons (see below).
Another possibility is that these two components (Mr 66,000 and 27,000) 
are structural elements important in anchoring LMDH in the membrane and 
not involved in LMDH activity per se.
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Polyclonal antibodies were raised against LMDH by cutting a 
Coomassie Blue stained protein band from an SDS polyacrylamide gel 
(Methods 2.26, Figure 18). This antiserum showed a positive band on 
immunoblots of extracts containing LMDH activity which had been prepared 
from induced strain 8250 as well as constitutive mutant strains C1005 
and C1219, whereas there was no band corresponding to LMDH in extracts 
from mutants C1123 and C1408 which contain no detectable IMDH activity 
(Figure 19). That no protein corresponding to LMDH was detected in 
extracts from C1123 and C1408 suggests that these mutants do not 
synthesise an inactive protein but that the IMDH gene has been silenced 
in some way or, less likely, that the mutated gene product' is very labile 
or is not recognised by the antibodies.
Although the IMDH antiserum showed a positive band on immunoblotting 
(Figure 19), no enzyme inhibition by the antiserum could be demonstrated 
(3.3.10). So-called 'null' antibodies have been raised against other 
enzymes, such as lysozyme (Maron et al., 1971; Amon et al.,1971), 
j£-D-galactosidase (Frackelton & Rotman, 1980) and shikimate 
dehydrogenase (personal communication, Dr. I.D. Hamilton). Cinder (1977) 
has pointed out that as a rule, antisera contain predominantly non- 
inhibitory antibodies which do not interfere with enzyme catalysis.
There are two types of antigenic determinants in proteins: (a) contiguous
or linear determinants which are represented by a continuous stretch of 
amino acid residues found together in the primary structure of the protein 
and (b) discontiguous or conformational determinants which are formed 
by 3-dimensional folding of the protein, bringing together amino acid 
residues far apart in the protein’s primary structure (Sela, 1969;
Nagradava & Grozdova, 1978). Since the antibodies were raised against 
denatured LMDH (Methods 2.26) it is most likely that the anti-LMDH is 
reactive towards contiguous determinants which may be exposed only on 
denaturation of the enzyme. It should also be borne in mind that
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adsorption of contaminants from the anti-LMDH was only possible after 
treatment with denatured non-induced strain 8250 extracts (Figure 19B).
It is therefore not surprising that antibodies raised against epitopes 
exposed only after denaturation of the enzyme do not interfere with 
enzyme catalysis. The antibodies raised against DMDH and PGDC were, 
however, raised against the native enzymes (personal communication, Dr.
I.D. Hamilton) and so it is more likely that these have been raised 
against discontiguous determinants; this is reflected in the ability of 
these antibodies to inhibit enzyme activity (3.3.10).
The partial characterisation of IMDH (3.3) allows us to make an 
overall comparison of the two mandelate dehydrogenases and the two lactate 
dehydrogenases (Table 13). The four dehydrogenases are similar in many 
respects and the striking similarities of the two D(-)-specific enzymes 
and the two L(+)-specific enzymes which were observed in crude extracts 
(Fewson & O'Donnell, 1981; Hills & Fewson, 1983k; Table 14) prevail 
in the purified enzymes (Tables 13 Sc 14). The properties summarised 
in Table 13 for the purified enzymes are largely unchanged from the 
properties of the enzymes in crude extracts (Fewson Sc O'Donnell, 1981; 
Hills Sc Fewson, 1983a, Table 14) which suggests that the four 
dehydrogenases have been purified in their native conformation. This is 
in contrast to some other membrane-bound dehydrogenases which have shown 
changes in pH optima, K values and substrate specificities on 
purification (e.g. Futai, 1973; Kohn Sc Kaback, 1973; Jones Sc Venables, 
1983) which suggests that the native conformation has been altered during 
the purification of these enzymes.
The subunit Mr of IMDH is very similar to that of LLDH from 
A . calcoaceticus (Table 13) and to that of the membrane-bound LLDH from 
E.coli (Mr = 43,000; Futai Sc Kimura, 1977). The latter two enzymes 
behave as multimeric proteins on gel filtration analysis e.g. LLDH from 
A.calcoaceticus has an apparent Mr of 670,000 (Allison Sc Fewson, 1986);
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Table 13. Properties of the four purified dehydrogenases
D-Mandelate
dehydrogenase
D-Lactate
dehydrogenase
L-Mandelate
dehydrogenase
L-Lactate
dehydrogenase
Location All are integral components of the cytoplasmic membrane
Solubilisation (%) by non-ionic 
detergents (e.g. Triton X-100 or 
Lubrol PX)
87-91 83-88 60-70 55-76
Solubilisation (%) by ionic 
detergents (e.g. cholate or 
deoxycholate)
70-91 63-87 4-42 13-32
Mr (monomer) 59,000 63,000 44,000 40,000
pi value 5.5 5.8 4.2* <4.0
pH optimum 8.0 7.7 7.5 7.5
Stereospecificity All are stereospecific for their substrates
Km value (|iM) for substrate 385 (In addition, D- 308 186 83
Assay conditions 
Inhibitors
lactate is a substrate 
but Km=4.8mM)
DCIP reduction measured in the presence of PMS or PES. All require 
BSA or Triton X-100 in the reaction mixture for full activity.
None is affected by a wide range of chelating agents.
All are moderately susceptible to several thiol-blocking reagents.
All are inhibited by oxalate.
Sensitivity to p-chloromercuribenzoate Very severe Severe Moderate Severe
(concn. giving 50% inhibition) (<1pM) (approx. 5pM) (approx. 30|iM) (approx. 5p.M)
Cofactor (non-covalently bound) FAD FAD FMN FMN
Data for this table were taken from section 3.3 and from Allison et al., 1985 a. and b.; Allison and Fewson, 1986. 
* Dr. N. Allison, personal communication.
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Table 14 Comparison of the properties of purified LMDH with that of 
LMDH in sonic extracts
Pure enzyme Sonic extract
K value (pM) for L-mandelate 186 207m
pH optimum 7.5 7.8
Concentration (pM) of HgCl~ 
giving 50% inhibition 1.0 3.0
Concentration (pM) of £-chloromercuri- 
benzoate giving 50% inhibition 30 200
% inhibition obtained with 20mM 
D-mandelate in the presence of
lOOpM L-mandelate 60 69
Data for this table were taken from section 3.3 and Hills & Fewson (1983a)
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however, the apparent Mr of IMDH as estimated by gel filtration is
64,000 (3.3.2) implying that the enzyme exists as a monomer which binds 
approx. 0.5mg Triton X-100/mg protein (calculated by subtraction).
Purified DMDH and DLDH from A.calcoaceticus (Allison et al., 1985b) as 
well as the DLDH from E.coli (Futai, 1973; Kohn & Kaback, 1973) are also 
monomeric proteins. The apparent Mr of the purified IMDH obtained by 
gel filtration (64,000) is very different from the apparent M obtained 
at the gel filtration step during the purification (3.2.3 d; Mr = 300,000). 
Presumably the difference is due to more proteins being present in the 
Triton X-100 micelle in addition to IMDH at this earlier stage of the 
purification. Even although the elution pattern of standard molecular 
mass proteins is unaffected by the presence of Triton X-100 (Figure 10), 
the accuracy of molecular sizing of enzyme-Triton X-100 complexes is 
questionable (Tanford & Reynolds, 1976). There is also the possibility 
of erroneous subunit Mr estimations being made for integral membrane 
proteins on SDS PAGE (Helenius & Simons, 1975; Tanford & Reynolds, 1976; 
Campbell et al., 1984). This is due to integral membrane proteins 
binding more SDS (5-7g SDS/g protein) than a typical 'soluble' protein 
(1.4g SDS/g protein)(Helenius & Simons, 1975). The uncertainty involved 
in Mr estimations of integral membrane proteins means that comparisons 
and conclusions can only be made with some caution.
Purified DMDH was 80% inhibited by 2mM L-mandelate (Allison, et al., 
1985b); purified IMDH was also inhibited by the non-substrate enantiomer 
of mandelate but was much less sensitive to this inhibition in that IMDH 
was inhibited by 60% in the presence of 20mM D-mandelate. A similar 
inhibition of both DMDH and LMDH by the opposite isomer of mandelate 
was also demonstrated in crude extracts (Hills & Fewson, 1983a; Table 14).
Some NAD(P) independent lactate dehydrogenases from other bacteria 
have been shown to require divalent metals ions for activity and are
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inhibited by metal-chelating agents (Olsen Sc Massey, 1979) but LMDH 
(Table 5) like DMDH, DLDH and LLDH (Allison et al., 1985b; Allison Sc 
Fewson, 1986) is not affected by metal ion chelators and therefore 
presumably has no metal ion requirement, unless the chelators are 
sterically prevented from removing the metal.
IMDH, DLDH and LLDH both in crude extracts (Hills Sc Fewson, 1983a; 
Fewson Sc O'Donnell, 1981) and the purified enzymes (Allison et al.,
1985b; Allison Se Fewson, 1986) are very sensitive to reagents which 
react with sulphydryl groups e.g. £-chloromercuribenzoate and mercuric 
chloride (Table 13). LMDH both in crude extracts and the purified 
enzyme is also inhibited by these reagents but is much less sensitive 
than the other enzymes (Tables 4, 13 Sc 14). This inhibition by thiol- 
blocking agents suggests that there may be reactive cysteine residues in 
the active sites of these dehydrogenases, although substrate-protection 
experiments followed by characterisation of active site peptides would 
be necessary to confirm this.
Although the difference spectrum of the purified LMDH (Figure 16) 
is different from the classical difference spectrum of 'soluble' 
flavoproteins [which usually have two peaks of approx. equal intensity 
at 380nm and 450nm (Mahler Sc Cordes, 1969)] , the result obtained with 
IMDH (Figure 16) was indicative of it being a flavoprotein. This was 
confirmed when the fluorescence of the acid-extractable flavin from the 
purified IMDH was studied and identified as that of FMN (Figure 17).
FMN has also been identified as the non-covalently bound prosthetic 
group of LLDH from A.calcoaceticus (Allison Sc Fewson, 1986) and of 
LLDH from E.coli (Futai Sc Kimura, 1977). By contrast, FAD was identified 
as the prosthetic group in both DMDH and DLDH from A. calcoaceticus 
(Allison et al., 1985b) and in this respect these latter two enzymes 
resemble the membrane-bound DLDH from E.coli (Futai, 1973) and the soluble 
DLDH from M.elsdenii (Brockman Sc Wood, 1975) both of which contain FAD.
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The striking similarities of IMDH and LLDH and of DMDH and DLDH 
with reference to their subunit molecular masses, pH optima, susceptibility 
to sulphydryl group reagents and presence of FMN or FAD as cofactors 
(Table 13) may suggest that these enzymes have a common evolutionary 
origin. It is tempting to suggest that DMDH evolved as a result of a 
mutation in the gene encoding DLDH and similarly IMDH may have evolved 
from LLDH. However, DMDH and LMDH appear to be co-regulated (Hills & 
Fewson, 1983b) as do DLDH and LLDH (Allison et al., 1985a) and the genes 
responsible for DMDH and IMDH appear to map close to each other 
(Vakeria et al., 1984) and so it is possible that in mutants of 
A.calcoaceticus NCIB 8250, DMDH has arisen as a result of expression of 
a previously silent gene closely related to that coding for IMDH 
(Hills & Fewson, 1983b; Vakeria et al., 1984). At this stage, it is 
difficult to speculate on the evolutionary relationships of these four 
enzymes. Perhaps cloning and sequencing of the genes encoding these 
enzymes will elucidate their evolutionary origins.
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4.3 Enzyme interactions in the mandelate pathway of A.calcoaceticus
The major part of this thesis involved a study of enzyme interactions 
in the mandelate pathway of A. calcoaceticus. Weak protein interactions 
are notoriously difficult to study because, by their very nature, they 
are easily disrupted. As a result of this easy disruption, experiments 
which show no evidence of enzyme interactions are inconclusive because it 
could be that enzyme associations do occur but that the techniques 
available are inadequate for their detection. Several approaches were 
therefore used in the study of the mandelate enzyme interactions in 
A.calcoaceticus (3.5). The aim of these experiments was to show whether 
or not the enzymes of the mandelate pathway interacted specifically.
The physiological significance of such interactions (should they occur) 
was not studied.
4.3.1 Artifactual possibilities
Throughout this study the possibility that results were artifactual 
was always considered. Artifacts could arise as a result of non-specific 
binding in non-physiological buffers or trapping in vesicles. Many of 
the reported examples of 'soluble' enzyme interactions discussed in the 
Introduction (1.5.4; 1.5.5; particularly Mowbray & Moses, 1976; Gorringe
& Moses, 1980) did not include the appropriate controls. In the present 
study, the behaviour of control enzymes was monitored; CO was taken as 
an example of a control 'soluble' enzyme from a related part of metabolism 
(Figure 1) whereas ICDH and GS were taken as examples of control 'soluble' 
enzymes from unrelated parts of metabolism. In addition, particular 
attention was paid to the pH and ionic strength of buffers used (Table 
9) and frozen bacteria and extracts were not used since freezing and 
thawing would probably disrupt any protein interactions. Several 
workers have emphasised the need to work under physiological conditions 
of protein concentration, pH and ionic strength (Clarke & Masters, 1975; 
Clegg, 1984b); no doubt this is fundamentally correct but Clegg (1984a)
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is of the opinion that we simply do not know enough about cellular 
conditions and therefore cannot mimic them. Fulton (1982) and Srere (1980) 
have gone as far as to say that the cytoplasm does not exist as an aqueous 
solution since the protein concentration is so high (approx. 50%) and that 
protein crystals (approx. 40% of which are water) would be useful models 
for considering conditions in the cell.
4.3.2 Evidence for co-purification
If enzymes associate, it should be possible to co-purify them, and 
so several methods were used to investigate the possible co-purification 
of the mandelate enzymes,
a) U1tracentrifugation
Extracts prepared after disrupting bacteria by sonication,French 
pressing and lysozyme treatment were examined by ultracentrifugation 
(3.5.3; Figures 22 & 23). Sonication is a rather harsh method of 
disruption and therefore probably results in the membranes being broken 
into small fragments which do not sediment. This would account for the 
observation that only 50-60% LMDH was recovered in the pellet after 
sonication (Figure 22A) whereas approx. 95% LMDH sedimented after 
lysozyme treatment (Figure 22B) and French press disruption (Figure 23).
PGDC is a rather large enzyme with an apparent of 230,000 (Barrowman 
Sc Fewson, 1985) and so there was the possibility that some PGDC would 
sediment because of the high Mr of this enzyme. GS was therefore assayed 
to illustrate the behaviour of a very large 'soluble' enzyme (M = 600,000) 
under the conditions of centrifugation used; 30-40% GS sedimented 
irrespective of the method of disruption (Figures 22 Sc 23) whereas the 
amount of PGDC recovered in the pellet varied (5-55%) with the disruption 
conditions (Figures 22 S« 23) indicating that the presence of PGDC in the 
pellet was not a result of its high Mr» The indirect assay for PGDC 
involves linking PGDC activity to that of alcohol dehydrogenase (Figure 20) 
and so the 40-50% PGDC recovered in the pellet after 1 or 2 passages
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through the French press is probably not trapped in vesicles since alcohol 
dehydrogenase would not have access to such trapped PGDC.
Asakawa et al. (1968) reported a similar variation in the 
distribution of phenylpyruvate decarboxylase from Archromobacter eurydice
extracts were prepared by grinding bacteria with quartz sand, 95% of 
the phenylpyruvate decarboxylase was recovered in the high speed 
supernatant consistent with this being a 'soluble' enzyme whereas, 
surprisingly, when the bacteria were disrupted by sonication, 20-25% 
of the enzyme was located in the high speed pellet (Asakawa et al., 1968). 
Phenylpyruvate decarboxylase and PGDC from A. calcoaceticus are very 
similar enzymes (Barrownan & Fewson, 1985) and so this property of 
differential sedimentation may be an inherent property of these enzymes 
or it may reflect a specific association with the membrane fraction.
It is well established that the orientation of membrane vesicles varies 
with the method of disrupting bacteria. Disruption by sonication or French 
pressing results in inverted (inside out) membrane vesicles (Rosen & McClees, 
1974; Futai, 1974; Yamato et al., 1978) whereas disruption by lysosyme 
produces right-side-out vesicles (Yamato et al., 1978). There was no 
evidence of PGDC specifically interacting with the membrane fraction after 
lysozyme treatment (Figure 22B), however, owing to the membrane vesicles 
being right-side-out after lysozyme treatment (Yamato et al., 1978), there 
is the possibility that PGDC interacts with the inner side of the membrane 
and is therefore trapped inside these vesicles and is inaccessible to assay.
Not only did the amount of PGDC associated with the membrane vary 
with different methods of disrupting bacteria (Figures 22 & 23) but the 
protein concentration of the French press homogenate had a dramatic 
effect on the amount of PGDC recovered in the pellet (Figure 24).
Although there are apparently no data for prokaryotic intracellular 
protein concentrations, the protein concentration in eukaryotic cytoplasm
[Brisou & Prevot (1954) suggested that this bacteria should be classified 
as A.calcoaceticus} which had been disrupted in different ways. When
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and in mitochondria is said to be as high as 50% (Sols Sc Marco, 1970;
Ottaway Sc Mowbray, 1977; Srere, 1981, 1982, 1984) and so perhaps this 
protein concentration dependent interaction of PGDC with the membrane 
takes place in vivo.
High speed pellets were washed by different conditions in an effort 
to elucidate the interaction of PGDC with the membrane (3.5.6). Conditions 
commonly used to dissociate extrinsic membrane proteins (Tables 10 8c 11) were 
used to try to achieve a differential release of ICDH while leaving PGDC 
associated. In all cases, where ICDH was washed off, PGDC was also 
washed from the pellets; however, there was always more PGDC than ICDH 
recovered in the membrane fraction. The difficulty in this study was 
in trying to maintain a balance between keeping the protein concentration 
high and minimising non-specific binding. All other attempts to wash 
non-specifically bound protein from the membrane proved to be unsuccessful 
since a condition was not found where ICDH could be washed from the 
membrane while leaving PGDC associated. Of course, this could mean that 
PGDC does not specifically interact or it may be that any specific 
interaction was disrupted during the handling of samples,
b) Gel filtration chromatography
Analysis of French press homogenates or high speed pellets by gel 
filtration chromatography gave no evidence of co-elution of LMDH and PGDC 
(Figure 26). This could possibly have been due to dilution of the 
sample during the chromatography resulting in the dissociation of the 
enzymes. Weitzman St Barnes (1985) and Barnes 8c Weitzman (1986) found it 
necessary to include either 20% (v/v) glycerol, 14% (w/v) PEG or BSA 
(lOmg ml"’^') in all buffers used in the gel filtration study of the Krebs 
cycle enzyme interaction in E.coli. However, PEG was shown to interfere 
with the association of PGDC with the membrane (3.5.9) and so was not 
included in the present gel filtration experiments. In contrast to the
results reported by Barnes Sc Weitzman (1986) for the Krebs cycle enzymes,
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there was no evidence for the co-elution of LMDH and PGDC even in the 
presence of 20% (v/v) glycerol or high protein concentrations (30mg ml 
(3.5.8).
c) Density gradient centrifugation : Percoll gradients
French press homogenates were analysed by density gradient 
centrifugation on Percoll gradients (Figure 25) which have proved useful 
in the studies of glycosomes (Opperdoes, 1981) and of plasma membranes 
(Belsham et al., 1980). The advantage of these gradients is that their 
running time (approx. 30 min) makes them far more convenient than other 
density gradients (e.g. sucrose) whose extended running conditions 
(24-48h) may have possible detrimental effects on weak interactions. 
However, there was no evidence of co-sedimentation of LMDH and PGDC on 
Percoll gradients (Figure 25), even in the presence of high protein 
concentrations.
4.3.3 Immunoprecipitation
It was thought that imnunoprecipitation could be a useful technique 
for studying enzyme interactions in that an antibody raised against one 
enzyme could co-precipitate an associating enzyme. Such an effect was 
observed in a study on the pyruvate dehydrogenase complex (De Marcucci, 
1985). It was possible to immunoprecipitate lipoamide dehydrogenase 
(E3) from bovine kidney cells using antisera raised against pyruvate 
dehydrogenase complex even although this antisera did not cross-react 
with E3 on immunoblotting the purified complex. On the other hand, E3 
was not immunoprecipitated from pig kidney cells and this was taken to 
reflect a difference in the association of E3 with the pyruvate 
dehydrogenase complex in these two cell lines (De Marcucci, 1985). 
However, under the conditions of immunoprecipitation used, there was no 
evidence of the antibodies raised against EMDH, LMDH or PGDC having any 
effect on the other enzyme activites (Table 12).
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4.3.4 Use of crosslinkers
Chemical crosslinkers have been used with great success in the study 
of subunit structures of oligomeric proteins (Davis 8c Stark, 1970;
Coggins, 1978). More recently, these reagents have been used to study 
'nearest neighbours' of mitochondrial enzymes in situ (D 'Souza 8c Srere, 
1983) and of ribosomal proteins (Maassen, 1979) as well as in studies on 
pyruvate dehydrogenase (Packman 8c Perham, 1982; Packman et al., 1982) 
and the enzymes in the glycosome of T.brucei (Aman et al., 1985). Of 
more relevance to the present study, Halpin et al. (1981) reported in vivo 
stabilisation of a putative complex of the mandelate enzymes from P.putida 
using the crosslinking reagent DMSI.
When the experiments conducted by Halpin et al. (1981) on P.putida 
were repeated (Table 6), their results were confirmed in that there was a 
5-50 fold increase in the specific activities of the 'soluble' mandelate 
enzymes recovered in the high speed pellet after DMSI treatment. However, 
this was not a specific effect since there was not only an increase in 
the mandelate enzymes but also an increase in the control enzymes CO,
ICDH and GS (Table 6). Haplin et al. (1981) reported a similar increase 
in the specific activities of CO and GS in the pellets after DMSI 
treatment (Table 7) but did not interpret this as indicating that non­
specific crosslinking had taken place. Unfortunately, Halpin et al.
(1981) did not express their results as a percentage of total enzyme 
activity but in fact only 2-9% of the 'soluble' enzymes was found in the 
high speed pellet whereas approx. 95% of IMDH was recovered in this 
fraction (Table 6).
On analysis of control and crosslinked complexes on gel-filtration 
chromatography, Halpin et al. (1981) suggested that there was an 'all 
or nothing' trapping of the high molecular weight complex of proteins 
since there was little evidence of dimers, trimers or tetramers of the 
individual enzymes and so concluded that the crosslinking was not
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completely random. However, when similar gel filtration experiments 
were carried out on Ultrogel AcA 34 which has a higher resolving power 
than Ultrogel AcA 22 which was used by Halpin et al. (1981), it could be 
seen that a substantial amount of non-specific crosslinking had taken 
place (Figure 21).
The results obtained with in vivo crosslinking of A. calcoaceticus 
(Table 8) were similar to those for P.putida (Table 6) in that only 
non-specific crosslinking was observed. It was thought that a specific 
effect could have been obtained if the bacteria were supplied with 
substrates and cofactors for the mandelate enzymes since if a transient 
complex exists it may only form in the presence of these factors. In 
order that the substrates and cofactors could enter the bacteria, they 
were treated with toluene in the presence of PEG (3.5.2). Toluene 
permeabilises the membrane (Beggs & Fewson, 1977) whereas PEG is thought 
to prevent cytoplasmic proteins leaking from the bacteria after 
permeabilisation (Matlib et al., 1977). Slightly more crosslinking 
was observed after toluene/PEG treatment and crosslinking was obtained 
in stationary phase bacteria (3.5.2), suggesting that the crosslinker 
cannot normally enter stationary phase bacteria. However, no specific 
cross linking was achieved in the presence of substrates and cofactors 
for the mandelate enzymes (3.5.2).
The inability to demonstrate specific cross linking between LMDH and 
PGDC in these in vivo experiments (3.5.2) may have been because TNM 
buffer, pH8.0 had been used[ to allow a direct comparison with the 
results reported by Halpin et al. (1981)]. Since the PGDC tetramer 
from A.calcoaceticus is known to dissociate at this pH (Barrowman, 1982) 
there is the possibility that the buffer conditions used (TNM buffer, 
pH8.0) are detrimental to any enzyme interactions which may occur. 
Furthermore, differential centrifugation may be an inadequate method for 
detecting crosslinking especially since only 60% LMDH was recovered in
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the pellet fraction in these ecperiments (Table 8) and so there is the 
possibility that’ PGDC had been crosslinked to this ’soluble' species of 
LMDH. It is generally thought that a high pH ( > 8.0) is required for 
the activity of the dimethylimidate crosslinkers. However, a method 
was developed which allowed cross linking with DMSI and DMPI at pH7.5 
(Figure 27). Furthermore, control and crosslinked extracts were 
analysed by inmunoblotting with antibodies raised against DMDH, LMDH 
and PGDC (3.5.10). Although sane non-specific crosslinking was expected 
(on the basis of the earlier in vivo experiments, 3.5.2) it was 
anticipated that any significant specific crosslinking would be detected 
by immunoblotting.
In the first instance these experiments were carried out on 
crosslinked French press homogenates (Figure 28) but similar results were 
obtained after analysing extracts prepared after in vivo crosslinking at 
pH7.5 by immunoblotting (3.5.13). The results obtained (Figure 28) 
confirmed that the crosslinking reaction had taken place since high Mr 
species were detected with anti-LMDH, anti-PGDC and anti-DMDH although 
in the latter case, it appeared that DMDH had been cross linked to a 
variety of species with different Mr values. There was also evidence 
of intra-molecular crosslinking of DMDH (Figure 28). In addition to 
others, there was a band with an apparent of 100,000 and one of
98.000 in the imnunoblots obtained with anti-LMDH and anti-PGDC 
respectively (Figure 28). If LMDH and PGDC associate, one would expect 
to see a band with an apparent Mr of 102,000 [by addition of the M of 
LMDH (44,000) and that of PGDC (58,000) and assuming that crosslinked 
proteins do not behave differently from uncross linked proteins on SDS 
PAGE] on both the blots obtained with anti-LMDH and anti-PGDC. To 
try to establish whether the band with an apparent Mr of approx.
100.000 was a crosslinked species of LMDH and PGDC or due to crosslinking 
of both enzymes to some other unknown species, a sample with no LMDH
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activity but with PGDC activity and conversely, one with LMDH activity 
but no PGDC activity were crosslinked (Figure 29). The same pattern was 
obtained as before (Figure 28), in that anti-IMDH reacted with a protein 
with an apparent Mr of 100,000 and anti-PGDC gave a positive reaction
with a species with an apparent Mr of 98,000 whether or not PGDC or LMDH
activity, respectively, was present (Figure 29) and so it can be concluded 
that LMDH and PGDC were crosslinked to some other cellular component but 
not to each other. The non-specificity of crosslinking with DMSI was 
also confirmed by analysing control and DMSI treated French press
homogenates by gel filtration chromatography (Figure 30).
The dimethylimidate crosslinking reagents react with lysine residues 
on proteins and crosslinking between adjacent proteins takes place if there 
are two lysine residues, one on each protein, situated a fixed distance 
apart (dictated by the length of the crosslinking reagent)(Coggins, 1978). 
Even although several dimethylimidates of different lengths were studied 
(3.5.2), no specific crosslinking between LMDH and PGDC was observed and 
this may have been because there were no lysine residues in the correct 
positions. The effect of PDM, a bifunctional reagent which reacts with 
sulphydryl groups (Reisler et al., 1974), was studied in the hope that 
there would be two suitably positioned sulphydryl groups on LMDH and 
PGDC (3.5.14). However, there was no evidence of specific crosslinking 
of LMDH and PGDC when either intact bacteria or French press homogenates 
were treated with PDM (3.5.14).
4.3.5 Conclusions
This study (3.5) illustrates the difficulties in investigating weak 
protein interactions. Although several approaches have been used to 
study enzyme interactions in the mandelate pathway in A.calcoaceticus, 
there is only one positive piece of evidence (Figures 23 Sc 24) which 
indicates that PGDC interacts with the membrane fraction. It is not 
possible to say with certainty that LMDH and PGDC do not specifically
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interact because the trouble with negative results in these studies is that 
there is always the possibility that the correct conditions had not been 
found or that the techniques available are inadequate for demonstrating weak 
protein interactions. The results obtained on differential centrifugation 
of French press homogenates (Figures 23 Sc 24) may be due to an inherent 
' stickiness1 of the PGDC molecule which is accentuated at high protein 
concentrations. There is also the possibility that PGDC interacts 
specifically with another unknown membrane component and that LMDH and 
PGDC are linked via this unknown species.
4.3.6 Future experiments
Two major questions remain to be answered:
1) Do enzyme interactions take place in prokaryotes?
Since there is the possibility that enzyme interactions are disrupted 
on breaking bacteria it may not be possible to isolate such complexes and 
so elucidation of enzyme intractions may have to rely on indirect 
approaches including studies using purified enzymes (Srere, 1985).
However, there are many difficulties in translating from the binding
properties of purified enzymes in vitro to the realities and complexities
in the cellular environment. This notwithstanding, evidence for the 
specificity of enzyme interactions may be achieved using purified enzymes 
either in solutions which mimic cellular conditions e.g. PEG mimics 
high protein concentrations (Fahien Sc Kmioteck, 1979; Sumegi et al.,
1985; Datta et al., 1985) or immobilised on Sepharose columns either 
directly or via antibodies (Koch-Schmidt et al., 1977; Mosbach, 1978; 
Mosbach Sc Mattiasson, 1978). Such studies have not been carried out 
on the mandelate enzymes because of the low yields of the purification 
procedures it has not yet been possible to purify sufficient amounts of
DMDH, LMDH or PGDC (Section 3.2; Barrowman Sc Fewson, 1985; Allison et al.,
1985b). Perhaps after the mandelate genes have been cloned and 
overexpressed and the mandelate dehydrogenases and PGDC have been
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purified in much greater quantities, it may be possible to determine 
whether these enzymes interact specifically or not. In addition, 
binding studies with purified PGDC and inner membranes could be carried 
out.
2) If enzyme interactions take place in the cell, what advantages,
if any, do they confer on the cell?
Some of the possible advantages of enzyme interactions discussed 
in the Introduction (1.5.2) may be illustrated using purified enzymes 
co-precipitated in PEG solutions (Datta et al., 1985) or co-immobilised 
on inert matrices (Srere et al., 1973; Koch-Schmidt et al., 1977); 
e.g. Datta et al. (1985) have demonstrated substrate channeling of 
oxalacetate in a complex of malate dehydrogenase and citrate synthase 
which had been precipitated from a PEG solution. In addition, mutants 
may prove useful in these studies, e.g. if a mutated protein is unable 
to interact with the next enzyme of a pathway then such a mutant would 
not experience the possible advantages of enzyme interactions (1.5.2).
Owing to the possibility that conditions used in experiments on 
purified enzymes may be so far removed from cellular conditions that such 
studies are of no physiological significance, a better understanding of 
metabolic compartmentation could possibly be obtained from in vivo 
isotope tracer experiments (Shipley & Clark, 1972; Srere & Mosbach, 1974; 
Ottaway & Mowbray, 1977; Bharagava, 1985; Bernhard Sc Srivastava, 1986). 
The disadvantages relating to difficulties in the interpretation of such 
experiments discussed in the Introduction (1.5.2b) may partly be overcome 
by the development of high resolution techniques, such as HPLC, and by 
the increased sensitivity of techniques such as NMR, for the detection 
of labelled intermediates. In addition, a thorough knowledge of the 
effectors controlling the individual enzymes and their effect on the 
flux through the system under study would be required for any meaningful 
interpretation of data from isotope tracer experiments. Perhaps it will
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only be worth studying the possibility of enzyme interactions in systems 
where substrate channeling can be demonstrated.
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